CUA 2012: Final Programme

GENERAL INFORMATION
RENSEIGNEMENTS GNRAUX
TABLE OF CONTENTS / TABLE DES MATIRES
SPONSORS AND EXHIBITORS / COMMANDITAIRES ET EXPOSANTS
Message from the Co-chairs of the Local Organizing Committee . . . . . . . 1 Message from the CUA President . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 CUA Executive & Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Continuing Professional Development . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Future CUA Meetings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 Floor Plan of the Fairmont The Banff Springs Hotel . . . . . . . . . . . . . . . . 10 Social Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 CUASF Fun Run/Walk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 Companions' Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 Kids' Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Mot de bienvenue des co-prsidents du Comit organisateur local . . . . 17 Mot de bienvenue du Prsident de l'AUC . . . . . . . . . . . . . . . . . . . . . . . . 18 Membres de l'xcutive et Comits de l'AUC . . . . . . . . . . . . . . . . . . . . . 19 Renseignements gnraux . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Dveloppement professionnel continu . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Congrs futurs de l'AUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Plan du Fairmont Banff Springs Hotel . . . . . . . . . . . . . . . . . . . . . . . . . . 26 Programme Social . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 Course et marche amicale au profit de la FBAUC . . . . . . . . . . . . . . . . . . 30 Programme des accompagnateurs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 Programme Jeunesse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
CUA 2012 B A NFF
CUA Sponsors 2012 / Commanditaires de lAUC 2012 . . . . . . . . . . . . . . 33 CUASF 2012 Sponsors / Commanditaires de la FBAUC 2012 . . . . . . . . . 34 Sponsored Sessions / Sances commandites . . . . . . . . . . . . . . . . . . . 35 Exhibit Information / Renseignements sur l'Exposition . . . . . . . . . . . . . . 36 Exhibit Floor Plan / Plan de l'exposition . . . . . . . . . . . . . . . . . . . . . . . . . 37 Exhibitor Listing / Liste des exposants . . . . . . . . . . . . . . . . . . . . . . . . . . 38 Exhibit Directory / Rpertoire des exposants . . . . . . . . . . . . . . . . . . . . . 39
SCIENTIFIC PROGRAM / PROGRAMME SCIENTIFIQUE DETAILED PROGRAM / PROGRAMME DTAILLS INDEX
TABLE OF CONTENTS / TABLE DES MATIRES
Invited Faculty / Confrenciers invits . . . . . . . . . . . . . . . . . . . . . . . . . . 63 CUA Prize Essays / Travaux prims de l'AUC . . . . . . . . . . . . . . . . . . . . . 64 CUA and Affiliated Meetings / Runions des socits affilies et des comits de l'AUC . . . . . . . . . . . . 65 Canadian Academy Of Urological Surgeons (CAUS) Banff 2012 . . . . . . . 68
Friday / Vendredi - June 22 juin . . . . . . . . . . . . . . . . . . . . . . 69 Saturday / Samedi - June 23 juin . . . . . . . . . . . . . . . . . . . . . 70 Sunday / Dimanche - June 24 juin . . . . . . . . . . . . . . . . . . . . 73 Monday / Lundi - June 25 juin . . . . . . . . . . . . . . . . . . . . . . . 83 Tuesday / Mardi - June 26 juin . . . . . . . . . . . . . . . . . . . . . . . 93 Unmoderated Posters / Posters non-modrs . . . . . . . . . . . 127 Disclosures / Divulgations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxx
CUA 2012 BA NFF
Invited Speakers Index / Index des confrenciers invits . . . . . . . . . . . . xx Presenters Index / Index des prsentateurs . . . . . . . . . . . . . . . . . . . . . . xx
MESSAGE FROM THE CO-CHAIRS OF THE LOCAL ORGANIZING COMMITTEE Well it is finally upon usCUA 2012. Welcome to Banff! As we have been promising all year we have quite a meeting in store for you. The academic sessions are filled with many educational opportunities and the nights are filled with things that will provide an opportunity for relaxation and enjoyment. I expect you may hear the mountains and meadows calling to you from the meeting, so be sure to answer, because it is a world of wonder out there. Come and learn lots, get involved, and catch up with old friends and new. But most of all HAVE FUN!
Marty & Howard
Co-chairs, CUA 2012 Local Organizing Committee
CUA 2012 B A NFF
MESSAGE FROM THE CUA PRESIDENT
Welcome to the 67th Annual Meeting CUA Meeting in beautiful Banff Alberta, the crown jewel of the Canadian Rockys. Our host hotel is the historic Fairmont Banff Springs Hotel. Its castle like design nestled along the banks of the Bow River is stunning and will provide the perfect venue for our gathering Drs. Jay Lee and Trevor Schuler and their Scientific Committee have planned the scientific portion of the meeting with a superb list of speakers and engaging educational fora. Drs. Howard Evans and Marty Duffy, Chairs of the Local Organizing Committee (LOC), have worked hard to create an entertaining social program for us to enjoy after a hard day at the office. 2 As President of the CUA, it is my pleasure to welcome you to Banff and to wish you a wonderful and productive CUA Annual Meeting. Michael Chetner President, CUA
CUA 2012 BA NFF
EXECUTIVE COMMITTEE ANNUAL MEETING PLANNING COMMITTEE
CUA EXECUTIVE AND COMMITTEES
AWARDS COMMITTEE
President President-Elect Past-President Vice-President Treasurer
Michael Chetner Joseph Chin Sender Herschorn Peter Anderson Anne Marie Houle Secretary Denis Lavoie Secretary-Elect Karen Psooy VP Education Gerald Brock Members-at-Large Greg Bailly
British Columbia
BY-LAWS COMMITTEE
John Dushinski
Prairies Ontario
Vladimir Kurgansky Christopher Morash

Qubec Atlantic
CONTINUING PROFESSIONAL DEVELOPMENT COMMITTEE ENDORSEMENT COMMITTEE
Peter Anderson, Chair John-Paul Capolicchio Michael Chetner Denis Lavoie John Mahoney
Joseph Chin, Chair Michael Chetner Sender Herschorn Denis Lavoie
Andrew McNeilly
Franois Bnard, Chair Kevin Carlson Marc Anthony Fischer Scott Murray Thomas Whelan
Gerald Brock, Chair Armen Aprikian Franois Bnard Ian Brown Serge Carrier Michael Chetner Joseph Chin Marty Duffy Howard Evans Dianne Heritz Jonathan Izawa Anil Kapoor Denis Lavoie Jay Lee Tiffany Pizioli Nadia Pace Trevor Schuler
Sender Herschorn, Chair Peter Anderson Gerald Brock Michael Chetner Joseph Chin Anne-Marie Houle Denis Lavoie
CUA 2012 B A NFF
FINANCE COMMITTEE HISTORIAN
GUIDELINES COMMITTEE
INFORMATION TECHNOLOGY COMMITTEE
LOCAL ORGANIZING COMMITTEE NOMINATING COMMITTEE PATIENT INFORMATION COMMITTEE PRIZE ESSAY COMMITTEE
Anne-Marie Houle, Chair Gerald Brock Ian Brown Michael Chetner Joseph Chin Marty Duffy Howard Evans Denis Lavoie Rob Siemens
Marty Duffy and Howard Evans, Co-Chairs
Sender Herschorn, Chair Peter Black John-Paul Capolicchio Joe Chin Jay Lee Dawn MacLellan Yves Fradet
Antonio Finelli, Chair Greg Bailly John Dushinski Vladimir Kurgansky Christopher Morash Andrew MacNeily 4
Vacant
Christopher Nguan, Chair Mike Leveridge
CUA 2012 BA NFF
Ben Chew, Chair Nafisa Dharamsi Samer Hanna Jay Lee Rob Siemens Troy Sitland Thomas Whelan
Jay Lee and Trevor Schuler, Co-Chairs Armen Aprikian Franois Bnard Jonathan Izawa Anil Kapoor Dawn MacLellan Ryan Paterson
POST-GRADUATE TRAINING COMMITTEE
SCIENTIFIC COMMITTEE
CUASF EXECUTIVE COMMITTEE CUASF ADMINISTRATIVE COMMITTEE CUASF SCIENTIFIC COUNCIL
Joseph Chin, Chair Turki Al-Essawi Greg Bailly Diego Barrieras Gerald Brock Bill Gourlay Anil Kapoor Wassim Kassouf Yves Ponsot Keith Rourke Rob Siemens Rob Stewart Frederic Soucy Jim Watterson
SOCIO-ECONOMIC COMMITTEE
CUA/ASTELLAS GRANT PROGRAM, SCIENTIFIC COUNCIL
Michael Chetner, Chair Anne-Marie Houle Denis Lavoie Ricardo Rendon Robert Siemens
Robert Siemens, Chair Anne-Marie Houle Jun Kawakami Chris Morash Paul Whelan
Ricardo Rendon, Chair Luis Guerra Wassim Kassouf Patrick Luke Ron Moore Alan So
Darrel Drachenberg, Chair Lorne Aaron Scott Bagnell Jack Barkin Greg Kozak Alan So
Peter Black Leslie Carr Serge Carrier Jonathan Izawa Jay Lee Andrew MacNeilly Bobby Shayegan
CUA 2012 B A NFF
VENUE
The Fairmont Banff Springs Hotel is the CUA Annual Meeting headquarter hotel and meeting venue. All scientific program activities listed take place at the hotel, unless otherwise indicated. The Fairmont Banff Springs Hotel 405 Spray Avenue Banff, AB, T1L 1J4 (403) 762-6866
ADMISSION POLICIES
GENERAL INFORMATION
Registered teens and children have access to the Opening Brunch as well as the following activities and meals: EXHIBIT HALL
1 Activities, snacks and dinner on Sunday
Name badges are required to gain access to all meeting functions. Tickets must be presented at social events and optional events. Registration categories are indicated by the colour band of the badge holder included in the registration package. Tickets for social and optional activities are included in the package. Upon claiming your registration material, please ensure that all of the activities you purchased have been included, and that your badge holder correctly corresponds to the legend below: Full Program (Scientific & Social) . . . . Blue Scientific Program Only . . . . . . . . . . . Red Industry . . . . . . . . . . . . . . . . . . . . . . Green Companion . . . . . . . . . . . . . . . . . . . Yellow Media . . . . . . . . . . . . . . . . . . . . . . . . Black Full Program delegates and companions have access to the Opening Brunch, Fun Night, Presidents Reception and Banquet. Registered companions are entitled to daily breakfast in the Companions Lounge.
CUA 2012 BA NFF
BOOK OF ABSTRACTS at the Kid's lounge
CERTIFICATE OF ATTENDANCE at the Kids'lounge (from 14:00)

2 Breakfast on Monday and Tuesday
3 Activities, snacks and lunch, on Monday
and Tuesday at the Banff Springs Hotel Kids' Club (8:45 to 16:30) 4 Monday night dinner and activities at the Kids' lounge
Delegates registered for the Scientific Program Only may purchase tickets to the social optional events in the main registration area.
The book of abstracts is included in the delegate bag. It is published by the Canadian Urological Association Journal (CUAJ).
A personalized certificate of attendance will be available via email after the event. This certificate can be used to claim CPD credits.
The Canadian Urological Association and the Local Organizing Committee wish to express their gratitude to the companies who have given their support to this meeting by taking part in the Exhibit. We invite you to visit our Industry partners and gain valuable, up-to-date knowledge of their products and services. Please refer to the Sponsors/Exhibitors section of this Program for a complete list and floor plan. The Exhibit Hall is located in Van Horne BC and will be open during the following hours: Sunday, June 24. . . . . . . . . . . . 0800-1700 Monday, June 25 . . . . . . . . . . . 0800-1530
GENERAL INFORMATION
INTERNET LIABILITY LOST AND FOUND PHOTOGRAPHS REGISTRATION DESK
SPEAKER READY ROOM UNMODERATED POSTER DISPLAYS 5-STAR POSTERS

Room: NR Crump
Wireless Internet is available on the convention level of the hotel. Please verify the housekeeping notes for the password.
The CUA Banff 2012 Annual Meeting and the Secretariat IS Event Solutions cannot accept responsibility for any accidents, injuries or illness that may occur during the Annual Meeting.
All podium, moderated video, moderated poster, educational fora and invited lecture presenters with PowerPoint slides and videos are asked to check in at the Speaker Ready Room, located in the NR Crump room, 24 hours before their scheduled talk. Saturday, June 23 . . . . . . . . . . 1300-1800 Sunday, June 24. . . . . . . . . . . . 0630-1730 Monday, June 25 . . . . . . . . . . . 0630-1700 Tuesday, June 26 . . . . . . . . . . . 0630-1600 A technician will be at the speakers disposal to assist with any audio-visual queries. Speakers are asked to bring their files on portable media devices (USB stick, flashcard, CD, etc.). The use of individual laptop computers is prohibited.
Found items should be handed in promptly to staff at the Registration Desk.
Souvenir photographs taken at the Annual Meeting will be posted online after the event.
The Registration Desk is located in the Hotels Convention Center, across the street from the Hotels main building. Hours of operation are as follows: Saturday, June 23 . . . . . . . . . . 1100-1800 Sunday, June 24. . . . . . . . . . . . 0630-1700 Monday, June 25 . . . . . . . . . . . 0630-1800 Tuesday, June 26 . . . . . . . . . . . 0630-1630
Unmoderated e-poster stations will be available in the Presidents Hall Foyer from 0930 on Sunday, June 24, until Tuesday, June 26, at 1400.
The moderators of each Moderated Poster session will select 5-star posters. The 5-star poster presenters will be announced in the Closing Session at 1600 on Tuesday, June 26.
CUA 2012 B A NFF
LEARNING OBJECTIVES AND CANMEDS ROLE COMPETENCIES OBJECTIVES
GOAL
CONTINUING PROFESSIONAL DEVELOPMENT
The goal of this program is to provide a forum to identify and discuss "state-ofthe-art" information concerning urological diseases, including the prevention diagnosis and treatments, and to support basic science and clinical research by urologists and other healthcare professionals.
1 To Identify modifications in SWL treatment protocols designed to maximize efficacy and decrease morbidity 2 To Identify techniques to optimize preoperative planning and intraoperative implementation of percutaneous renal access 3 To discuss relevant epidemiologic studies on patient safety 4 To review complications of medical management of kidney stone disease including medication interactions and side effects 5 To understand the methodology of analysis regarding the literature supported recommendations presented on urethral reconstruction 6 Gain an appreciation for the treatment of pelvic fracture urethral distraction defects (PFUDD) 7 Discuss the diagnosis and treatment of common genital injuries 8 To better understand the Regional Differences in Practice Patterns and Outcomes after Radical Cystectomy 9 To identify long term side effects of testis cancer chemotherapy 10 To conduct a critical evaluation of the treatment strategies for superficial Bladder cancer 11 To better understand the Understand the morbidity of cystectomy and the alternatives to this this surgery in bladder cancer 12 To discuss rules and regulations regarding diet and supplement for men's health 13 To discuss clinical studies that support or doe not support recommending specific dietary changes and supplements to your patients
CUA 2012 BA NFF
MoCert CREDITS
14 To understand how potential risks (side effects /complications) of medical and surgical intervention for benign prostatic enlargement drives patient decision making 15 To gain an awareness of how to prevent the development of LUTS through lifestyle management 16 To learn that long term financial implications of medical and surgical management for benign prostatic enlargement does not play a role in current decision making 17 To understand the future health problems for men with infertility (higher risk of cancer etc.) 18 To Appreciate the technical aspects of current sling procedures that can be incorporated into surgical armamentarium 19 Formulate a rational and effective plan for the evaluation and treatment of elderly patients with OAB symptoms 20 To correlate clinical findings of VUR with its genetic basis 21 To review the evidence for and against the use of 5-ARI in prostate cancer prevention 22 To better understand Need for Intervention and Survival in a Cohort of Patients on Active Surveillance (AS) for Low-risk Prostate Cancer 23 To Assess state-of-the-art management of CRCP, both in terms of guidelines as well as novel agents that will be available in the near future 24 To assess the existing scientific support for use of PDE5i's in BPH/LUTS 25 To discuss ethics in surgery and professional applications of these concepts
This program has been accredited by the CUA as a Section 1 Group Learning Activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. For the specialist, this activity qualifies for 1 credit per hour of participation as articulated in Section 1 of the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada for a maximum of 22 credits. Participants should only claim the credit corresponding to their attendance.
FUTURE CUA MEETINGS

2013 2014
68th CUA 69th CUA

JUNE 23-25
JUNE 29-JULY 1
2015 2016 2017
Niagara Falls, ON Sheraton on the Falls Hotel
70th CUA 71st CUA

JUNE 28-30 JUNE 26-28 JUNE 25-27
St. Johns, NL Delta St. Johns Hotel & Conference Center
72nd CUA
Ottawa, ON The Westin Ottawa Hotel
Vancouver, BC The Westin Bayshore Hotel 9
Toronto, ON Westin Harbour Castle Hote

CUA 2012 B A NFF
2016 VANCOUVER
2014 ST. JOHNS
2015 OTTAWA
2017 TORONTO
2013 NIAGARA FALLS
FLOOR PLAN OF THE FAIRMONT BANFF SPRINGS HOTEL
10
CUA 2012 BANFF
SOCIAL PROGRAM GRID
TIME
SOCIAL PROGRAM
COMPANION'S PROGRAM
KID'S PROGRAM
SUNDAY, JUNE 24
0800-1100
1130-1230
Breakfast & Private concierge Services

Companion's Lounge: Oak room
Opening Brunch VanHorne BC
1400-2200
FUN NIGHT Rockies & Rail
Fun Activities, Dinner & Entertainement

Kid's lounge: Norquay room
1900-2230
The Fairmont Banff Springs Hotel Riverview Lounge, Alberta & New-Brunswick rooms
MONDAY, JUNE 25
0700-0845
Breakfast
Kid's Lounge: Norquay room
0800-1100
0845-1630

1630-2300
President's Reception & Banquet Fire & Ice Ball / Cocktail at 18:30
The Fairmont Banff Springs Hotel Alberta room
1900-2300
TUESDAY, JUNE 26
CUASF Fun Run/Walk
0630-0730
0700-0845
Lobby The Fairmont Banff Springs Hotel
0800-1100
Breakfast & Private concierge Services:
0845-1630
CUA 2012 B A NFF
Fun Activities
Banff Springs Kid's Club
Fun Activities, Dinner & Entertainement
Kid's lounge: Norquay room
Breakfast
Kid's Lounge: Norquay room
Fun Activities
Banff Springs Kid's Club
11
S UNDAY , J UNE 24
SOCIAL PROGRAM
All Social Events are by ticket admission / registration badge only. Additional Social Event tickets are available for purchase at the Registration Desk.
1900-2230 CUA Fun Night Rockies & Rail

The Fairmont Banff Springs Hotel Riverview Lounge, Alberta & New Brunswick Room
1130-1230 Opening Brunch

Exhibit Hall Van Horne BC
Included for Full Program delegates and registered companions. Cost of additional ticket: $125, plus tax All aboard! For the first-time in CUA history, the Fun Night will take place on Sunday evening, once the exhibit hall closes and the sessions are over. You can expect a full house filled with CUA members and partners in industry. Eat, dance and relive the Golden Age of the Canadian Rockies at the grandiose Banff Springs Hotel, while the Livin in Swing band takes you back in time! This six-piece band will have attendees on their feet and dancing the night away. Playing Swing music as well as a variety of other tunes, this ensembles lively flair also has an extensive repertoire of sing along melodies. Let yourself be taken back in time in a fashionable dcor and savor the many flavors of the Great-Canadian-West with Buffalo mini-burgers, beef tenderloin pies, cedar planked salmon just to name a few. The night is sure to make CUA Fun Night history as we have a multitude of surprises planned which will keep you on the edge of your seat!
Included for all registered participants After a session-filled morning, CUA 2012 officially kicks off with a meetand-greet brunch in the Exhibit Hall. Catch up with friends you haven't seen since the last CUA meeting in Montreal and prepare yourself for 3 full days of exciting scientific updates. An assigned CUA concierge will be able to make restaurant reservations for you during the day on Sunday, June 24. 12
CUA 2012 BANFF
M ONDAY , J UNE 25 1900-2300 President's Reception and Banquet The CUA Fire & Ice Ball (Cocktails at 1830)
Alberta & New Brunswick room The Fairmont Banff Springs Hotel
SOCIAL PROGRAM
Included for Full Program delegates and registered companions. Cost of additional ticket: $150, plus tax The LOC Chairs have planned an event that will incorporate some of natures elements; let your senses take over and expect the unexpected! Join us to salute and to pay tribute to the Local Organizing Chairs, the Scientific Committee and CUA President, Dr. Michael Chetner, and to welcome the new CUA 2013 cast who are enthusiastically preparing to greet you in Niagara Falls! This years Presidents Reception and Banquet featuring a tantalizing 4-course dinner will bring you to a world where Fire & Ice create an explosion of dazzling beauty and refinement. Gentlemen, pull out your tuxedos and ladies, wear THAT stunning dress that will surprise and astonish! With the meeting drawing to an end, take some time to reflect on the previous 3 days of sessions and start looking forward to next year's meeting.
CUA 2012 B A NFF
13
TUES DAY , J UNE 26
CUASF FUN RUN/WALK
0630-0730 CUASF Charity Run/Walk *A fee of $50 applies (non-taxable) CUA will hold a Charity Run & Walk to support the Canadian Urological Association Scholarship Fund (CUASF) for a third time. The objective of the CUASF is to provide financial support for urologic research to be conducted in Canada. 14 Participants can choose a 2km walk or a 5km fun-run through the streets of Banff. Strike up some friendly competition as we band together to support this important CUA initiative! All proceeds will be donated to the CUASF.
CUA 2012 BANFF
COMPANIONS PROGRAM
COMPANIONS LOUNGE 1 Welcome gift 2 Access to Exhibit Hall 3 Daily breakfast in
Registration for companions includes:
TUESDAY, J UNE 26
0630-0730 CUASF Charity Run/Walk *A fee of $50 applies (non-taxable)

See page 18 for details.
Companions Lounge
4 Exhibit Opening and Opening
Brunch (Sunday) 5 Fun Night (Sunday) 6 Presidents Reception & Banquet (Monday)
Companions are invited to use the Lounge at the Fairmont Banff Springs Hotel to meet friends and enjoy the daily continental breakfast. The Lounge will be open Sunday, Monday & Tuesday, from 08:00-11:00. A private CUA concierge is posted in the Lounge during opening hours on Sunday, Monday and Tuesday to assist you in making your stay a memorable one. Information & Tour booking will be available on-site. If you are interested in visiting the Fairmont Banff Springs Hotel internationally acclaimed Willow Stream Spa, please contact the hotel Concierge desk, located in the hotel lobby.
CUA 2012 B A NFF
15
KIDS LOUNGE
KIDS PROGRAM
KIDS PROGRAM HOURS BABYSITTING
The 2012 CUA Kids Program will be extra-special as the Fairmont Banff Springs features a fantastic kids club which will be open for CUAs kids on Monday and Tuesday. The Banff Springs Kids Club, the hotels activity hub for kids, will be the star attraction for our young guests between the ages of 6 and 16 years old. The Kids Club offers supervised activities with enthusiastic camp leaders. Every day is a new adventure and each child receives a complimentary Banff Springs Kids Club ball cap, nametag, and lanyard on their first visit.
Sunday, June 24 Fun Activities in Kids Lounge......................14:00-23:00 Monday, June 25 Breakfast in Kids Lounge ..07:00-08:45 Activities at the Banff Springs Kids Club..............08:45-16:30 Dinner & Entertainment......16:30-23:00 Tuesday, June 26 Breakfast in Kids Lounge ..07:00-08:45 Activities at the Banff Springs Kids Club..............08:45-16:30
Outdoor activities will focus on learning new wilderness skills like navigation, emergency survival and cooking over an open fire. Inside, the centre has plenty of great games, crafts and activities to keep kids entertained. Registration for Kids Program includes: 1 Welcome kit
2 Activities from 14:00 on Sunday at
CUA 2012 BANFF
16
A babysitting service is available starting from 16$/hour for up to 2 children, and a minimum of 4 hours. The caregiver can look after the children in the room or take them to different hotel activities (swimming, bowling, movie theatre, etc...) Advance reservations are required and may be made through the concierge at bsh.concierge@fairmont.com. A 24-hour cancellation policy applies to all reservations.
the Kids Lounge & Tuesday
3 Breakfast in Kids Lounge on Monday 4 Bowling & pizza on Sunday evening 5 Dinner and movie night on Monday 6 Two full-days of activities on Monday
and Tuesday indoor and outdoor at the hotels Kids Club Tuesday at the hotels Kids Club.
7 Lunch and snacks on Monday and
MOT DE BIENVENUE DES CO-PRSIDENTS DU COMIT ORGANISATEUR LOCAL Finalement, nous y voil...AUC 2012. Bienvenue Banff! Comme nous vous l'avions promis toute l'anne, nous avons tout un congrs en rserve pour vous, en passant par un programme scientifique des plus complet, vous permettant de saisir de nombreuses opportunits ducatives de qualits, jusqu' nos clbres soires remplies comme toujours de moments mmorables! Comme nous sommes certains que vous entendrez l'appel des montagnes rocheuses et de leurs prs verdoyants, nous vous suggrons fortement d'tre prt y rpondre sans faute, car vous tes entours d'un monde de merveilles dcouvrir...ou redcouvrir. Apprenez, dcouvrez, paulez et revoyez d'anciennes connaissances ainsi qu' vous en faire de nouvelles. Mais surtout, surtout, amusez-vous!'
Marty & Howard
Co prsidents, CUA 2012 Comit scientifique
CUA 2012 B A NFF
17
MOT DE BIENVENUE DU PRSIDENT DE L'AUC
Bienvenue au 67e Congrs annuel de lAUC, dans la magnifique ville de Banff en Alberta, le joyau des Rocheuses canadiennes. Notre hte est lhtel historique Fairmont Banff Springs. Son architecture semblable celle dun chteau blotti sur la rive de la rivire Bow est tout fait impressionnante et offre un lieu de runion idal. Les docteurs Jay Lee et Trevor Schuler, ainsi que les membres de leur comit scientifique ont prpar dans le cadre de ce congrs un programme scientifique qui prvoit une liste impressionnante de confrenciers ainsi quun forum ducatif des plus intressants. Les docteurs Howard Evans et Marty Duffy, prsidents du comit local dorganisation ont dploy tous les efforts pour mettre sur pied un programme social notre intention, aprs une dure journe de travail. En qualit de prsident de lAUC, je suis trs heureux de vous souhaiter la bienvenue Banff et je vous souhaite un magnifique congrs annuel de lAUC, intressant et fructueux. Michael Chetner Prsident, CUA
CUA 2012 BANFF
18
COMIT EXCUTIF
COMIT DE PLANIFICATION DU CONGRS ANNUEL

Les Prairies Ontario Qubec Atlantic
MEMBRES DE L'EXCUTIF ET COMITS DE L'AUC
COMIT DES PRIX
Prsident Michael Chetner Prsident dsign Joseph Chin Prsident Sortant Sender Herschorn Vice-prsident Peter Anderson Trsorier Anne Marie Houle Secrtaire Denis Lavoie Secrtaire dsign Karen Psooy Vice-prsident Education Gerald Brock Excutifs extraordinaires Greg Bailly
Colombie-Britannique
COMIT DES RGLEMENTS
John Dushinski Vladimir Kurgansky Christopher Morash Andrew McNelly
COMIT DU DVELOPPEMENT PROFESSIONNEL CONTINU COMIT DES APPROBATIONS
Peter Anderson, Chair John-Paul Capolicchio Michael Chetner Denis Lavoie John Mahoney
Joseph Chin, Chair Michael Chetner Sender Herschorn Denis Lavoie
Franois Bnard, Chair Kevin Carlson Marc Anthony Fischer Scott Murray Thomas Whelan
Gerald Brock, Chair Armen Aprikian Franois Bnard Ian Brown Serge Carrier Michael Chetner Joseph Chin Marty Duffy Howard Evans Dianne Heritz Jonathan Izawa Anil Kapoor Denis Lavoie Jay Lee Tiffany Pizioli Nadia Pace Trevor Schuler
Sender Herschorn, Chair Peter Anderson Gerald Brock Michael Chetner Joseph Chin Anne-Marie Houle Denis Lavoie
CUA 2012 B A NFF
19
COMIT DES DES FINANCES COMIT DES GUIDES DE PRATIQUE HISTORIEN
COMIT DES TECHNOLOGIES DE L'INFORMATION
COMIT ORGANISATEUR LOCAL COMIT DES NOMINATIONS COMIT INFO-PATIENTS COMIT DES TRAVAUX PRIMS
Anne-Marie Houle, Chair Gerald Brock Ian Brown Michael Chetner Joseph Chin Marty Duffy Howard Evans Denis Lavoie Rob Siemens
Marty Duffy and Howard Evans, Co-Chairs
Sender Herschorn, Chair Peter Black John-Paul Capolicchio Joe Chin Jay Lee Dawn MacLellan Yves Fradet
Antonio Finelli, Chair Greg Bailly John Dushinski Vladimir Kurgansky Christopher Morash Andrew MacNeily 20
Vacant
Christopher Nguan, Chair Mike Leveridge
CUA 2012 BANFF
Ben Chew, Chair Nafisa Dharamsi Samer Hanna Jay Lee Rob Siemens Troy Sitland Thomas Whelan
COMIT DES AFFAIRES DES RSIDENTS COMIT SCIENTIFIQUE
COMIT EXCUTIF DE LA FBAUC CONSEIL D'ADMINISTRATION DE LA FBAUC CONSEIL SCIENTIFIQUE DE LA FBAUC
Joseph Chin, Chair Turki Al-Essawi Greg Bailly Diego Barrieras Gerald Brock Bill Gourlay Anil Kapoor Wassim Kassouf Yves Ponsot Keith Rourke Rob Siemens Rob Stewart Frederic Soucy Jim Watterson
COMIT SOCIOCONOMIQUE
CUA/ASTELLAS GRANT PROGRAM, SCIENTIFIC COUNCIL
Michael Chetner, Chair Anne-Marie Houle Denis Lavoie Ricardo Rendon Robert Siemens
Robert Siemens, Chair Anne-Marie Houle Jun Kawakami Chris Morash Paul Whelan
Ricardo Rendon, Chair Luis Guerra Wassim Kassouf Patrick Luke Ron Moore Alan So
Darrel Drachenberg, Chair Lorne Aaron Scott Bagnell Jack Barkin Greg Kozak Alan So
Peter Black Leslie Carr Serge Carrier Jonathan Izawa Jay Lee Andrew MacNeilly Bobby Shayegan
CUA 2012 B A NFF
21
SIGE DU CONGRS ADMISSION
Toutes les activits du programme scientifique ci-dessous s'y droulent, moins d'indication contraire. Le Fairmont Banff Springs Hotel 405, Spray Avenue Banff, AB, TIL 2J4 (403) 762-6866
Vous devez porter votre badge pour entrer au congrs. Vous devez prsenter votre billet lors des vnements sociaux facultatifs. La catgorie d'inscriptions se reconnat la couleur de la cocarde comprise dans votre trousse d'inscription. Les billets pour les vnement sociaux et facultatifs se retrouvent galement dans la trousse. Lorsque vous rcuprerez vore matriel d'inscription, veuillez vous assurer que toutes les activits que vous avez payes sont bien indiques et que la couleur de votre badge correspond la lgende cidessous: Programme complet (scientique et social) : . . . . . . . . . .Bleu Programme scientifique seulement : . . . . . . . . . . . . . . . . . . .Rouge Industrie : . . . . . . . . . . . . . . . . . . . .Vert Accompagnateur : . . . . . . . . . . . . .Jaune Mdia : . . . . . . . . . . . . . . . . . . . . . .Noir Les dlgus inscrits tout le programme ainsi que les accompagnateurs ont accs au Brunch de bienvenue, la Grande soire de l'AUC et au Banquet prsidentiel. Les accompagnateurs inscrits peuvent galement prendre leur petit-djeuner dans le Salon des accompagnateurs.
CUA 2012 BANFF
22
RECUEIL DES RSUMS HALL D'EXPOSITION
ATTESTATION DE PARTICIPATION Les dlgus inscrits au Programme scientifique seulement peuvent acheter des billets pour les activits sociales et facultatives au bureau d'inscription. Une attestation de participation vous sera envoye par courriel, sur demande, aprs l'vnement. Cette attestation peut tre utilise pour rclamer vos crdits de DPC.
Les enfants et adolescents inscrits ont accs au Brunch de bienvenue ainsi qu'aux activits et repas suivants: 1 Activits, collation et souper le dimanche au salon des enfants ( partir de 14h00) 2 Petits djeuners les lundi et mardi au salon des enfants 3 Activits, collations et lunch, les lundis et mardis au Club des enfants du Banff Springs Hotel (8h45 16h30) 4 Souper et activits du lundi soir au salon des enfants
Un recueil des rsums prsents, publi par le Journal de l'Association des urologues du Canada, est inclus dans la trousse des dlgus.
L'Association des urologues du Canada et leur Comit organisateur dsirent exprimer leur reconnaissance envers les compagnies qui ont prt leur soutien ce congrs en participant cette exposition. Nous vous invitons rendre visite nos partenaires de l'industrie et vous mettre jour sur leurs produits et services. Veuillez vous reporter la section Commanditaires/ Exposants de ce livret pour consulter le rpertoire des exposants et la plan de la salle.
INTERNET RESPONSABILIT PHOTOGRAPHIES OBJETS TROUVS
L'exposition se tiendra dans le salon Van Horne BC selon l'horaire suivant: Dimanche 24 juin: . . . . . . . . . . 0800-1700 Lundi 25 juin: . . . . . . . . . . . . . 0800-1530 BUREAU D'INSCRIPTION
SALON DES CONFRENCIERS Tous les prsentateurs ayant diapositives ou vidos doivent se prsenter au Salon des confrenciers, 24 heures avant leur prsentation. Samedi 23 juin . . . . . . . . . . . . . 1300-1800 Dimanche 24 juin. . . . . . . . . . . 0630-1730 Lundi 25 juin . . . . . . . . . . . . . . 0630-1700 Mardi 26 juin . . . . . . . . . . . . . . 0630-1600 Les confrenciers sont pris d'apporter leurs fichiers sur des dispositifs courant de stockage de donnes (cls USB, carte mmoire flash, DC, etc.) au moins 24 heures avant leur prsentation. Un technicien sera sur place en tout temps. L'utilisation du portable personnel est interdit. POSTERS NON-MODRS POSTERS 5-TOILES
Salle : NR Crump
Un accs internet sans fil gratuit est disponible au niveau de Centre des Congrs de l'htel. Le mot de passe sera affich sur les crans LCD.
Le congrs annuel de l'AUC 2012 et le Secrtariat du congrs IS Event Solutions ne peuvent tre tenus responsables de tout accident, blessure ou maladie survenant lors du congrs.
Les objets trouvs devraient tre remis rapidement au personnel du bureau d'inscription.
Des photographies seront prises lors du Congrs annuel et seront affiches en ligne aprs l'vnement.
Cette anne, les posters non-modrs seront prsents en format ''en-ligne''. Plusieurs stations seront disponibles dans le foyer du Prsident's Hall partir du 0930, dimanche le 24 juin , jusqu'au mardi 26 juin 1400.
CUA 2012 B A NFF
Le bureau d'inscription est situ dans le foyer President's Hall, au centre des congrs de l'htel. Ce dernier est situ en face du btiment principal de l'htel. Les heures d'ouverture sont les suivantes: Samedi 23 juin: . . . . . . . . . . . . 1100-1800 Dimanche 24 juin: . . . . . . . . . . 0630-1700 Lundi 25 juin: . . . . . . . . . . . . . 0630-1800 Mardi 26 juin: . . . . . . . . . . . . . 0630-1630
Les modrateurs des sances de posters modrs slectionneront des affiches 5-toiles de chaque session de posters modrs. Les prsentateurs d'affiches 5-toiles seront annoncs dans la sance de clture 1600, mardi le 26 juin.
23
OBJECTIF
OBJECTIFS DAPPRENTISSAGE ET RLE, COMPTENCES ET OBJECTIFS DE CanMEDS
DVELOPPEMENT PROFESSIONNEL CONTINU
Lobjectif du programme est doffrir un forum dchange qui permette didentifier les toutes dernires donnes sur les maladies urologiques, notamment sur le diagnostic et les traitements prventifs, et de sassurer que les urologues et dautres professionnels de la sant soutiennent la science fondamentale et la recherche clinique.
1 Identifier les modifications aux protocoles de traitement par ondes de choc SWL afin den maximiser lefficacit et de rduire la morbidit. 2 Dterminer les techniques destines optimiser la planification propratoire et laccs rnal percutan peropratoire. 3 Discuter des tudes pidmiologiques pertinentes sur la scurit des patients. 4 Examiner les complications lies la gestion des services mdicaux dans le cas dune nphrite, notamment les interactions mdicamenteuses et les effets secondaires. 5 Comprendre la mthodologie utilise pour analyser la documentation tayant les recommandations de reconstruction urtrale. 6 Mieux comprendre le traitement des problmes de distraction urtrale dune fracture du bassin (PFUDD). 7 Discuter du diagnostic et du traitement des lsions gnitales communes. 8 Mieux comprendre les diffrences rgionales dans les modles de pratiques et les rsultats dune cystectomie radicale. 9 Dterminer les effets secondaires long terme de la chimiothrapie pour le cancer des testicules. 10 Effectuer une valuation critique des stratgies de traitement du cancer superficiel de la vessie. 11 Mieux comprendre la morbidit relative la cystectomie et les solutions autres que la chirurgie pour traiter le cancer de la vessie. 12 Discuter des rgles et modes dapplication concernant lalimentation et les supplments pour les hommes. 13 Discuter des tudes cliniques qui appuient ou non les recommandations prnant un changement de rgime alimentaire et lapport de supplments pour les patients. 14 Comprendre comment les risques ventuels (effets secondaires ou complications) dune intervention mdicale et chirurgicale dans le cas
24
CUA 2012 BANFF
CRDITS DE FORMATION MDC
dune hypertrophie bnigne de la prostate permettent au patient de prendre une dcision. 15 Mieux connatre la faon de prvenir les infections des voies urinaires infrieures (LUTS) par une meilleure hygine de vie. 16 Savoir que les incidences financires long terme de la gestion mdicale et chirurgicale dune hypertrophie bnigne de la prostate ninfluent pas sur les dcisions actuelles. 17 Comprendre les problmes de sant dont souffriront plus tard les hommes prsentant une infertilit (risque plus lev de cancer, etc.) 18 Connatre les aspects techniques des interventions de fronde qui peuvent tre intgres larsenal chirurgical. 19 laborer un plan rationnel et efficace dvaluation et de traitement des patients plus gs souffrant de symptmes associs une hyperactivit vsicale (OAB). 20 Corrler les rsultats cliniques du reflux urinaire vsico-urtral (VUR) sa base gntique. 21 Examiner les preuves en faveur ou contre lutilisation du 5-ARI pour prvenir le cancer de la prostate. 22 Mieux comprendre la ncessit dintervenir et la survie dune cohorte de patients sous surveillance active en raison dun cancer de la prostate faible risque 23 valuer la gestion de pointe du CRCP, la fois ses lignes directrices et les nouveaux agents qui seront disponibles dans un avenir rapproch. 24 valuer le soutien scientifique actuel concernant lutilisation des PDE5i dans le cas de BPH/LUTS. 25 Discuter de questions dthique dans lapplication de ces concepts au niveau chirurgical et professionnel.
Ce programme est agr par la AUC en tant qu'activit de la section 1 (formation collective) comme dfini par le Programme de maintien du certificat du Collge royal des mdecins et chirurgiens du Canada. Pour un mdecin spcialiste, cette activit lui permet d'obtenir un (1) crdit par heure de participation, comme dfini dans la section 1 du Programme de maintien du certificat du Collge royal des mdecins et chirurgiens du Canada, jusqu' un maximum de 22 crdits. Les participants ne doivent rclamer que les crdits correspondant leur participation.
2013 2014
CONGRS FUTURS DE L'AUC
68 AUC 69 AUC
23-25 JUIN
e e
29 JUIN-1 JUILLET
2015 2016 2017
70e AUC 71e AUC 72e AUC

28-30 JUIN 26-28 JUIN 25-27 JUIN
Niagara Falls, ON Htel Sheraton on the Falls
Ottawa, ON The Westin Ottawa Hotel
St. Johns, NL Delta St. Johns Hotel & Conference Center
Vancouver, BC The Westin Bayshore Hotel 25
Toronto, ON Westin Harbour Castle Hotel

CUA 2012 B A NFF
2016 VANCOUVER
2014 ST. JOHNS
2015 OTTAWA
2017 TORONTO
2013 NIAGARA FALLS
PLAN DU FAIRMONT BANFF SPRINGS HOTEL
26
CUA 2012 BANFF
GRILLE DU PROGRAMME SOCIAL

PROGRAMME SOCIAL PROGRAMME DES ACCOMPAGNATEURS PROGRAMME JEUNESSE
HEURES
SUNDAY, JUNE 24
0800-1100
1130-1230
Petit-djeuner & Service de concierge priv

Salon des Accompagnateur : Oak room
Brunch de bienvenue VanHorne BC
1400-2200
GRANDE SOIRE DE L'AUC Rails & Rocheuses
Activits, souper et divertissement

Salon des enfants : Norquay room
Le Fairmont Banff Springs Hotel Riverview Lounge, Alberta & New-Brunswick rooms
1900-2230
MONDAY, JUNE 25
Petit-Djeuner
0700-0845
0800-1100
0845-1630

Activits
CUA 2012 B A NFF
Club des Jeunes du Banff Springs Hotel
1630-2300
Activits amusantes, souper et divertissement

1900-2300
Rception et banquet du Prsident Le bal de feu et de glace / RCEPTION 18:30

Le Fairmont Banff Springs Hotel / Alberta room
TUESDAY, JUNE 26
0630-0730
0700-0845
Course et marche amicale au profit de la FBAUC
Lobby The Fairmont Banff Springs Hotel
Petit-Djeuner
0800-1100
Petit-djeuner & Service de concierge priv

Salon des Accompagnateur : Oak room
Activits
0845-1630
Club des Jeunes du Banff Springs Hotel
27
DIMA NCHE 24 JUIN
PROGRAMME SOCIAL
Tous les vnements sociaux sont par billet d'admission / badge d'inscription seulement. Les billets additionnels pour des vnements sociaux sont disponibles l'achat au bureau d'enregistrement.
sances scientifiques. Nous prvoyons que de nombreux membres de l'AUC et partenaires de l'industrie rpondront notre invitation. Festoyez, dansez et revivez lge dor des Rocheuses canadiennes au grandiose htel Banff Springs, pendant que lorchestre Livin in Swing vous fera revivre le bon vieux temps! Cet ensemble de six musiciens vous fera danser toute la nuit sur des airs de swing et une varit dautres styles. Ce groupe plein dentrain comporte aussi son rpertoire un grand nombre de mlodies que vous vous plairez fredonner. Laissez-nous vous faire voyager dans le temps dans un dcor branch et dlectez-vous des nombreuses saveurs de lOuest canadien : miniburgers de bison, pts de filet de buf, saumon grill sur planche de cdre pour nen nommer que quelques-unes. La soire passera sans aucun doute l'histoire des congrs de l'AUC, car nous avons en rserve de nombreuses surprises qui vous tiendront en haleine!
1130-1230 Brunch de bienvenue

Salle d'exposition - VanHorne BC
Compris dans toutes les catgories d'inscription Partez du bon pied en dmarrant l'AUC 2012 par un brunch de bienvenue dans le hall d'exposition. Retrouvez les amis que vous n'avez pas vu depuis le dernier congrs annuel de l'AUC Montral, et prparez-vous passer trois jours stimulants remplis des dernires nouveauts scientifiques. 1900-2230 Grande Soire de l'AUC Rails & Rocheuses
Le Fairmont Banff Springs Hotel Riverview Lounge, salles Alberta & New Brunswick CUA 2012 BANFF
28
Inclus dans le programme complet et pour les accompagnateurs inscrits. Prix d'un billet supplmentaire : $125, plus tax Tout le monde bord! Pour la premire fois dans lhistoire des congrs de lAUC, la Grande Soire aura lieu le dimanche soir, aprs la fermeture du hall des exposants et la fin des
PROGRAMME SOCIAL
LUNDI LE 25 JUIN
1900-2300 Rception et Banquet du Prsident - Le bal de feu et de glace de l'AUC (Rception 1830)
Salles Alberta & New Brunswick Le Fairmont Banff Springs Hotel
Messieurs, sortez votre smoking! Mesdames, l'heure est arrive d'acheter LA fabuleuse robe qui vous rendra poustouflante!
Inclus dans le programme complet et les accompagnateurs inscrits. Prix du billet supplmentaire : $150, plus tax Les prsidents du Comit d'organisation locale ont mis sur pied un vnement qui intgrera certains lments de la nature. Laissez-vous emporter par vos sens et attendez-vous linattendu! Joignez-vous nous pour saluer et fliciter les prsidents du Comit d'organisation locale, les membres du Comit scientifique et le prsident de l'AUC, le Dr Michael Chetner, et pour accueillir la nouvelle quipe du congrs de 2013 qui se prpare avec enthousiasme vous recevoir Niagara Falls! Cette anne, le cocktail et le banquet prsidentiel, qui comprendront un succulent repas quatre services, vous mneront dans un univers o lunion du feu et de la glace engendrera une explosion dont la beaut et le raffinement vous blouiront.
CUA 2012 B A NFF
29
MARDI 26 JUIN
COURSE ET MARCHE AMICALE AU PROFIT DE LA FBAUC
0630-0730 Course et marche amicale au prot de la FBAUC *Un tarif de 50$ s'applique (non-taxable) Levez-vous tt pour une matine sportive! Pour la troisime fois l'AUC tiendra une Marche/Course bnfice afin de soutenir la Fondation des bourses de l'Association des urologues du Canada (FBAUC). Son objectif est de fournir un soutien financier pour effectuer de la recherche en urologie au Canada. Les participants peuvent choisir d'effectuer une marche de 2 km ou une course amusante de 5 km dans les rues de Banff. Lancez la concurrence amicale dans ce rassemblement pour soutenir cette importante initiative de l'AUC. Tous les dons seront remis la FBAUC. 30
CUA 2012 BANFF
PROGRAMME DES ACCOMPAGNATEURS

SALON DES ACCOMPAGNATEURS
Salle: Oak
Les frais d'inscription pour les accompagnateurs incluent : 1 un cadeau de bienvenue 2 accs la salle d'exposition 3 petit djeuner continental le matin dans le salon des accompagnateurs 4 brunch d'ouverture (dimanche) 5 la Grande Soire de l'AUC (dimanche) 6 ainsi que le banquet prsidentiel (lundi)
M ARDI 26 J UIN
0630-0730 Course et marche amicale au prot de la FBAUC *Un tarif de 50$ s'applique (non-taxable)
Voir page XXX pour dtails
Les accompagnateurs sont invits utiliser le Salon des accompagnateurs situ au Fairmont Banff Springs pour rencontrer des amis ainsi que pour profiter du petit djeuner continental quotidien. Le Salon des accompagnateurs sera ouvert les dimanche, lundi et mardi de 8h 11h. Un concierge priv de l'AUC sera prsent pendant ces heures pour vous aider rendre votre sjour mmorable. Information et rservation de visites guides seront disponibles sur place. Si vous tes intresss visiter le rput Willow Stream Spa de l'htel Fairmont Banff Springs, nous vous invitons communiquer avec le concierge de l'htel situ au Lobby principal.
CUA 2012 B A NFF
31
KIDS LOUNGE
PROGRAMME JEUNESSE
KIDS PROGRAM HOURS SERVICE DE GARDE Dimanche 24 juin Activits et jeux au Salon des jeunes ...............................14:00-23:00
Le programme pour les jeunes du congrs 2012 sera trs spcial! En effet, le Fairmont Banff Springs comprend un superbe club des jeunes qui sera la disposition des enfants des membres de lAUC lundi et mardi. Le Club des jeunes du Banff Springs, la plaque tournante des activits pour les jeunes lhtel, sera la principale attraction pour nos jeunes de 6 16 ans. Le club offre des activits supervises par des moniteurs enthousiastes. Chaque jour sera une nouvelle aventure et les jeunes recevront tous gratuitement une casquette du Club des jeunes du Banff Springs et un porte-nom avec cordon lors de leur premire visite. Les activits extrieures permettront aux enfants dacqurir de nouvelles habilets comme la navigation, la survie en cas durgence et la prparation de nourriture sur feu ouvert. Les activits intrieures comprennent une grande varit de jeux, dactivits de bricolage et d'autres activits pour amuser les jeunes. Linscription au programme pour les jeunes comprend : 1 Trousse de bienvenue 2 Activits partir de 14 h dimanche au Salon des jeunes (Kids Lounge) 3 Petit-djeuner au Salon des jeunes lundi et mardi 4 Partie de quilles et pizza dimanche soir 5 Souper et cinma lundi soir 6 Deux journes compltes d'activits lundi et mardi lintrieur et lextrieur au Club des jeunes de lhtel 7 Dner et collation lundi et mardi au Club des jeunes de lhtel
CUA 2012 BANFF
Le Salon des jeunes comprend des jeux sur console Wii, des activits de bricolage et des jeux de socit. Les activits sont supervises pendant les heures d'ouverture du salon.
Lundi 25 Juin Djeuner au Salon des jeunes ..07:00-08:45 Activits au Club des jeunes du Banff Springs Hotel ..............08:45-16:30 Souper & divertissement...........16:30-23:00 Mardi 26 Juin Djeuner au Salon des jeunes...07:00-08:45 Activits au Club des jeunes du Banff Spring.........................08:45-16:30
32
Les services de gardiennage sont offerts 16 $ l'heure pour un maximum de deux enfants et pour un minimum de quatre heures de service. Les gardiens peuvent s'occuper des enfants dans la chambre ou ils peuvent participer diffrentes activits l'intrieur de l'htel (baignade, quilles, cinma, etc.) Le service de concierge peut se charger d'effectuer les rservations. La politique d'annulation pour ce service est de 24 heures. noter que les prix sont sujets changement sans pravis. Veuillez rserver ce service en communiquant avec le concierge de l'htel au bsh.concierge@fairmont.com ou en vous prsentant au bureau du concierge situ au Lobby principal de l'htel.
CUA SPONSORS 2012 / COMMANDITAIRES DE LAUC 2012

CUA 2012 ANNUAL MEETING SPONSORS / COMMANDITAIRES DU CONGRS ANNUEL 2012 PATRON SPONSORS OF THE CUA / GRANDS COMMANDITAIRES DE LAUC
The members of the CUA would like to acknowledge the following organizations for their generous support for the 67th Annual Meeting. Their outstanding commitment to urological research and education will benefit urologists and their patients throughout Canada. Les membres de lAUC tiennent souligner le soutien gnreux des laboratoires suivants pour la tenue du 67e Congrs annuel. Leur implication dans le recherche et la formation en urologie fait bncier les urologues et leurs patients dans tout le Canada.
Platinum
Pfizer
Gold
Allergan GSK Janssen Ortho Sanofi

Silver
Bayer Healthcare
CUA 2012 B A NFF
33
CUASF 2012 SPONSORS / COMMANDITAIRES DE LA FBAUC 2012

PATRON SPONSORS OF THE CUA / GRANDS COMMANDITAIRES DE LAUC
The Canadian Urological Association Scholarship Foundation (CUASF) was established in 1973 as a means of supporting promising Canadian urological researchers. More recently, scholarship funding has also been provided to support international urologists to visit Canadian centres of excellence. These scholarships would not be possible without the generous financial support of our Industry sponsors. The Canadian Urological Association Scholarship Foundation (CUASF) recognizes the following companies for their generous contributions in 2012 and their ongoing commitment to fostering high-caliber urological research in Canada.
34
FRENCH TO COME
CUA 2012 BANFF
SPONSORED SESSIONS / SANCES COMMANDITES
PODIUM SESSIONS ARE SUPPORTED BY OUR CUA 2012 ANNUAL MEETING PLATINUM SPONSOR UNMODERATED POSTER SESSIONS ARE SUPPORTED BY OUR CUA 2012 ANNUAL MEETING SILVER SPONSOR MODERATED POSTER SESSIONS ARE SUPPORTED BY OUR CUA 2012 ANNUAL MEETING GOLD SPONSORS
PLENARY SESSIONS AND EDUCATIONAL FORA ARE SUPPORTED BY OUR CUA PATRON SPONSORS
Allergan GSK Janssen Ortho sanofi
Bayer Healthcare
CUA 2012 B A NFF
35
EXHIBIT HALL LOCATION EXHIBIT HOURS
EXHIBIT INFORMATION / RENSEIGNEMENTS SUR LEXPOSITION
ACTIVITIES IN THE EXHIBIT HALL
The Exhibit Hall is located in the Van Horne Ballroom BC.
Sunday, June 24 0940-1010 Networking Break 1130-1230 Opening Brunch 1430-1500 Networking Break Laparoscopic Skills Competition Monday, June 25 0950-1020 Networking Break 1150-1300 Luncheon
Registered exhibitors with badges, will be allowed into the Exhibit Hall 30 minutes before opening and 30 minutes after closing. Sunday, June 24 . . . . . . . . . 0800-1700 Monday, June 25 . . . . . . . . 0800-1530 36
CUA 2012 BANFF
1450-1520 Networking Break
EXHIBIT FLOOR PLAN / PLAN DE LEXPOSITION
CUA 2012 BA NFF
37
EXHIBITOR LISTING / LISTE DES EXPOSANTS
Abbott Laboratories. . . . . . . . . . . . . . 24/25 Allergan Canada . . . . . . . . . . . . . . . . 27/32 American Urological Association (AUA) . 63 American Urological Association (AUA) - Western Section . . . Table in Foyer Amgen Canada Inc. . . . . . . . . . . . . . . 16/17 AMS Canada Inc. . . . . . . . . . . . . . . . . 10/11 AMT Electrosurgery . . . . . . . . . . . . . . . . 15 Anexxa Medical Technologies Inc. . . . . . . 3 Astellas Pharma Canada Inc. . . . . . . 22/23 Baxter. . . . . . . . . . . . . . . . . . . . . . . . . . . 28 BK Medical . . . . . . . . . . . . . . . . . . . . . . . 42 Bladder Cancer Canada. . . . Table in Foyer Boston Scientic . . . . . . . . . . . . . . . . 53/54 Bracco Imaging Canada . . . . . . . . . . . . . 34 Calmoseptine, Inc. . . . . . . . . Table in Foyer CAN-AM HIFU . . . . . . . . . . . . . . . . . . . . . 38 Canadian Urological Association (CUA) - Corporate Ofce . . . . . . . . . . . . . 62 Canadian Urological Association Journal (CUAJ) . . . . . . . . . . . . . . . . . . . . 62 Clarion Medical Technologies . . . . . . 44/45 Coloplast Canada . . . . . . . . . . . . . . . 30/31 Cook Medical . . . . . . . . . . . . . . . . . . . . 1/2 Covidien . . . . . . . . . . . . . . . . . . . . . . . . . . 6 Ethicon . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Ethicon Endo-Surgery . . . . . . . . . . . . . . 20 European Association of Urology (EAU) . 65 Ferring Pharmaceuticals . . . . . . . . . . . . 41 Fibertech Canada E.R. Inc. . . . . . . . . . . . 26 GlaxoSmithKline . . . . . . . . . . . . . 40/51/52
CUA 2012 BANFF
Jac-Cell Medic Inc.. . . . . . . . . . . . . . . . . 35 Janssen Inc. . . . . . . . . . . . . . . . . . . . . . . 18 Karl Storz Endoscopy Canada . . . . . . 46/47 Kidney Cancer Canada . . . . Table in Foyer Laborie Medical . . . . . . . . . . . . . . . . . . . 33 Eli Lilly Canada . . . . . . . . . . . . . . . . . 59/60 mdBriefCase Inc. . . . . . . . . . Table in Foyer Mediwatch USA Inc. . . . . . . . . . . . . . . . . 36 Medtronic of Canada Ltd. . . . . . . . . . . . . 12 Minogue Medical Inc. . . . . . . . . . . . . . . . 39 Novartis Oncology . . . . . . . . . . . . . . . . . 29 Olympus Canada Inc. . . . . . . . . . . . . . . 8/9 Paladin Labs Inc.. . . . . . . . . . . . . . . . . . 4/5 Pendopharm . . . . . . . . . . . . . . . . . . . . . . . 7 Pzer Canada Inc. . . . . . . . . . . . . . . . 48/50 Prostate Cancer Canada . . . Table in Foyer Red Leaf Medical Inc. . . . . . . . . . . . . . . . 21 Royal College of Physicians and Surgeons of Canada . . . Table in Foyer sano aventis Canada Inc. . . . . . . . . . . . 43 Science and Medicine . . . . . Table in Foyer SeeMore Imaging Canada . . . . . . . . . . . 66 Siemens . . . . . . . . . . . . . . . . . . . . . . . . . 13 Socit internationale d'urologie (SIU). . 64 Thunder Bay Regional Health Sciences Centre . . . . . . . . . . . . . . . . . . . 67 Triton Pharma Inc . . . . . . . . . . . . . . . . . . 37 Ultramed Inc. . . . . . . . . . . . . . . . . . . . . . 61 Urology Nurses of Canada . . Table in Foyer Vantage Endoscopy . . . . . . . . . . . . . . . . 14 Warnex Medical Laboratories. . . . . . . . . 56 Watson Pharma Company. . . . . . . . . 57/58
38
ALLERGAN CANADA Booths / Kiosques : 27/32 Contact: Geoff Morrow 500-85 Enterprise Blvd. Markham, ON, L6G 0B5 T: 905-940-7020 F: 416-606-7198 E: morrow_geoff@allergan.com
EXHIBIT DIRECTORY / RPERTOIRE DES EXPOSANTS

ABBOTT LABORATORIES Booths / Kiosques : 24/25 Contact: Mike Tweedle 8401 TransCanada Highway St. Laurent, QC, H4S 1Z1 T: 705-733-4466 F: 514-832-7837 E: mike.tweedle@abbott.com
AndroGel once daily provides proven efficacy for hypogonadism in a clear odourless gel.
AMERICAN UROLOGICAL ASSOCIATION (AUA) Booth / Kiosque : 63 Contact: Caroline Williams 1000 Corporate Boulevard Linthicum, MD 21090, United States T: 410-689-3933 F: 410-689-3939 E: membership@AUAnet.org
Lupron has been helping prostate cancer patients for 25 years.
AndroGel est un gel transparent et sans odeur qui a l'efcacit prouve dans l'hypogonadisme.
Lupron aide les patients atteint de cancer de la prostate depuis 25 ans.
The American Urological Association (AUA), founded in 1902, works towards the advancement of urologic patient care, and ensures that its more than 18,000 members are current on the latest research and practices in urology. The AUA also pursues its mission of fostering the highest standards of urologic care by providing a wide range of services including publications, research, the Annual Meeting, continuing medical education (CME) and the formulation of health policy.
CUA 2012 BA NFF
Allergan Canada is proud to bring Botox (onabotulinumtoxin A) to Canadian Urologists for treatment of Urinary Incontinence due to Neurogenic Detrusor Overactivity resulting from Neurogenic bladder associated with Multiple Sclerosis or subcervical spinal cord injury in adults who had an inadequate response to or are intolerant of anticholinergic medications.
L'Association Urologique Amricaine (AUA), fonde en 1902, travaille vers l'avancement de soin patient urologique et sassure que ses plus de 18,000 membres sont actuels sur la dernire recherche et les pratiques dans l'urologie. L'AUA poursuit aussi sa mission d'encourager les plus hautes normes de soin urologique en fournissant une large gamme de services en incluant des publications, la recherche, la Runion Annuelle, l'ducation mdicale continue (CME) et la formulation de politique de sant.
39
AMERICAN UROLOGICAL ASSOCIATION (AUA) WESTERN SECTION Table in Foyer Contact: Teri Sechler 1950 Old Tustin Avenue Santa Ana, CA, 92705, United States T: 714-550-9155 F: 714-550-9234 E: info@wsaua.org
AMGEN CANADA INC. Booths / Kiosques : 16/17 Contact: James Austin 6775 Financial Dr., Suite 100 Mississauga, ON, L5N 0A4 T: 905-285-3215 F: 905-286-4991 E: jaaustin@amgen.com
The Western Section AUA invites CUA members to join us October 7-12, 2012 on the Big Island of Hawaii at the magnificent Hilton Waikoloa Hotel for our 88th Annual Meeting. Please visit our website at 2012meeting.wsaua.org for all the meeting details. We look forward to seeing you in Hawaii!
40
AMS CANADA INC. Booths / Kiosques : 10/11 Contact: Lisa Cribb 381 Elmira Rd. N., Unit #1 Guelph, ON, N1K 1H3 T: 800-265-2611 F: 519-821-1356 E: Lisa.Cribb@ammd.com
Amgen, pionnire en biotechnologie, dcouvre, labore et distribue des traitements novateurs. Nos mdicaments ont aid des millions des patients combattre le cancer, les maladies rnales, la polyarthrite rhumatode et dautres maladies graves. Nantis dune solide ppinire de produits, nous faisons avancer la science pour toujours mieux servir les patients.
Amgen, a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients.
CUA 2012 BANFF
AMS is the world's leading independent company focused on developing, manufacturing and marketing medical devices that restore pelvic health. We are committed to serving the increasing number of people coping with male and female incontinence, erectile dysfunction, prostate disorders, urethral strictures and other pelvic floor conditions including prolapse. AMS est le leader mondial pour la fabrication et la mise en march de dispositifs mdicaux pour la Sant Pelvienne. Nous sommes engags servir le nombre croissant d'hommes et de femmes aux prises avec l'incontinence, la dysfonction rectile, les troubles de la prostate, le rtrcissement urtral et les autres conditions pelviennes incluant les prolapsus.

AMT ELECTROSURGERY Booth / Kiosque : 15 20 Steckle Place, Unit 16 Kitchener, ON, N2E 2C3 T: 888-803-6799 F: 519-895-2299 E: info@amtelectrosurgery.com ANEXXA MEDICAL TECHNOLOGIES INC. Booth / Kiosque : 3 Contact: Jean Catafard 13-5115 Harvester Rd. Burlington, ON, L7L 0A3 T: 905-333-1557 F: 888-234-2063 E: jcatafard@anexxamed.com
AMT Electrosurgery is focused on providing our customers with surgical solutions that optimize patient safety, clinical performance, ease of use and cost effectiveness in Electrosurgery, Laparoscopic Surgery and Cyrotherapy.
Anexxa prsentera des nouvelles technologies sans prcdent l'AUC. Zephyr, un sphincter urinaire articiel, le premier depuis plus dune dcennie. AxoGen, une matrice pour la rgneration des nerfs. Arista, un agent hmostatique unique base de plante et nalement Cuda, une lampe frontale sans corde. On vous attends!
AMT Electrosurgery vise fournir nos clients des solutions chirurgicales qui optimisent la scurit des patients, la performance clinique, la facilit d'utilisation et la rentabilit dans les domaines dlectrochirurgie, la chirurgie laparoscopique et cyrothrapierapy.
ASTELLAS PHARMA CANADA INC. Booths / Kiosques : 22/23 Contact: Neil Sarin 675 Cochrane Drive, Suite 500, West Tower Markham, ON, L3R 0B8 T: 905-470-7990 F: 905-470-2538 E: neil.sarin@astellas.com
Astellas Pharma Canada Inc. is committed to improving patients lives. In addition to offering Vesicare (solifenacin succinate) for overactive bladder Astellas continues its commitment to add value through research, innovation and partnerships in Urology and Uro-Oncology. Astellas Pharma Canada, Inc. est dtermine amliorer la vie des patients. En plus de proposer Vesicare (succinate de solifnacine) pour le traitement de l'hyperactivit vsicale, Astellas poursuit son engagement apporter une valeur ajoute par le biais de la recherche, de l'innovation et de partenariats tant en urologie qu'en uro-oncologie.
CUA 2012 BA NFF
Anexxa will showcase new and unprecedented technology at CUA. Zephyr, an Artificial Urinary Sphincter, the first new artificial sphincter in over a decade. Axogen creates the first nerve Allograft to the medical area. Medafor, a unique hemostatic agent and Cuda, a powerful cordless headlight. Come by and see whats new!
41
BAXTER

BK MEDICAL
Booth / Kiosque : 28 Contact: Gordon Blair 7125 Mississauga Road Mississauga, ON, L5N 0C2 T: 905-369-6791 F: 905-659-5398 E: Gordon_Blair@Baxter.com BAYER, INC.
animals and communities. We put science to work in the vital areas of health, nutrition and high-tech materials, both across Canada and around the world.
In Canada, Baxter BioSurgery provides a complete portfolio of surgical sealants that can be used to achieve haemostasis, seal or glue tissues, and support wound healing. The core products of the BioSurgery portfolio are TISSEEL VH/SD, Floseal and CoSeal. They have a long track record in terms of safety and efficacy and are supported by an extensive number of clinical studies.
Entreprise innovatrice, Bayer cre des produits novateurs, traitements rvolutionnaires et solutions saines qui amliorent la vie des gens, des animaux et des communauts. Nous mettons la science prot dans les domaines de la sant, de la nutrition et des matriaux de haute technologie, au Canada et ailleurs dans le monde.
Booth / Kiosque : 55 Contact: Jodi Benowski 77 Beleld Road Toronto, ON, M9W 1G6 T: 416-240-5338 F: 416-248-8072 E: jodi.benowski@bayer.com
42
La division Biochirurgie de Baxter offre une gamme complte dagent hmostatique, de scellant, de colle avec des facteurs de croissance qui favorisent la gurison des plaies. Les principaux produits de biochirurgie sont Floseal, Tisseel et Coseal. Nous possdons toutes les donnes cliniques prouvant leur efcacit et la scurit des produits.
CUA 2012 BANFF
Booth / Kiosque : 42 Contact: Natacha Treskin 8 Centennial Drive Peabody, MA 01960, United States T: 978-326-1300 F: 978-326-1399 E: info@us.bkmed.com
BK Medicals Flex Focus 800 Ultrasound system featuring Quantum Technology is tailored for the Surgical Suite. It is lightweight and mobile and supports a wide range of sterilizable transducers, and can be battery powered. Le systme ultrasons, Flex Focus 800 de BK mdical est dot de la technologie quantique et est adapt pour les Suites de Chirurgie. Il est lger, mobile et prend en charge un large ventail de sondes strilisables. Le systme est autonome, aliment par piles.
As an inventor company, Bayer creates innovative products, breakthrough treatments and healthier alternatives to improve the quality of life for people,

BLADDER CANCER CANADA
Table in Foyer Contact: David Guttman 21 Jason Crescent Georgetown, ON, L7G 4Z3 T: 416-571-0016 E: davidg@bladdercancercanada.org
BOSTON SCIENTIFIC Booths / Kiosques : 53/54 Contact: Kristin Muzylo 500-5060 Spectrum Way Mississauga, ON, L4W 5N5 T: 905-696-1947 F: 905-696-1893 E: Kristin.Muzylo@bsci.com
devices and procedures. This is accomplished through continuing refinement of existing products and procedures and investigation and development of technologies that reduce risk, trauma, cost, procedure time & aftercare.
Bladder Cancer Canada is a national organization helping bladder cancer patients and their support team. We raise awareness of bladder cancer and advocate for allocation of government and private funds directed to medical research. Canadian Bladder Cancer Network is our research group comprised of leading Canadian researchers. Cancer de la Vessie Canada est un organisme national qui aide les patients atteints de cancer de la vessie et leur quipe de soutien. Nous voulons sensibiliser les gens pour le cancer de la vessie et plaidons pour lallocation des fonds publics et privs destins la recherche mdicale dans ce domaine. Rseau canadien du cancer de la vessie est notre groupe de recherche compos dminents chercheurs canadiens.
BRACCO IMAGING CANADA Booth / Kiosque : 34 Contact: Hlne Potier 11065 boul. Louis-H. Lafontaine Anjou, QC, H1J 2Z4 T: 800-465-5820, x 5308 F: 514-807-9499 E: helene.potier@bic.bracco.com
Notre mission : lamlioration de la qualit des soins cliniques et de la productivit de ladministration des soins par promotion et la dfense de mthodes et dispositifs mdicaux moins invasifs. Tout cela est atteint grce un perfectionnement continuel des produits et mthodes existants par recherche ainsi qte parla de nouvelles technologies rduisant les risques, traumatismes, cots, dure des interventions et ncessit de suivi.
CUA 2012 BA NFF
BRACCO IMAGING Canada, located in Montral, is a member of the Bracco Group, a global leader in the manufacture of contrast agents, medical devices, and injection systems dedicated to medical imaging.
Boston Scientifics mission: improve quality of patient care and productivity of health care delivery through development and advocacy of less-invasive medical
At the CUA, BRACCO IMAGING Canada will be presenting Invivos DynaCAD for Prostate, a digital imaging system with a comprehensive set of advance visualization tools for performing real-time
43
CALMOSEPTINE, INC.

CAN-AM HIFU CANADIAN UROLOGICAL ASSOCIATION (CUA) CORPORATE OFFICE Booth / Kiosque : 62 Contact: Raffaella Leroux 185 Dorval, Suite 401 Dorval, QC, H9S 5J9 T: 514-395-0376 F: 514-395-1664 E: raffaella.leroux@cua.org
image analysis of prostate MRI studies and precise biopsy. BRACCO IMAGING Canada, situ Montral, est un membre du Groupe Bracco, un leader mondial dans la fabrication dagents de contraste, instruments mdicaux, et systmes dinjection ddis limagerie mdicale. Au congrs de lAUC, BRACCO IMAGING Canada prsentera DynaCAD pour Prostate, un systme dimagerie digitale comportant des outils avancs de visualisation, permettant une analyse en temps rel des images par Rsonance Magntique de la prostate et des biopsies prcises.
gurison de lirritation de la peau contre: l'urine, la diarrhe, la transpiration, les coulements venant d'une stule ou d'une plaie, l'rythme fessier, les petites brulres, les coupures, les corchures, les gerures et les dmangeaisons.
Booth / Kiosque : 38 Contact: Mary Duggan 123 Edward St., Suite 1401 Toronto, ON, M5G 1E2 T: 647-654-1499 F: 905-873-1811 E: maryduggan@internationalhifu.com
Calmoseptine Inc. promotes Calmoseptine Ointment for the prevention and treatment of skin irritations from moisture such as urinary and fecal incontinence. It is also effective for irritations from perspiration, wound drainage, fecal & vaginal fistulas and feeding tube site leakage. Calmoseptine Ointment temporarily relieves discomfort and itching. Free samples at our booth! Un onguent multifonctionnel agissant comme barrire contre l'humidit et qui protge, apaise et aide favoriser la
44
Table in Foyer Contact: Kim Saeng 16602 Burke Lane Huntington Beach, CA 92647, United States T: 714-840-3405 F: 714-840-9810 E: shows@calmoseptine.com
CUA 2012 BANFF
High Intensity Focused Ultrasound (HIFU) is a minimally invasive, outpatient procedure for men diagnosed with localized prostate cancer. The Sonablate 500 is the medical device that delivers HIFU to the tissues affected by prostate disease.
The Canadian Urological Association represents and provides a voice for all Canadian urologists and fosters dedications of all members of the profession toward ensuring the highest possible standard of urologic care of Canadians.

CANADIAN UROLOGICAL ASSOCIATION JOURNAL (CUAJ) Booth / Kiosque : 62 Contact: Joesphine Sciortino 185 Dorval, Suite 401 Dorval, QC, H9S 5J9 T: 514-395-0376 F: 514-395-1664 E: josephine.sciortino@cua.org
La vocation de lAUC est de reprsenter tous les urologues canadiens et inciter tous les membres de la profession se consacrer loptimisation de la qualit des soins urologiques offerts au Canada.
CLARION MEDICAL TECHNOLOGIES Booths / Kiosques : 44/45 125 Fleming Drive Cambridge, ON, N1T 2B8 T: 800-668-5236 F: 866-320-7287
The Canadian Urological Association Journal (CUAJ) is a peer reviewed, indexed journal, specializing in original scientific publications and selected review articles from Canadian and international authors. Le Journal de LAssociation des urologues du Canada (JAUC) est une revue scientique index dans le domaine de lurologie et chaque manuscrit est soumis un examen critique par les pairs. Le JAUC publie aussi des rapports de cas, des articles de rsidents et des articles dopinion.
Clarion Medical Technologies is one of the leading specialty medical technology providers in Canada, offering the most sophisticated and high performance technologies including 100W holmium and 980 diode laser systems, and specialty instruments for urologic and endourologic applications. The Clarion product portfolio gives office-based physicians and hospitals the ability to treat a wide range of conditions. Clarion Medical Technologies Inc. est le chef de le des fournisseurs de technologie mdicale spcialise au Canada, offrant les technologies les plus perfectionnes au rendement suprieur, notamment les appareils Laser Holmium de 100 watts et Diode 980. Le portefeuille de produits spcialiss de Clarion offre aux praticiens en cabinet ainsi qu'aux hpitaux la capacit de traiter une vaste gamme de conditions mdicales en Urologie.
CUA 2012 BA NFF
45
COLOPLAST CANADA Booths / Kiosques : 30/31 Contact: Joe Holloway 3300 Ridgeway Drive, Unit #12 Mississauga, ON, L5L 5Z9 T: 416-578-0427 F: 905-820-8218 E: cajho@coloplast.com

COVIDIEN
COOK MEDICAL Booths / Kiosques : 1/2 Contact: Alex Szabo 165 Mostar Street Stouffville, ON, L4A 0Y2 T: 905-640-7110 F: 905-640-7408 E: alex.szabo@cookmedical.com
Les socits du Groupe Cook effectuent le dveloppement des dispositifs mdicaux. Nous sommes au premier rang de la recherche mdicale et du dveloppement des produits et de la technologie des dispositifs mdicaux effraction minimale aux ns des interventions diagnostiques et thrapeutiques.
Coloplast develops products that make life easier for people with very personal and private medical conditions. Within the field of urology, Coloplast offers a wide range of devices that help people who suffer from urinary incontinence and erectile dysfunction.
46
Booth / Kiosque : 6 Contact: Caroline Robert 7300 TransCanada Highway Pointe-Claire, QC, H9R 1C7 T: 514-695-1220 F: 514-695-2379 E: caroline.robert@Covidien.com
Coloplast dveloppe des produits et services qui simplient la vie des personnes aux prises avec des problmes mdicaux intimes et trs personnels. Dans le domaine de lurologie, Coloplast offre une vaste gamme de dispositifs pour aider les personnes qui souffrent dincontinence urinaire et de dysfonction rectile.
CUA 2012 BANFF
The V-Loc Wound Closure Device family is a revolutionary technology that supports optimal patient outcomes by closing wounds securely without the need to tie knots. It has evenly-spaced unidirectional barbs throughout the strand which allows for a secure closure of the incision. It also features premium cutting needles with NuCoat technology. The benefits include: distribution of tension throughout the wound, closing wounds up to 50% faster than conventional sutures with comparable holding strength and a potential to reduce knot-related complications. Le dispositif de fermeture de plaies V-LocMC prsente une technologie rvolutionnaire qui permet dobtenir des rsultats optimaux grce la fermeture de plaies sans nud. Le dispositif possde des crans unidirectionnels uniformment rpartis tout le long du l qui permettent de fermer lincision de
Cook Group companies develop healthcare devices. We are at the forefront of medical research and product development in minimally invasive medical device technology for diagnostic and therapeutic procedures.

ETHICON
faon sre. Il est offert avec des aiguilles tranchantes de qualit suprieure dote de la technologie NuCoat. Ses principaux avantages comprennent la rpartition de la tension sur toute la longueur de la plaie, la fermeture de plaies 50 % plus rapide que les sutures traditionnelles pour une force de maintien comparable et le potentiel de rduction des complications lies aux nuds.
Ethicon Products est le chef de le mondial des produits et des technologies de suture. Ses marques sont parmi les plus reconnues et respectes dans le domaine hospitalier. Cette division est forte dune longue tradition dinnovation, notamment en matire de solutions de suture, dadhsifs topiques et de mchage chirurgical, sans compter quelle propose une gamme complte de produits dhmostase chirurgicale.
Booth / Kiosque : 19 Contact: Kendal Singh T: 1-800-642-6748 E: Ksingh8@its.jnj.com Franchise Info: Ethicon, a division of Johnson & Johnson Medical Companies
ETHICON ENDO-SURGERY Booth / Kiosque : 20 Contact: Maria Altomare E: maltomar@its.jnj.com
For nearly a century products from Johnson and Johnsons Medical Companies have been in the hands of healthcare practitioners, transforming their work and restoring the lives of patients they serve. As part of the Surgical Care Group of Johnson & Johnson, our commitment to improving and enhancing the lives of patients is fully realized when our products are in the hands of our customers. With a legacy of innovation and industry-leading experience, weve created new ways to care for patients. By understanding the complex ways in which materials interact with tissue weve created a portfolio of products that advance healthcare across the spectrum of medicine. Such products can be categorized into the following product lines, Biosurgery, Sutures & Dermabond.
At Ethicon Endo-Surgery, we want to transform patient care through innovation. We believe that advances in surgery and surgical education, in particular, minimally invasive techniques, offer value and important advantages for all stakeholders. Our partnerships have proven instrumental in the design and development of new surgical products that benefit patients, surgeons, and hospitals. To find out more about how we are transforming patient care, visit www.ethiconendosurgery.com
CUA 2012 BA NFF
Chez Ethicon Endo-Surgery, nous voulons transformer les soins aux patients au moyen de l'innovation. Nous croyons que les perces en matire de chirurgie et de formation chirurgicale, particulirement en ce qui a trait aux techniques peu effractives, offrent de la valeur et des avantages importants tous les intervenants. Nos partenariats ont jou un
47
EUROPEAN ASSOCIATION OF UROLOGY (EAU) Booth / Kiosque : 65 Contact: Angela Terberg Mr. E.N. van Kleffensstraat 5 6842 CV Arnhem, The Netherlands T: +31 26 3890 680 F: +31 26 3890 674 E: eau@uroweb.org
rle cl dans la conception et l'laboration de nouveaux produits chirurgicaux qui sont avantageux pour les patients, les chirurgiens et les hpitaux. Pour en savoir plus sur la faon dont nous transformons les soins aux patients, visitez le site www.ethiconendosurgery.com
The European Association of Urology (EAU) represents more than 16,000 urology professionals across Europe and worldwide. Its mission is to raise the level of urological care in Europe. The EAU Annual Congress is one of the largest urological congresses in the world. Check our website for more information: www.uroweb.org.
CUA 2012 BANFF
FERRING PHARMACEUTICALS Booth / Kiosque : 41 Contact: Stephen Zisis 200 Yorkland Blvd., Suite 800 North York, ON, M2J 5C1 T: 416-490-0121 F: 416-493-1692 E: Stephen.zisis@ferring.com
48
FIBERTECH CANADA E.R. INC. Booth / Kiosque : 26 Contact: Paul Laborie 6513A Mississauga Road N. Mississauga, ON, L5N1A6 E: info@bertech.ca
testosterone control for better cancer management.
FirmagonMD de Ferring est le premier antagoniste de la GnRH de sa classe pour les patients atteints de cancer de la prostate. Apprenez pourquoi le mcanisme daction direct de Firmagon sans lvation initiale du niveau de testostrone permet doffrir un contrle plus complet et soutenu pour un meilleur traitement du cancer.
Fibertech Canada E.R. Inc. is now the exclusive Canadian distributor for EDAP Extracorporeal Lithotriptors with Exclusive Intuitive Localization System technology. In addition, Fibertech provides a wide range of endoscopic services and offers the Endoboy Surgical Assist Arm. Fibertech Canada Inc. ER est maintenant le distributeur canadien exclusif pour EDAP Lithotripteurs extracorporelles avec la technologie exclusive de localisation systme intuitif. En outre, Fibertech offre une vaste gamme de services endoscopiques et offre le bras ENDOBOY Pneumatique, la troisime main du chirurgien.
Ferrings FirmagonTM is a first class GnRH antagonist for prostate cancer patients. Learn why Firmagons direct mechanism of action with no initial surge provides faster, more profound and sustained

GLAXOSMITHKLINE Booths / Kiosques : 40/51/52 Contact: Patricia Gauthier 7333 Mississauga Road Mississauga, ON, L5N 6L4 T: 905-819-3015 E: patricia.g.gauthier@gsk.com
GlaxoSmithKline (GSK) is a leading research-based pharmaceutical company with a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better, and live longer. This mission gives GSK the purpose to develop innovative medicines, vaccines and healthcare solutions that help millions of people. GSK is consistently recognized as one of the 50 best employers in Canada and is a top 20 investor in Canadian research and development, contributing more than $100 million in 2011 alone. With a proud tradition of charitable and community support, GSK is designated a Caring Company by Imagine Canada. Discover more at www.gsk.ca. GSK has a strong presence in biologicals, pharmaceuticals and vaccines, with a product portfolio that extends across a variety of therapeutic areas and diseases including urology. GlaxoSmithKline (GSK) est un gant pharmaceutique vou la recherche dont la mission ambitieuse et diante est damliorer la qualit de la vie en aidant les gens tre plus actifs, se sentir mieux et vivre plus longtemps. De cette mission dcoule lobjectif de GSK qui est de concevoir des mdicaments, des vaccins et des solutions de soins de sant
JAC-CELL MEDIC INC. Booth / Kiosque : 35 Contact: Mark Meltzer 5764 Pare Street Mont-Royal, QC, H4P 2M2 T: 514-731-4567, x 222 F: 514-731-0002 E: mark@jaccell.com
novateurs qui aident des millions de personnes. GSK est constamment reconnue comme lun des 50 employeurs de choix au Canada et gure parmi les 20 entreprises qui investissent le plus en recherche et dveloppement au Canada, ayant consacr plus de 100 millions de dollars ce secteur en 2011 seulement. De plus, grce sa re tradition de philanthropie et de soutien communautaire, GSK a t dsigne Socit gnreuse par le programme Imagine Canada. GSK joue un rle prpondrant dans les secteurs des agents biologiques, des spcialits pharmaceutiques et des vaccins; sa gamme de produits vise un large ventail de champs thrapeutiques et de maladies, y compris urologie. www.gsk.ca
CUA 2012 BA NFF
Jac-cell Medic is a leading distributor of instruments and accessories for cosmetic surgery. We provide value and savings on the highest quality of disposable and reusable products. Breast retractors, microsurgery instruments, precision dissection needles, cautery pens, saline transfer kits, aspiration and infiltration tubing and the lowest prices on silicon drains and reservoirs, including the new ouchless 2 in 1 round drains.
49
JANSSEN INC.
Specialists in Fat Grafting equipment with our Autoclavable fat transfer systems, 60cc & 10cc Manual Centrifuge, Fat harvesting Canula and reinjection needles, transfer adaptors
Booth / Kiosque : 18 Contact: Luis Fernandes 19 Green Belt Drive Toronto, ON, T3C 1L9 T: 416-382-5000 F: 416-449-2658 E: lferna10@its.jnj.com
KARL STORZ ENDOSCOPY CANADA LTD. Booths / Kiosques : 46/47 Contact: Florian Stegen 7171 Millcreek Drive Mississauga, ON, L5N 3R3 T: 905-816-4500 F: 905-816-4599 E: Florian.Stegen@karlstorz.com
nous collaborons de nouvelles solutions, produits et services pour le bien des patients dans le monde entier.
As a member of the Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Inc. is dedicated to addressing the most important unmet medical needs in pain management, psychiatry, oncology, immunology, psoriasis, virology, anemia, attention deficit hyperactivity disorder, dementia, gastroenterology and womens health. Driven by our commitment to the passionate pursuit of science for the benefit of patients, we work together to bring innovative ideas, products and services to patients around the world.
50
titre de membre du groupe des entreprises pharmaceutiques Johnson & Johnson, Janssen Inc. semploie rpondre aux besoins non satisfaits les plus importants dans le domaine de la douleur, la psychiatrie, loncologie, limmunologie, le psoriasis, la virologie, lanmie, le trouble dcitaire de lattention avec hyperactivit, la dmence, la gastroentrologie et la sant de la femme. Pousss par notre passion de mettre la science au service des patients,
CUA 2012 BANFF
KIDNEY CANCER CANADA Table in Foyer Contact: Joan Basiuk 27 Bayberry Crescent Toronto, ON, M2K 1T9 T: 416-223-8001 E: joanbasiuk@kidneycancercanada.ca
Karl Storz Endoscopy Canada is a leader in Endoscopic equipment and instruments that emphasize visionary design, craftsmanship and clinical effectiveness and facilitate demanding Urology procedures. Karl Storz Endoscopy Canada est un meneur dans la production dquipement et dinstruments endoscopiques. Le concept visionnaire de nos artisans met l'accent sur l'efcacit clinique de tous nos produits avec emphase de faciliter vos procdures durologie.
Kidney Cancer Canada (KCC) is a charitable patient-led support organization established to improve the quality of life for patients living with kidney cancer. KCC advocates for access to new treatments, provides support and information to

LABORIE MEDICAL Booth / Kiosque : 33 Contact: Christine Frewen 6415 Northwest Drive, Unit 10 Mississauga, ON, L4V 1X1 T: 1-888-522-6743, x 4232 F: 450-671-7182 E: cfrewen@laborie.com
patients, funds much-needed kidney cancer research, and works to increase awareness of kidney cancer.
recherche, nos solutions sont conues pour voluer avec votre pratique.
LAssociation canadienne du cancer du rein (ACCR) est un organisme de bienfaisance cr et dirig par des patients avec mission damliorer la qualit de vie de ceux-ci et de leurs proches. LACCR milite pour laccs aux nouveaux traitements, informe et soutient les patients, nance la recherche et travaille faire connatre cette forme rare de cancer.
ELI LILLY CANADA Booths / Kiosques : 59/60
Contact: Monita Chan 3650 Danforth Ave. Toronto, ON, M1N 2E8 T: 416-693-3790 F: 416-699-7234 E: chan_monita@lilly.com Lilly is a leading, innovation-driven Pharmaceutical Corporation committed to developing a growing portfolio of best-inclass/first-in-class pharmaceutical products that help people live longer, healthier and more active lives. We are committed to providing answers that matter through medicines and information, for some of the world's most urgent medical needs.
CUA 2012 BA NFF
LABORIE, the worldwide industry leader in Urodynamics, is pleased to provide you with the most advanced solutions in Pelvic Floor Dysfunction Management. LABORIE is committed to bringing you the most innovative products: from private offices to world class research institutions, our solutions are designed to expand with your practice. LABORIE, leader mondial de lurodynamie, vous offre les solutions les plus performantes dans la gestion des dysfunctions du plancher pelvien. LABORIE sengage a vous apporter les produits les plus innovants: pour votre consultation prive ou votre centre de
Lilly est une socit pharmaceutique de pointe axe sur linnovation qui sapplique dvelopper un portefeuille toujours croissant de produits pharmaceutiques, parmi les meilleurs et les premiers de leur classe, an de permettre aux patients de vivre plus longtemps, en meilleure sant et de mener une vie plus active. Lilly est fermement rsolue apporter des rponses qui comptent, sous forme de mdicaments et d'informations, certains des impratifs mdicaux les plus urgents dans le monde.
51
MDBRIEFCASE INC.
Table in Foyer Contact: Janet Kimura 20 Eglinton Avenue West, Suite 1300 Toronto, ON, M4R 1K8 T: 416-488-5500, x 221 F: 416-288-0566 E: janet.kimura@mdbriefcase.com
MEDIWATCH USA INC. Booth / Kiosque : 36 Contact: Nick Darker 1501 Northpoint Parkway, Suite 103 West Palm Beach, FL 33407, United States T: 561-471-2611 F: 866-871-8262 E: info@mediwatchusa.com
mdBriefCase Inc. has been the leading provider of online continuing education for Canadian health care professionals since 2002. mdBriefCase creates more than 100 online learning programs annually in collaboration with leading experts, professional societies and academic institutions for its 85,000+ health care professional membership. Programs are offered through www.mdBriefCase.com, www.AdvancingIn.com,and www.rxBriefCase.com.
The Mediwatch range of urology & pelvic floor diagnosis products includes: Intuitive Sensic urodynamics systems, Encompass anorectal manometry & pudendal stimulation, Portascan+ PVR scanners, Uroval bulbocavernosus reflex testing, Venus pelvic floor rehabilitation and Urodyn+ & Portaflow uroflowmeters. Ask for more information on any product and a demonstration at our stand. Mediwatch possde une gamme de produits servant au diagnostique des problmes urinaires et du plancher pelvien : Le systme Sensic pour lurodynamie, Encompass pour la manomtrie rectal et la stimulation du nerf pudendal, Portascan+ PVR, Uroval pour vrier le rexe bulbocaverneux,Vnus pour la rhabilitation du plancher pelvien et Urodyn+ & Portaow pour les dbimtries. Pour toute autre information ou dmonstration, sil vous plait visiter notre kiosque.
52
mdBriefCase Inc. est le principal prestataire de formation mdicale continue en ligne pour les professionnels de la sant au Canada depuis 2002. mdBriefCase cre chaque anne plus de 100 programmes dapprentissage en ligne en collaboration avec des spcialistes de premier plan, des associations professionnelles et des tablissements denseignement lintention de ses membres : plus de 85 000 professionnels de la sant. Les programmes sont offerts par www.mdBriefCase.com, www.AdvancingIn.com, et www.rxBriefCase.com.
CUA 2012 BANFF

MEDTRONIC OF CANADA LTD. Booth / Kiosque : 12 Contact: Kitty Zanata 99 Hereford Street Brampton, ON, L6Y 0R3 T: 905-460-3642 F: 905-460-3999 E: kitty.zanata@medtronic.com
MINOGUE MEDICAL INC. Booth / Kiosque : 39 Contact: Danny Minogue 180 Peel Street, Suite #300 Montreal, QC, H3C 2G7 T: 1-800-665-6466 F: 514-287-0853 E: danny@minogue-med.com
Medtronic is the worlds leading medical technology company offering InterStim therapy for the management of chronic intractable fecal and urinary incontinence. We offer a simple functional evaluation test to select patients and a minimally invasive implant procedure for the system. Clinical evidence for long term success is well established. Come to our booth to see how easy it is to do the peripheral nerve evaluation. Medtronic est lentreprise chef mondiale en technologie mdicale, offrant la thrapie InterStim pour le traitement de l'incontinence fcale et urinaire rfractaire chronique. Nous vous offrons un test simple pour l'valuation fonctionnelle simple pour aider slectionner les patients et une procdure d'implant minimalement invasive. Les vidences clinicaux de russite long terme sont bien tablie pour l'incontinence fcale. Venir nous visiter notre table pour voir comment il est facile de faire l'valuation des nerfs priphriques.
Minogue Medical Inc. is the exclusive Canadian distributor of the Intuitive Surgical da Vinci Si HD Surgical System. The da Vinci Prostatectomy (dVP) is the fastest growing treatment for prostate cancer today. Other procedures include the da Vinci Nephrectomy/Partial Nephrectomy, Radical Cystectomy, and Pyeloplasty. We are also the exclusive Canadian distributor for Neotract who have developed the innovative Urolift System for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). Minogue Medical Inc. est le distributeur canadien exclusif du systme chirurgical da Vinci Si HD. La prostatectomie da Vinci (dVP) est le traitement en volution le plus rapide pour le cancer de la prostate aujourdhui. Les autres procdures incluent la nphrectomie/ nphrectomie partielle, cystectomie radicale, et pyeloplastie. Egalement le distributeur canadien exclusif pour Neotract qui a mis au point le Systme Urolift, une technologie pour le traitement des symptmes du tractus urinaire caus par une hyperplasie bnigne de la prostate.
CUA 2012 BA NFF
53
NOVARTIS ONCOLOGY Booth / Kiosque : 29 Contact: Paule Racine 385 Bouchard Blvd. Dorval, QC, H9S 1A9 T: 514-631-6775, x 3207 F: 514-631-1867 E: paule.racine@novartis.com
OLYMPUS CANADA INC. Booths / Kiosques : 8/9 Contact: Roxanne DeAbreu-Breen 25 Leek Crescent Richmond Hill, ON, L4B 4B3 T: 289-269-0204 F: 905-886-7469 E: Roxanne.deabreu@olympus.com
Novartis Oncology is dedicated to answering unmet medical needs. Our priority is to discover, develop and make broadly available novel therapies that may improve and extend the lives of patients.
54
Novartis Oncologie se consacre satisfaire les besoins mdicaux non combls. Notre priorit est de dcouvrir, de mettre au point, et doffrir tous des traitements novateurs pouvant amliorer et prolonger la vie des patients.
CUA 2012 BANFF
PALADIN LABS INC. Booths / Kiosques : 4/5 Contact: Philippe Leblond 100 Alexis Nihon Blvd., Suite 600 St-Laurent, QC, H4M 2P2 T: 514-340-1112 x 5445 F: 514-344-4675 E: pleblond@paladinlabs.com
Olympus Canada offre aux urologues la vision et le pouvoir de traiter avec une visualisation de pointe et une gestion des tissus chirurgicaux reconnue comme meilleure dans sa catgorie. Nos technologies permettent aux urologues d'effectuer une varit de procdures avec haute prcision et scurit maximale. Pour de plus amples informations sur nos produits, veuillez contacter Olympus Canada : 1-800-387-0437 www.olympuscanada.com
Paladin Labs is a Canadian specialty pharmaceutical company focused on bringing innovative therapies to Canada. Key products include Trelstar (LHRHa), Testim (testosterone gel), and Urocit-K (potassium citrate) in urology. Visit our booth to find out more about our products! www.paladinlabs.com Paladin est une compagnie pharmaceutique canadienne avec mission dapporter des produits pharmaceutiques spcialiss au Canada. Les produits principaux comprennent Trelstar (LHRHa), Testim (gel de testostrone) et Urocit-K (citrate de potassium) en urologie. Visitez notre kiosque pour en savoir plus sur nos produits! www.paladinlabs.com
Olympus Canada offers urologists the vision to see and the power to treat with leading edge visualization and best in class surgical tissue management. Our leading edge technologies enable urologists to perform a wide range of procedures with pinpoint precision and maximum safety. For more information on our products, please contact Olympus Canada: 1-800-387-0437 www.olympuscanada.com

PENDOPHARM
Booth / Kiosque : 7 Contact: 6111 Royalmount Ave., Suite 100 Montreal, QC, H4P 2T4 T: 514-340-9800 F: 514-733-9684
que raliser les derniers stages de dveloppement de mdicaments dordonnance spcialiss et de produits destins aux consommateurs, an de les commercialiser.
A Strong Focus on Specialty Medicines PENDOPHARM is a rapidly growing and independent business that focuses on commercializing a portfolio of specialty prescription products and an established line of OTC/BTC products. Strategically committed to growth, PENDOPHARM is actively engaged in licensing, developing and marketing late-stage prescription products as well as consumer brands. Axe sur les produits pharmaceutiques spcialiss PENDOPHARM est une entreprise pharmaceutique indpendante ayant une forte croissance et dont les activits de commercialisation se concentrent sur un portefeuille de produits dordonnance spcialiss ainsi quune gamme importante et tablie de produits offerts en vente libre et derrire le comptoir de la pharmacie. Engage par sa stratgie commerciale prendre de lexpansion, PENDOPHARM travaille activement pour acqurir des licences, tablir des partenariats ainsi
PFIZER CANADA INC. Booths / Kiosques : 48/50 Contact: Karen Southin 17300 TransCanada Highway Kirkland, QC, H9J 2M5 T: 514-426-7549 E: Karen.Southin@Pzer.com
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc, the world's leading biopharmaceutical company. Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals. At Pfizer, we're working together for a healthier world. For more information, visit www.pfizer.ca
CUA 2012 BA NFF
Pzer Canada inc. est la liale canadienne de Pzer Inc., premire entreprise pharmaceutique l'chelle mondiale. Pzer dcouvre, met au point, fabrique et commercialise des mdicaments dordonnance pour les humains et les animaux. Chez Pzer, nous btissons ensemble un monde en meilleure sant. Pour en savoir plus, visitez le site www.pzer.ca
55
PROSTATE CANCER CANADA Table in Foyer Contact: Katherine patterson 2 Lombard Street, 3rd Floor Toronto, ON, M5C 1M1 T: 416-441-2131 E: kpatterson@prostatecancer.ca
of premier medical products to help patients get the most out of life every day. The Company is rapidly growing and specializes in the acquisition, development and commercialization of innovative medical devices in the field of urology.
Nos objectfs sont de deux ordres pour financer la recherche qui va dcouvrir des meilleures faons de diagnostiquer et les options de traitement et de fournir des services de soutien complets pour les personnes vivant avec le cancer de la prostate.
RED LEAF MEDICAL INC. Booth / Kiosque : 21 Contact: Charles Ko 4055 Sladeview Crescent, Unit 12 Mississauga, ON, L5L 5Y1 T: 905-569-7771 F: 905-569-7778 E: info@redleafmedical.com
Prostate Cancer Canada is the only national foundation dedicated to the elimination of the disease through research, education support and awareness.
56
Our goals are twofold to fund research that will uncover better diagnostic and treatment options and to provide comprehensive support services for those living with prostate cancer.
Cancer de la Prostate Canada est la seule foundation nationale voue llimination de la maladie par la recherche, soutien lducation et la sensibilisation.
CUA 2012 BANFF
ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA Table in Foyer Contact: Sandra Canniff 774 Echo Drive Ottawa, ON, K1S 5N8 T: 613-730-6243 F: 613-730-2410 E: scanniff@royalcollege.ca
Red Leaf Medical Inc. est un fournisseur de produits mdicaux de premier plan pour aider les patients mieux proter de la vie chaque jour. La socit, dont la croissance est rapide, se spcialise dans l'acquisition, le dveloppement et la commercialisation d'instruments mdicaux novateurs dans le domaine de l'urologie.
The Royal College sets the highest standards for specialty medical education in Canada. At the same time, we support lifelong learning for specialist physicians and promote sound health policy. Le Collge royal tablit les normes les plus leves qui soient en formation mdicale spcialise au Canada. Paralllement, nous soutenons l'apprentissage continu des mdecins spcialistes et faisons la promotion de politiques de sant rchies.
Red Leaf Medical Inc. is a provider
SANOFI AVENTIS CANADA INC. Booth / Kiosque : 43 Contact: 2150 St. Elzear Blvd. West Laval, QC, H7L 4A8 T: 514-331-9220 1-800-363-6364 (general enquiries); 1-800-265-7927 (customer service)

SEEMORE IMAGING CANADA Booth / Kiosque : 66 Contact: Jane Timmis 4099 Burkehill Road West Vancouver, BC, V7V 3L9 T: 604-922-0874 F: 604-922-0875 E: jtimmis@seemore.ca
SCIENCE AND MEDICINE CANADA Table in Foyer Contact: Gary Browne 120 East Beaver Creek Road, Suite 315 Richmond Hill, ON, L4B 4V1 T: 905-762-0772, x 304 F: 905-762-0776 E: gbrowne@scimedcan.com
years of experience in urology/urooncology and demonstrated excellence in medical education. The Canadian Urological Association has recently partnered with SMC to develop and provide urology-related CHE to healthcare providers across Canada.
As a leading healthcare partner we provide, and are developing, innovative medicines for treatments in several therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic disorders, the central nervous system, and internal medicine. We also play a role by investing in activities that improve health and quality of life in our communities. Partenaire de premier plan du secteur de la sant, nous fournissons et mettons au point des mdicaments innovants dans des domaines thrapeutiques varis : la cardiologie, la thrombose, le systme nerveux central, loncologie, les maladies mtaboliques et la mdecine interne. Nous investissons aussi dans des activits qui amliorent la sant et la qualit de vie dans les collectivits o nous sommes implants.
Science & Medicine Canada (SMC) est une agence base Toronto offrant de la formation mdicale continue (FMC). Possdant plus de 20 annes dexprience, elle a fait preuve dexcellence en formation mdicale dans les domaines de lurologie et de lurooncologie. LAssociation des urologues du Canada (AUC) s'est rcemment associe SMC pour mettre sur pied et fournir des activits de FMC en lien avec l'urologie aux fournisseurs de soins de sant partout au Canada.
CUA 2012 BA NFF
Science & Medicine Canada (SMC) is a Toronto-based continuing health education (CHE) agency with over 20
SeeMore USB ultrasound probes are affordable & application-specific abdominal, endocavity, vascular access, MSK, and regional nerve block. The system is compatible with most laptop, netbook & tablet computers running Windows; all software is included and can be downloaded to any number of computers the ultimate in portability. www.seemore.ca
57
SIEMENS
Booth / Kiosque : 13 Contact: Richard Newman 6865 Century Ave., Suite 3001 Mississauga, ON, L5N 2E2 T: 416-786-1949 F: 905-593-4602 E: richard.newman@siemens.com
For 100 years the innovative ideas from Siemens have helped make Canada a better place. From the Atlantic to Pacific oceans, more than 4,400 employees in Canada work together to provide answers that last in the fields of industry, energy and healthcare, as well as deliver infrastructure solutions for cities. Since it was federally chartered in August of 1912, Siemens has stood for technical achievements, innovation, quality and reliability. Sales for Siemens in Canada in fiscal 2011 (ended September 30), were $3.0 billion CAD. The company has 61 offices and 13 manufacturing/assembly facilities across Canada. Further information is available at www.siemens.ca.
SOCIT INTERNATIONALE D'UROLOGIE (SIU) Booth / Kiosque : 64 Contact: 1155 University, Suite 1155 Montreal, QC, H3B 3A7 T: 514-875-5665 F: 514-875-0205 E: central.ofce@siu-urology.org
septembre) slevaient 3 milliards de dollars canadiens. La compagnie exploite 61 bureaux et 13 usines au Canada. Pour en savoir davantage, consultez le site www.siemens.ca.
58
Depuis 100 ans, les ides novatrices de Siemens contribuent la qualit de vie au Canada. De lAtlantique au Pacique, plus de 4 400 employs travaillent ensemble au Canada pour apporter des rponses dans les domaines de lindustrie, de lnergie et de la sant, tout en proposant des solutions pour les infrastructures urbaines. Depuis quelle a obtenu sa charte fdrale en aot 1912, Siemens est synonyme de ralisations techniques, dinnovation, de qualit et de abilit. Les ventes de Siemens Canada pour lexercice nancier 2011 (qui a pris n le 30
CUA 2012 BANFF
The SIU is an international professional organization serving urologists and acting as a platform for sustainable urological education and collaborative humanitarian activities to improve urological care worldwide. Visit our booth for details on SIU 2012 in Fukuoka, Japan, September 30-October 4, and our 2013 Congress in Vancouver, October 20-24! La SIU est une organisation internationale professionnelle au service des urologues, une tribune servant leducation continue et au dveloppement de projets humanitaires pour lamlioration et le perfectionnement des soins urologiques travers le monde. Visitez notre stand pour obtenir plus de dtails sur les prochains congrs de la SIU, Fukuoka au Japon, du 30 Septembre au 4 octobre 2012 et Vancouver, du 20 au 24 octobre 2013!
THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE Booth / Kiosque : 67 Contact: Linda Molenda 980 Oliver Road Thunder Bay, ON, P7B 6V4 T: 807-684-6028 F: 807-684-5893 E: molendal@tbh.net
TRITON PHARMA INC. Booth / Kiosque : 37 Contact: Robert Ohayon 1001, de Maisonneuve Blvd. West, Room #940 Montreal, QC, H3A 3C8 T: 514-288-0333, x 22 F: 514-288-5397 E: robert.ohayon@tritonpharma.ca
Thunder Bay Regional Health Sciences Centre (TBRHSC) is recruiting a full time Urologist. TBRHSC is a state-of-the-art Academic Health Sciences Centre, with 375 acute care beds, providing regional services to a population base of 250,000 people. We are the Regional Trauma and Cancer Referral Centre(s) for Northwestern Ontario, and are affiliated with the Northern Ontario School of Medicine (NOSM) and the Thunder Bay Regional Research Institute (TBRRI).
Privately held - President: Sybil Dahan Operational as of January 2005 Markets several products with particular focus on womens health Vaniqa: unwanted facial hair Enablex: overactive bladder Oesclim Patch: estrogen TD therapy Bellergal Spacetabs: non-hormonal treatment of menopause - Estragyn Vaginal Cream: atrophic vaginitis Dermatology:
CUA 2012 BA NFF
- Topiderm HC 2% cream: dermatoses - Dermaflex-20 cream: urea cream - Dermaflex HC 1% cream & lotion: urea & hydrocortisone 1% Q-Urol: Natural Health Product: chronic pelvic pain syndrome (CPPS)
Cysta-Q: Natural Health: painful bladder syndrome/interstitial cystitis Website: www.tritonpharma.ca
59
ULTRAMED INC.
Booth / Kiosque : 61 Contact: 50 Steeles Avenue East, Suite 15 Milton, ON, L9T 4W9 T: 905-878-4400 F: 905-878-5044 E: sales@ultramedinc.com
Ultramed Inc. is pleased to exhibit the finest quality equipment for members. R. Wolf Endoscopy, Downs Surgical hand held instruments, PNN (Wallsten) Balloon Ablation, Uroplasty Urinary Incontinence and Wallach Diagnostic and Therapeutic Gynaecology equipment are just some of the superior products we have available for no charge trial and evaluation.
UROLOGY NURSES OF CANADA Table in Foyer Contact: Francis Stewart East Wing - 3rd Floor, Women's College Hospital Toronto, ON, M5S 1B6 T: 416-323-6400, x 4437 F: 416-323-6237 E: fran.stewart@hotmail.com VANTAGE ENDOSCOPY Booth / Kiosque : 14 Contact: Kevin Noseworthy 151 Amber St., Unit 14 Markham, ON, L3R 3B3 T: 866-677-4121 F: 866-677-4122 E: kevinn@vantageendoscopy.com
60
The Urology Nurses of Canada is a National Not-for-Profit Organization whose mandate is to enhance the specialty of Urologic nursing in Canada by promoting education research and clinical practice. The activities of the UNC are designed to enrich members' professional growth and development. We thank the CUA for their ongoing support.
Ultramed Inc. est heureuse de prsenter son matriel de la plus grande qualit vos membres. Les instruments de gyncologie diagnostique et thrapeutique R. Wolf Endoscopy, Downs Surgical hand held instruments, PNN (Wallsten) Balloon Ablation, Uroplasty Urinary Incontinence et Wallach ne sont que quelques-uns des produits suprieurs que nous offrons dans le cadre dun programme gratuit dessai et dvaluation.
CUA 2012 BANFF
Vantage Endoscopy based in Markham with national Canadian representation is pleased to service the urology and Urogynecological markets as the exclusive supplier of Life-Tech urodynamics and Neomedic slings. With outstanding products, Canadian service and support and very competitive pricing, please stop by our booth and come see what we have to offer.

WARNEX MEDICAL LABORATORIES Booth / Kiosque : 56 Contact: Catherine Sartoros 3885 Industriel Blvd. Laval, QC, H7L 4S3 T: 450-663-6724, x 277 F: 450-663-4428 E: pca3@gamma-dynacare.ca
WATSON PHARMA COMPANY Booths / Kiosques : 57/58 Contact: Peter Dale 2295 Bristol Circle, Unit 104 Oakville, ON, L6H 6P8 T: 905-855-4428 F: 905-855-4433 E: peter.dale@watson.com
Warnex Medical Laboratories offers a PCA3 testing service, a new gene-based tool to help detect prostate cancer from a urine sample. PCA3 can be used to help identify new prostate cancers, patients who should have a repeat biopsy, or candidates for active surveillance following a prostate cancer diagnosis. Warnex laboratoires mdicaux offre un service danalyse PCA3, un nouvel outil bas sur la gntique aidant dtecter le cancer de la prostate partir dun chantillon durine. Lanalyse PCA3 peut tre utilis pour aider dtecter un nouveau cancer de la prostate, identier les patients chez qui une autre biopsie serait ncessaire et identier les candidats ncessitant une surveillance active suite un diagnostic de cancer de la prostate.
Watson Pharma Company is the newly formed Canadian subsidiary of Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading integrated global pharmaceutical company. Watson Pharma Company is engaged in the marketing, sale and distribution of branded pharmaceutical products and biologics within the Canadian market. We are focused on delivering innovative products that address key therapeutic categories in Urology and Women's Health.
CUA 2012 BA NFF
Watson Pharma Company est la nouvelle liale canadienne de Watson Pharmaceuticals, Inc. (NYSE : WPI), une importante socit pharmaceutique internationale intgre. Watson Pharma Company soccupe du marketing, de la vente et de la distribution de produits et biologiques pharmaceutiques de marque sur le march canadien. Nous nous concentrons offrir des produits innovateurs dans les domaines thrapeutiques de lurologie et de la sant des femmes. Abbott
61
INVITED FACULTY / CONFRENCIERS INVITS
Richard S. Foster, MD Indiana University School of Medicine Department of Urology Indianapolis, IN Keith Jarvi, MD Professor of Surgery, Division of Urology, Department of Surgery at the University of Toronto, Chief of Urology; Director of the Murray Koffler Urologic Wellness Centre at the Mount Sinai Hospital Toronto, ON Gerald Jordan, MD Urology Professor, Eastern Virginia Medical School Chairman Devine Center for Genitourinary Reconstructive Surgery, Sentara Norfolk General Hospital Norfolk, VA Kevin T. McVary, MD, FACS Attending Urologist Professor of Urology, Feinberg School Northwestern Memorial Hospital Chicago, IL Manoj Monga, MD, FACS Director, Stevan B. Streem Center for Endourology & Stone Disease Glickman Urological & Kidney Institute The Cleveland Clinic Foundation Shaker Heights, OH
Mark A. Moyad, MD, MPH Jenkins/Pokempner Director of Preventive & Complementary Medicine at the University of Michigan Medical Center (Department of Urology) Ann Arbour, MI Victor Nitti, MD Professor and Vice Chairman Department of Urology New York University Langone Medical Center New York, NY Hiep Nguyen, MD Urology Children's Hospital Boston, Harvard Medical School Boston, MA
CUA 2012 B A NFF
Richard M. Satava, MD, FACS Professor of Surgery Department of Surgery University of Washington Medical Center Seattle, WA Mark Schoenberg, MD Director of Urologic Oncology The James Buchanan Brady Urological Institute The Johns Hopkins Medical Institutions Baltimore, MD
Pramod C. Sogani, MD Attending Surgeon Professor of Urology Memorial Sloan-Kettering Cancer Center New York, NY
63
WINNER IN A CLINICAL TOPIC
GAGNANT DE LA CATGORIE SUJET CLINIQUE
CUA PRIZE ESSAY / TRAVAIL PRIM DE LAUC
The prize for the winning essay in a Clinical topic is awarded to Dr. Philippe Denis Violette of Division of Urology, McGill University Health Centre, Montreal, QC, for his essay Solitary Solid Renal Mass: Can We Predict Malignancy? (abstract POD-03.05). No essays were submitted in the Basic Science category.
Le prix du meilleur travail portant sur un sujet en recherche clinique a t dcern au Dr. Philippe Denis Violette de la Division of Urology, McGill University Health Centre, Montral, QC, pour son travail intitul Solitary Solid Renal Mass: Can We Predict Malignancy? (rsum POD-03.05). 64 Aucun travail na t soumis dans la catgorie recherche fondamentale.
CUA 2012 BANFF
CUA AND AFFILIATED MEETINGS / CUA ET VNEMENTS AFFILIS

FRIDAY / VENDREDI J UNE 22 JUIN S ATUR DAY / SA MEDI JUNE 23 J UIN
0900-1200 CUA Finance Committee

Comit des nances de lAUC
Room / Salle : Angus
0730-1330 7th Annual Canadian Association of Genitourinary Medical Oncology (CAGMO) Meeting | Part 2
7ime Assemble annuelle de lAssociation canadienne doncologie mdicale gnito-urinaire I Part 2
Room / Salle : New Brunswick
1000-1700 7th Annual Canadian Association of Genitourinary Medical Oncology (CAGMO) Meeting | Part 1
7ime Assemble annuelle de lAssociation canadienne doncologie mdicale gnito-urinaire I Part 1
Room / Salle : New Brunswick
0800-1200 Canadian Academy of Urological Surgeons (CAUS)
Acadmie canadienne des chirurgiens oncologues (CAUS)
1200-1700 CUA Executive Committee

Comit excutif de lAUC
Room / Salle : Alberta
Room / Salle : Baron Shaughnessy
0800-1230 CUA Patient Information Committee (PIC)

Comit info-patients de lAUC (PIC)
Room / Salle : Empress CUA 2012 B A NFF
1700-1800 Medical Advisory Board of Kidney Cancer Canada

Le Conseil mdical consultatif de l'Association canadienne du cancer du rein
0830-1300 CUA Socioeconomic Committee
Comit socioconomique de lAUC

Room / Salle : Victoria
1200-1430 CUOG Executive Committee Meeting

Comit excutif du CUOG
1200-1700 CUA Executive Committee

Comit excutif de lAUC
Room: Alberta
65

S UNDAY / DIMA NCHE JUNE 24 J UIN
1200-1700 Specialty Committee, Royal College of Physicians and Surgeons of Canada

Comit des Spcialits, Collge royal des mdecins et chirurgiens du Canada
Room / Salle : Coleman
0700-0830 Canadian Urological Research Consortium (CURC)

Runion du CURC
Room / Salle : Beatty
1230-1400 CKCIS Meeting

Runion CKCIS
Room / Salle : Ivor Petrak
0800-1100 CUAJ - Peer-Reviewed Workshop

Atelier JAUC: valuation par les pairs
Room / Salle : Coleman
1300-1700 Residency Affairs Committee (RAC) 66

Comit des affaires des rsidents (RAC)
Room / Salle : McKenzie
0830-1000 CUA Nominating Committee

Comit des candidatures de lAUC
1400-1600 Canadian Endourology Group

CUA 2012 BANFF
Groupe canadien dendo-urologie

0840-0940 Clinical Epidemiology Group

Runion du Groupe dpidmiologie clinique
1430-1700 CUOG Annual General Meeting

Assemble gnrale annuelle du CUOG
1000-1100 CUASF Scientic Council

Conseil scientique de la FBAUC
Room / Salle : Empress
1015-1115 Continuing Professional Development Meeting

Conseil scientique de l'AUC - Programme de bourse Astellas
Room / Salle : Strathcona

MONDAY / LUNDI J UNE 25 J UIN TUESDAY / M ARDI J UNE 26 J UIN
1100-1200 CUA Astellas Grant Program Scientic Council

Comit de dveloppement professionnel continu (CDP)
1600-1730 Bladder Cancer Canada Medical Advisory Board and Medical Research Board Meeting
Cancer de la vessie Canada
Room / Salle : Frontenac
1300-1500 CUASF Administrative Council

Comit administratif de la FBAUC
1600-1800 Urology Nurses of Canada

Inrmires en urologie du Canada
1330-1730 Pediatric Urologists of Canada (PUC) Meeting

Runion de la PUC
1700-1800 International Volunteer Urology - Cancirc

Bnvoles en urologie internationale
0700-0900 CUA Annual General Meeting

Assemble gnrale annuelle de lAUC
Room / Salle : Baron Shaughnessy/Beatty
0630-0800 Council of Canadian University Urology Chairs (CCUUC)

CCUUC
Room / Salle : Palliser
0900-1130 Canadian Male Sexual Health Council (CMSHC)

Conseil canadien sur la sant sexuelle de lhomme (CMSHC)
Room / Salle : Strathcona
0800-1000 CUAJ Editorial Board Meeting

Comit de redaction du Journal de lAUC
1200-1300 SIU Canadian Section

Section Canadienne de la SIU
Room / Salle : AngusThis event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and is co-developed and approved by the Canadian Urological Association
CUA 2012 B A NFF
67
AGENDA HOW TO DEVELOP A STRONG ACADEMIC PROGRAM IN CANADA

8:00 to 8:30 8:30 to 8:40 8:40 to 9:10 9:10 to 9:20 9:20 to 9:50 9:50 to 10:00 10:00 to 10:20 10:20 to 10:50 10:50 to 11:00 11:00 to 11:30 11:30 to 12:00 Room: Baron Shaughnessy Date: Saturday June 23rd, 2012
CANADIAN ACADEMY OF UROLOGICAL SURGEONS (CAUS) BANFF 2012
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and is co-developed and approved by the Canadian Urological Association
Breakfast Welcome and Opening Remarks Dr. Larry Goldenberg - Department of Urology vs. Division. Does It Matter? Discussion Dr. Sender Herschorn- Developing a Culture of Research and Academics Discussions Health Break Dr. John Denstedt- Academic Urology: A Chairman of Surgery's Perspective Discussion Panel Discussion (Financial and Funding Strategies) Dr. Armen Aprikian (Moderator). Business Meeting
68
CUA 2012 BANFF
FRIDAY / VENDREDI
JUNE 22 JUIN
0900-1200
CUA Finance Committee / Comit des finances de lAUC

Room Salle: Angus
1000-1700
7th Annual Canadian Association of Genitourinary Medical Oncology (CAGMO) Meeting | Part 1
7e Runion annuelle de lAssociation canadienne doncologie mdicale gnito-urinaire
Room Salle: New Brunswick
1200-1700
CUA Executive Committee / Comit excutif de lAUC

Room Salle: Alberta
1700-1800
The Medical Advisory Board of Kidney Cancer Canada

Le Conseil mdical consultatif de lAssociation canadienne du cancer du rein
Room Salle: Angus
CUA 2012 B A NFF
69
SATURDAY / SAMEDI
JUNE 23 JUIN
0730-1330
7th Annual Canadian Association of Genitourinary Medical Oncology (CAGMO) Meeting | Part 2
7ime Assemble Annuelle de lAssociation canadienne doncologie mdicale gnito-urinaire
Room Salle: New Brunswick
0800-1200
Canadian Academy of Urological Surgeons (CAUS)

Acadmie canadienne des chirurgiens oncologues (CAUS)
Room Salle: Baron Shaughnessy
0800-1230
CUA Patient Information Committee (PIC)

Comit info-patients de lAUC (PIC)
Room Salle: Empress
70
0800-1300
CUA Socioeconomic Committee / Comit socioconomique de lAUC

Room Salle: Victoria
1200-1430
CUOG Executive Committee Meeting / Comit excutif du CUOG

Room Salle: Angus
1200-1700
CUA 2012 BANFF
CUA Executive Committee / Comit excutif de lAUC

Room Salle: Alberta
SATURDAY / SAMEDI
JUNE 23 JUIN
1200-1700
RCPSC Specialty Committee Meeting in Urology

Comit des Spcialits, Collge Royal des mdecins et chirurgiens du Canada
Room Salle: Coleman
1230-1400
CKCIS Meeting / Runion CKCIS

Room Salle: Ivor Petrak
1300-1700
Residency Affairs Committee (RAC)

Comit des affaires des residents (RAC)
Room Salle: McKenzie
1400-1600
Canadian Endourology Group / Groupe canadien dendo-urologie

Room Salle: Beatty
1430-1700
CUOG Annual General Meeting

Assemble gnrale annuelle du CUOG
Room Salle: Baron Shaughnessy CUA 2012 B A NFF
71
SUNDAY / DIMANCHE
JUNE 24 JUIN
0700-0830
Canadian Urological Research Consortium (CURC) Meeting

Runion du CURC
1 2 3 4 5 1 2 3 Room Salle: Beatty
0800-1100
CUAJ Peer-Reviewed Workshop

Atelier JAUC: valuation par les pairs
Room Salle: Coleman
0800-0810
Welcome / Mot de Bienvenue

Room Salle: Van Horne A
Michael Chetner, CUA President | Prsident de lAUC Jay Lee & Trevor Schuler Scientific Committee Co-chairs | Co-prsident du comit scientifique
0810-0840
SOA1
State-of-the-Art Lecture 1 / Confrence d'honneur 1

Update in Endourology: SWL and PCNL Mise jour en endo-urologie : LECOC et NLPC
Introduction: Trevor Schuler, Edmonton, AB
Speaker/Confrencier: Manoj Monga, Shaker Heights, OH
Objectives / Objectifs Review current literature to refine patient selection for SWL
Identify modifications in SWL treatment protocols designed to maximize efficacy and decrease morbidity
Discuss role for ureteral stenting and medical expulsive therapy Identify techniques to optimize preoperative planning and intraoperative implementation of percutaneous renal access
Describe new innovations in technique and technology for PCNL designed to optimize results
Passer en revue les articles rcents an d'amliorer la slection des patients pour une LECOC
Prciser les modications apporter aux protocoles thrapeutiques par LECOC en vue de maximiser lefcacit et de rduire la morbidit Discuter du rle des endoprothses urtrales et du traitement par des mdicaments favorisant l'expulsion
CUA 2012 B A NFF
73
SUNDAY / DIMANCHE
4 5
JUNE 24 JUIN
Identier les techniques permettant doptimiser la planication propratoire et linstauration peropratoire dun accs rnal percutan Dcrire les rcentes innovations techniques et technologiques concernant la NLPC en vue de loptimisation des rsultats
0830-1000
CUA Nominating Committee / Comit des candidatures de lAUC

Room Salle: Angus
0840-0940
Clinical Epidemiology Group

Runion du Groupe dpidmiologie clinique
0840-0940
POD-01
Podium Session 1: Stones and Imaging 74

Sance Podium 1: Lithiases et imagerie
Moderators/Modrateurs: Ben Chew, Vancouver, BC Manoj Monga, Shaker Heights, OH

CUA 2012 BANFF
0840-0850
POD-01.01
Surgical Management of Kidney Stone Disease: a Population-based Time Series Analysis

Ordon, Michael1; Saskin, Rek2; Mamdani, Muhammad3; Urbach, David2; Honey, R. John D'A.1; Pace, Kenneth1 1 St. Michael's Hospital, Toronto, ON, Canada; 2Institute for Clinical and Evaluative Sciences, Toronto, ON, Canada; 3Applied Health Research Centre, St. Michael's Hospital, Toronto, ON, Canada
0850-0900
POD-01.02
Ultra-low Dose CT Comparable to Standard CT in Patients with Suspected Renal Colic

Archambault, Jason1; Sivalingam, Sri2; Hrymak, Carmen1; Kirkpatrick, Iain1 1 University of Manitoba, Winnipeg, MB, Canada; 2University of Wisconsin, Madison, WI, United States
SUNDAY / DIMANCHE
JUNE 24 JUIN
0900-0910
POD-01.03
Therapeutic Benefits of Solifenacin (Vesicare) in the Mitigation of Ureteral Stent-induced Pain and Lower Urinary Tract Symptoms (LUTS) Post Ureteroscopy for Stone Management
1
Zadra, Joseph1; Hoare, Dylan2; Hartsburg, Cory1; Ray, Andrew1; Iocca, Angelo1 Barrie Urology Associates, Barrie, ON, Canada; 2Queen's University, Kingston, ON, Canada
0910-0920
POD-01.04
Impact of Radiological Technologists on the Outcome of Shock Wave Lithotripsy

Elkoushy, Mohamed; Morehouse, Douglas; Anidjar, Maurice; Elhilali, Mostafa; Andonian, Sero McGill University Health Center, Montreal, QC, Canada
0920-0930
POD-01.05
Cost-effectiveness of Shock Wave Frequencies of 60 versus 120 Shocks per Minute for Upper Ureteral Stones: Economic Analysis of a Randomized, Double-blind Trial
1
Klinghoffer, Zachary1; Tu, Hin Yu Vincent1; Pace, Kenneth2 McMaster University, Hamilton, ON, Canada; 2University of Toronto, Toronto, ON, Canada
0930-0940
POD-01.06
The Influence of Body Mass Index on Outcomes Following Percutaneous Nephrolithotomy: a Global Perspective
Fuller, Andrew1; Razvi, Hassan1; Denstedt, John D.1; Nott, Linda1; de la Rosette, Jean2 1 Division of Urology, Department of Surgery, The University of Western Ontario, London, ON, Canada; 2Department of Urology, AMC University Hospital, Amsterdam, Netherlands
0940-1010
Break in Exhibit Hall / Pause dans le hall dexposition

Room Salle: Van Horne BC and/et Foyer
1000-1100
CUASF Scientific Council / Conseil scientifique de la FBAUC

Room Salle: Empress
CUA 2012 B A NFF
75
SUNDAY / DIMANCHE
1 2 3 1 2 3
JUNE 24 JUIN
1010-1100
EF1
Educational Forum 1 / Forum ducatif 1

Complications of Stone Management Complications de la prise en charge des calculs rnaux

Moderator/Modrateur: Ben Chew, Vancouver, BC Faculty/Facult: Trevor Schuler, Edmonton, AB John Dushinski, Calgary, AB
Objectives / Objectifs
To review the complications and management of operative surgical procedures for kidney stones including extracorporeal shockwave lithotripsy, ureteroscopy and percutaneous nephrolithotomy To review complications of residual stone fragments and their natural history To review complications of medical management of kidney stone disease including medication interactions and side effects Examiner les complications et la gestion des interventions chirurgicales visant lextraction des calculs rnaux, dont la lithotripsie extracorporelle par ondes de choc, lurtroscopie et la nphrolithotomie percutane Examiner les complications lies aux fragments rsiduels de calculs et leur volution naturelle
76
1015-1115
CUA 2012 BANFF
Examiner les complications de la prise en charge par mdicaments des calculs rnaux, y compris les interactions mdicamenteuses et les effets secondaires
Continuing Professional Development Meeting

Runion du comit de dveloppement professionnel continu (CDP)
Room Salle: Strathcona
SUNDAY / DIMANCHE
1 2 3 4 1 2 3 4
JUNE 24 JUIN
1100-1130
SOA2
State-of-the-Art Lecture 2 (CAUS Lecture) /

Confrence d'honneur 2 (Confrence de la CAUS)
Uretheral Reconstruction: What Does the Evidence Support? Reconstruction urtrale : Vers quoi pointent les donnes?
Introduction: Keith Rourke, Edmonton, AB Speaker/Confrencier: Gerald Jordan, Norfolk, VA
Objectives / Objectifs The attendees will after this lecture have an understanding of the current terminology and anatomy of the urethra, as they relate to Urethral reconstruction
The attendees will after this lecture have an understanding of the thinking mechanisms related to selection of urethral management or curative techniques The attendees will after this lecture have been exposed to select techniques of urethral reconstruction as they relate to the general urologists practice
CUA 2012 B A NFF
The attendees will have been apprised concerning the methodology of analysis regarding the literature supported recommendations presented Aprs cette prsentation, les participants auront une bonne comprhension de lanatomie de lurtre et de la terminologie connexe, en particulier en lien avec la reconstruction urtrale
Aprs cette prsentation, les participants auront une bonne comprhension des mcanismes de rexion en lien avec la slection des techniques de prise en charge ou de traitement des troubles urtraux Aprs cette prsentation, les participants auront pris connaissance de techniques particulires de reconstruction urtrale pouvant tre utilises dans la pratique gnrale de lurologie Les participants auront t informs au sujet de la mthodologie analytique utilise avec les recommandations appuyes par la documentation
1100-1200
CUA Astellas Grant Program Scientific Council

Room Salle: Empress
Conseil Scientifique de lAUC - Programme de bourse Astellas
1130-1230
Opening Brunch in the Exhibit Hall

Brunch de bienvenue dans le hall d'exposition
77
SUNDAY / DIMANCHE
1 2 3 1 2 3
JUNE 24 JUIN
1230-1320
EF2

Current Management of Genitourinary Trauma Prise en charge actuelle des traumatismes de lappareil gnito-urinaire
Moderator/Modrateur: Keith Rourke, Edmonton, AB Faculty/Facult: Ron Kodama, Toronto, ON Gerald Jordan, Virgina, VA Keith Rourke, Edmonton, AB
Objectives / Objectifs Outline the acute management options for a posterior urethral disruption
Gain an appreciation for the treatment of pelvic fracture urethral distraction defects (PFUDD) Discuss the diagnosis and treatment of common genital injuries Faire ressortir les options de prise en charge aigu dune rupture de lurtre postrieur Comprendre le traitement des lsions urtrales aprs fracture pelvienne Discuter du diagnostic et du traitement des lsions gnitales courantes
78
1300-1500
1320-1330
1330-1730
1330-1430
CUA 2012 BANFF
CUASF Administrative Council / Comit administratif de la FBAUC

Room Salle: Empress
AUA Presidential Address / Allocution du Prsident de l'AUA

Introduction: Michael Chetner, Calgary, AB Speaker/Confrencier: Dr. Pramod Sogani, New York, NY
Pediatric Urologists of Canada (PUC) Meeting / Runion de la PUC

POD-02
Podium Session 2: Oncology

Sance Podium 2: Oncologie
Moderators/Modrateurs: John Izawa, London, ON Yves Fradet, Quebec, QC
SUNDAY / DIMANCHE
JUNE 24 JUIN
1330-1340
POD-02.01
MDV3100, an Androgen Receptor Signaling Inhibitor (ARSI), Improves Overall Survival in Prostate Cancer Patients Post-docetaxel: Results from the Phase 3 Affirm Study
Saad, Fred1; Scher, Howard2; Fizazi, Karim3; Mulders, Peter4; Taplin, Mary Ellen5; Sternberg, Cora6; Miller, Kurt7; de Wit, Ron8; Hirmand, Mohammad9; Selby, Bryan9; De Bono, Johann10 1 Centre hospitalier de lUniversit de Montral, Montral, QC, Canada; 2 Memorial Sloan-Kettering Cancer Center, New York, NY, United States; 3University of Paris Sud, Villejuif, France; 4Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; 5 Dana-Farber Cancer Institute, Boston, MA, United States; 6San Camillo-Forlanini Hospital, Rome, Italy; 7Charit Universittsmedizin, Berlin, Germany; 8Erasmus University Medical Center, Rotterdam, Netherlands; 9Medivation Inc., San Francisco, CA, United States; 10 The Institute for Cancer Research and Royal Marsden Hospital, Sutton, United Kingdom
1340-1350
POD-02.02
Neoadjuvant Gemcitabine/Cisplatin Chemotherapy for Muscle Invasive Urothelial Carcinoma of the Bladder: a Single Institution Experience
1
El-Gehani, Faraj1; Venner, Peter2; Ghosh, Sunita2; North, Scott2 Department of Medical Oncology, Edmonton, AB, Canada; 2Cross Cancer Institute, Edmonton, AB, Canada
1350-1400
POD-02.03
Regional Differences in Practice Patterns and Outcomes after Radical Cystectomy
Bachir, Bassel G.1; Ya, Faysal A.1; Aprikian, Armen1; Chin, Joseph L.2; Izawa, Jonathan2; Fradet, Yves3; Lacombe, Louis3; Drachenberg, Darrel4; Estey, Eric5; Farey, Adrian5; Rendon, Ricardo6; Bell, David6; Lattouf, Jean-Baptiste7; Cagiannos, Ilias8; Kassouf, Wassim1 1 McGill University Health Center, Montreal, QC, Canada; 2University of Western Ontario, London, ON, Canada; 3Laval University, Quebec, QC, Canada; 4University of Manitoba, Winnipeg, MB, Canada; 5University of Alberta, Edmonton, AB, Canada; 6Dalhousie University, Halifax, NS, Canada; 7University of Montreal, Montreal, QC, Canada; 8University of Ottawa, Ottawa, ON, Canada
1400-1410
POD-02.04
The Association between Statin Medication Use and Progression after Surgery for Localized Renal Cell Carcinoma
Hamilton, Robert; Morilla, Daniel; Cabrera, Fernando; Bernstein, Melanie; Reuter, Victor; Russo, Paul Memorial Sloan-Kettering Cancer Center, New York, NY, United States
CUA 2012 B A NFF
79
SUNDAY / DIMANCHE
JUNE 24 JUIN
1410-1420
POD-02.05
Does Surgeon and Hospital Volume Impact Outcomes of Surgery for Renal Cell Carcinoma with Inferior Vena Caval Involvement? Results of a Canadian Population-based Study
Toren, Paul1; Abouassaly, Robert2; Yap, Stanley1; Timilshina, Narhari1; Kulkarni, Girish1; Finelli, Antonio1 1 University of Toronto, Toronto, ON, Canada; 2Case Western University, Cleveland, OH, United States
1420-1430
1 2 3 1
POD-02.06
The Association between Renal Tumor Scoring System and Partial Nephrectomy Complications
Darren Desantis, Darren1; Lavalle, Luke T.1; Breau, Rodney H.1; Kamal, Fadi1; Watterson, James1; Blew, Brian1; Mallick, Ranjeeta2; Fergusson, Dean2; Morash, Chris1; Cagiannos, Ilias1 1 University of Ottawa / The Ottawa Hospital, Ottawa, ON, Canada; 2The Ottawa Hospital Research Institute, Ottawa, ON, Canada
80
1430-1500
Break in Exhibit Hall and Laparascopic Skills Competition

Pause dans le hall d'exposition et concours dadresse en laparoscopie
1500-1530
CUA 2012 BANFF
SOA3

Testis Cancer Cancer du testicule

Introduction: Niels Jacobsen, Edmonton, AB Speaker/Confrencier: Richard Foster, Indianapolis, IN
Objectives / Objectifs Discuss controversies in the management of low stage testis cancer
Discuss different approaches to the post chemotherapy mass in high stage testis cancer Identify long term side effects of testis cancer chemotherapy
Discuter des controverses entourant la prise en charge du cancer du testicule aux premiers stades
SUNDAY / DIMANCHE
2 3 1 2 3 1 2 3
JUNE 24 JUIN
Discuter diffrentes approches thrapeutiques en cas de masse postchimiothrapie dans les cancers du testicule aux stades avancs Identier les effets secondaires long terme de la chimiothrapie utilise contre le cancer du testicule
1530-1620
EF3

High Risk Superficial Bladder Cancer Cancer vsical superficiel risque lev
Moderator/Modrateur: Bobby Shayegan, Hamilton, ON Faculty/Facults: Wassim Kassouf, Montreal, QC Jonathan Izawa, London, ON Bobby Shayegan, Hamilton, ON
Objectives / Objectifs Define high risk non-muscle invasive urothelial carcinoma of the bladder (high risk NMIBC) and describe its natural history
Describe intravesical options for management of high risk NMIBC Describe salvage options for high risk NMIBC
CUA 2012 B A NFF
Dnir le carcinome urothlial de la vessie risque lev sans envahissement musculaire et dcrire son volution naturelle Dcrire les options thrapeutiques intravsicales dans ce type de carcinome Dcrire les options de sauvetage possibles avec ce type de carcinome
81
SUNDAY / DIMANCHE
1 2 3 1 2 3
JUNE 24 JUIN
1620-1650
SOA4

Quality Assurance in Bladder Cancer Assurance de la qualit dans le cancer de la vessie

Introduction: Eric Hyndman, Calgary, AB Speaker/Confrencier: Mark Schoenberg, Baltimore, MD
Objectives / Objectifs Understand the morbidity of cystectomy

Understand strategies for minimizing morbidity related to cystectomy Understand the alternatives to cystectomy Comprendre la morbidit associe la cystectomie Comprendre les stratgies permettant de rduire au minimum la morbidit lie la cystectomie Comprendre les options de rechange la cystectomie
82
1900-2230
CUA 2012 BANFF
CUA Fun Night / Grande soire de l'AUC The Fairmont Banff Springs Hotel
Rooms Salles: Riverview Lounge, Alberta & New Brunswick
MONDAY / LUNDI
JUNE 25 JUIN
0700-0900
CUA Annual General Meeting / Assemble gnrale annuelle de lAUC

Rooms Salles: Baron Shaughnessy/Beatty
0900-1130
1 2 3 1 2 3
Canadian Male Sexual Health Council (CMSHC)

Conseil Canadian sur la sant sexuelle de lhomme (CMSHC)
Room Salle: Strathcona
0910-0920
CP1
Clinical Pearls That Could Change Your Practice

Des perles cliniques qui pourraient changer votre pratique
Speaker/Confrencier: Niels Jacobsen, Edmonton, AB
0920-0950
SOA5
State-of-the-Art Lecture 5 / Confrence dhonneur 5

Mens Health-Diet and Supplementation from A to Z: What Works and What is Worthless? Sant des hommes Alimentation et supplments de A Z : Ce qui fonctionne et ce qui ne vaut pas le coup
Introduction: Martin Duffy, Calgary, AB
Speaker/Confrencier: Mark Moyad, Ann Arbour, MI
Objectives / Objectifs To discuss rules and regulations regarding diet and supplements for mens health
To discuss clinical studies hat support recommending specific dietary changes and supplements to your patients To discuss clinical studies that do NOT support recommending some specific dietary changes and supplements to your patients
Discuter des rgles concernant lalimentation et les supplments dans la sant des hommes
Discuter des tudes cliniques appuyant la recommandation de modications particulires lalimentation et lemploi de supplments prcis pour vos patients Discuter des tudes cliniques qui nappuient PAS la recommandation de modications particulires lalimentation et lemploi de supplments prcis pour vos patients
CUA 2012 B A NFF
83
MONDAY / LUNDI
JUNE 25 JUIN
0950-1020

1020-1120
POD-03
Podium Session 3: General Topics

Sance Podium 3: Sujets gnrales
Moderators/Modrateurs: Andrew McNeilly, Vancouver, BC Hiep Ngyen, Boston, MA
1020-1030
POD-03.01
Laparoscopic Ureteric Clipping: a Simple Alternative in the Treatment of Ectopic Ureters Associated with a Non-functioning Upper Moiety 84
Romao, Rodrigo L.P.; Figueroa, Victor H.; Pippi Salle, Joao L.; Koyle, Martin; Bagli, Darius; Lorenzo, Armando J. The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
1030-1040
POD-03.02
1040-1050
1050-1100
CUA 2012 BANFF
The Association between Continence, Shunt, and Quality of Life in Spina Bifida
Olesen, Jamie; Kiddoo, Darcie; Metcalfe, Peter University of Alberta, Edmonton, AB, Canada
POD-03.03
Does Antibiotic Prophylaxis Prevent Urinary Tract Infections in Infants with Antenatally Detected Hydronephrosis? A Systematic Review and Meta-analysis
Braga, Luis1; Lorenzo, Armando2; Pemberton, Julia1; DeMaria, Jorge1; Kim, Soojin1; Milijovic, Hana1 1 McMaster University, Hamilton, ON, Canada; 2University of Toronto, Toronto, ON, Canada
POD-03.04
Role of a Novel Internet Mediated Feedback Instrument in a New Age of Simulation Training: a Randomized Control Study
Weber, Bryce1; Bagli, Darius2; Carnahan, Heather3; Gualdron, David Rojas4; Cheung, Jeffrey4; Dubrowski, Adam3 1 Alberta Childrens Hospital, Calgary, AB, Canada; 2Hospital for Sick Children, Toronto, ON, Canada; 3Wilson Centre, Toronto, ON, Canada; 4Sick Kids Learning Institute, Toronto, ON, Canada
MONDAY / LUNDI
JUNE 25 JUIN
1100-1110
1 2 3 4 5 1 2 3 4 5
POD-03.05
Solitary Solid Renal Mass: Can We Predict Malignancy?

Philippe Violette1, Samuel Abourbih1, Konrad M. Szymanski1, Simon Tanguay1, Armen Aprikian1, Keith Matthews1, Fadi Brimo2, and Wassim Kassouf1 1 Division of Urology, McGill University Health Centre, Montreal, QC, Canada; 2Division of Pathology, McGill University Health Centre, Montreal, QC, Canada
1110-1120
POD-03.06
A Prospective Randomized Trial of Povidone-iodine Prophylactic Cleansing of the Rectum prior to Transrectal Ultrasound-guided Prostate Biopsy
Abughosh, Zeid1; Margolick, Joseph1; Goldenberg, Larry1; Afshar, Kourosh1; Taylor, Stephen1; Gleave, Martin1; Bowie, William2; Roscoe, Diane1; Machan, Lindsay1; Black, Peter1 1 Vancouver Prostate Centre, Vancouver, BC, Canada; 2University of British Columbia, Vancouver, BC, Canada
1120-1150
SOA6

BPH & ED / HBP et DE

Introduction: Jay Lee, Calgary, AB Speaker/Confrencier: Kevin McVary, Chicago, IL
CUA 2012 B A NFF
Objectives / Objectifs Know the relationships between ED and LUTS

Know the impact of ED meds on LUTS
Know how treatment of LUTS may impact sexual function
Understand the metabolic risks on the development of LUTS/BPH
Gain an awareness of how to prevent the development of LUTS through lifestyle management Connatre le lien entre la DE et les TUBA Savoir comment le traitement des TUBA peut inuer sur la fonction sexuelle Connatre leffet des mdicaments contre la DE sur les TUBA Comprendre les risques mtaboliques sur lapparition de TUBA ou dune HBP
Dcouvrir comment prvenir lapparition de TUBA par les modications au style de vie
85
MONDAY / LUNDI
JUNE 25 JUIN
1150-1300
1 2 3 1 2 3
Lunch in Exhibit Hall / Djeuner dans le hall dexposition

1200-1300
SIU Canadian Section / Section Canadienne de la SIU

Room Salle: Beatty
1300-1350
EF4

86
Medial vs Early Surgical Intervention for Benign Prostatic Hyperplasia: Treatment Decisions are Driven by Risks, Benefits and Costs Intervention mdicamenteuse ou chirurgicale prcoce dans lhyperplasie bnigne de la prostate : Les dcisions quant au traitement sont fondes sur les risques, les avantages et les cots
Moderator/Modrateur: Ryan Paterson, Vancouver, BC Faculty/Facults: Curtis Nickel, Kingston, ON
(Pro-medical Therapy / Pour le traitement mdicamenteux)
CUA 2012 BANFF
Paul Whelan, Hamilton, ON

(Pro-surgical Therapy / Pour le traitement chirurgical)
Objectives / Objectifs To understand how potential risks (side effects/complications) of medical and surgical intervention for benign prostatic enlargement drives patient decision-making
To learn that long term financial implications of medical and surgical management for benign prostatic enlargement does not play a role in current decision-making To determine whether a new strategy of therapeutic decision-making for benign prostatic hyperplasia should be the future
Comprendre comment les risques potentiels (effets secondaires/complications) des interventions mdicamenteuses et chirurgicales utilises pour traiter lhyperplasie bnigne de la prostate (HBP) inuent sur le processus dcisionnel des patients Voir que les rpercussions nancires long terme de la prise en charge mdicamenteuse et chirurgicale de lHBP ne jouent aucun rle dans le processus dcisionnel actuel Dterminer si une nouvelle stratgie dcisionnelle quant au traitement de lHBP est requise pour lavenir
MONDAY / LUNDI
1 2 3 1 2 3
JUNE 25 JUIN
1350-1420
CUASF Lecture / Allocution de la FBAUC

Male Infertility: The Canary in the Coal Mine Male Infertility Is a Marker for Mens Health: Past, Present and Future Infertilit masculine : le canari dans la mine de charbon Linfertilit comme marqueur de la sant chez les hommes : pass, prsent et futur
Introduction: Ethan Grober, Toronto, ON Speaker/Confrencier: Keith Jarvi, Toronto, ON
Objectives / Objectifs To understand what medical issues are associated with male infertility (Metabolomic syndrome etc.)
To understand the future health problems for men with infertility (higher risk of cancer etc.) To understand which tests are needed to identify men with these other health problems Comprendre les enjeux mdicaux associs linfertilit masculine (syndrome mtabolique, etc.)
CUA 2012 B A NFF
Comprendre les problmes de sant futurs des hommes infertiles (risque accru de cancer, etc.)
Comprendre quels examens sont requis pour cerner les hommes prsentant ces autres problmes de sant
1420-1450
SOA7
The Use of Synthetic Mesh in Vaginal Surgery: Past, Present and Future Utilisation de filet synthtique en chirurgie vaginale: pass, prsent et avenir
Introduction: Kevin Carlson, Calgary, AB Speaker/Confrencier: Victor Nitti, New York, NY
87
MONDAY / LUNDI
1 2 3 1 2 3 1 2 3 1 2 3
JUNE 25 JUIN
Objectives / Objectifs To understand the development of mesh for vaginal prolapse and incontinence surgery
To know the common complications of vaginal mesh and why they happen To understand the current state of governmental and society positions on the use of transvaginal mesh and how this may affect practice Comprendre lutilisation de let en chirurgie pour le prolapsus vaginal et lincontinence. Connatre les complications courantes de lutilisation de let vaginal et les raisons de ces complications Comprendre les positions actuelles au niveau du gouvernement et de la socit concernant lutilisation du let transvaginal et son impact sur la pratique
1450-1520

88
1520-1610
EF5

CUA 2012 BANFF
Office Evaluation and Management of LUTs: Focus on OAB valuation et prise en charge des TUBA en cabinet : Point de mire sur la vessie hyperactive
Moderator/Modrateur: Kevin Carlson, Calgary, AB Faculty/Facult: Greg G. Bailly, Halifax, NS Victor Nitti, New York, NY Kevin Carlson, Calgary, AB
Objectives / Objectifs Develop a strategy for the evaluation and management of a patient with OAB failing an initial trial of anticholinergic therapy
Formulate a rational and effective plan for the evaluation and treatment of men with OAB symptoms Formulate a rational and effective plan for the evaluation and treatment of elderly patients with OAB symptoms
laborer une stratgie pour lvaluation et la prise en charge de cas de vessie hyperactive aprs chec dun traitement initial par anticholinergique Formuler un plan rationnel efcace pour lvaluation et le traitement des hommes afchant des symptmes de vessie hyperactive
Formuler un plan rationnel efcace pour lvaluation et le traitement des personnes ges afchant des symptmes de vessie hyperactive
MONDAY / LUNDI
JUNE 25 JUIN
1600-1730
1600-1800
1610 - 1640
1 2 3 1 2 3
Bladder Cancer Canada Medical Advisory Board and Medical Research Board Meeting
Cancer de la vessie Canada et Runion du Conseil de recherche mdicale
Room Salle: Frontenac
Urology Nurses of Canada / Infirmires en urologie Canada

SOA8

The Genetic of Vesicoureteral Reflux: Not as Straightforward as We Think La gntique du reflux vsico-urtral : pas aussi simple quon le croit
Introduction: Dawn McLellan, Halifax, NS Speaker/Confrencier: Hiep Nguyen, Boston, MA
CUA 2012 B A NFF
Objectives / Objectifs To understand the genetic basis for vesicoureteral reflux
To understand the principles of SNPs genome wide analysis To correlate clinical findings of VUR with its genetic basis
Comprendre le fondement gntique du reux vsico-urtral
Comprendre les principes de lanalyse des SNP lchelle gnomique tablir des corrlations entre les rsultats cliniques lis au reux vsico-urtral et le fondement gntique
1645-1745
POD-04
Podium Session 4: Lower Urinary Tract

Room / Salles: Van Horne A
Sance Podium 4: Troubles du bas appareil urinaire

Moderators/Modrateurs: Sender Herschorn, Toronto, ON Curtis Nickel, Kingston, ON
89
MONDAY / LUNDI
JUNE 25 JUIN
1645-1655
POD-04.01
Mirabegron Improves Patient-reported Outcomes in Patients with Overactive Bladder Syndrome: Results from a North-American Study
Nitti, Victor1; Herschorn, Sender2; Auerbach, Stephen3; Martin, Nancy4; Blauwet, Mary Beth4 1 NYU School of Medicine, New York, NY, United States; 2University of Toronto, Toronto, ON, Canada; 3Hoag Memorial Presbyterian Hospital, Newport Beach, CA, United States; 4Astellas, Deereld, IL, United States
1655-1705
POD-04.02
Greenlight HPS-120W vs XPS-180W Laser Vaporization of the Prostate for Benign Prostatic Hyperplasia: a Prospective Comparative Outcomes Analysis
Zorn, Kevin; Liberman, Dan; Hueber, Pierre-Alain; Ben-Zvi, Tal; Ploquin, Franois University of Montreal Hospital Center (CHUM), Montreal, QC, Canada
1705-1715
90
POD-04.03
Changes in Erectile Function after Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia
Abdulla, Alym; Zareba, Piotr; Bowen, Jim; Hopkins, Rob; Tarride, Jean-Eric; Whelan, Paul McMaster University, Hamilton, ON, Canada
1715-1725
1725-1735
1735-1745
CUA 2012 BANFF
POD-04.04
A Prospective Analysis of Consultation for Difficult Urinary Catheter Insertion at Tertiary Care Centers in Northern Alberta
Rourke, Keith; Van Zyl, Stephan; Bacsu, Chasta-Dawne University of Alberta, Edmonton, AB, Canada
POD-04.05
A Novel Urethral Catheter Design for Safer Placement and Outcomes

Garcia, Maurice1; Wu, Alex1; Bullock, Thomas1; Aaronson, David2 University of California San Francisco, San Francisco, CA, United States; 2The Kaiser Permanente Medical Group, Oakland, CA, United States
POD-04.06
Urethroplasty for Pelvic Fracture Urethral Distraction Defects (PFUDD): Factors Influencing Surgical Outcome and Erectile Dysfunction
Kinnaird, Adam; Zorn, Jeff; Rourke, Keith University of Alberta, Edmonton, AB, Canada
MONDAY / LUNDI
JUNE 25 JUIN
1700-1800
International Volunteer Urology - Cancirc

Bnvoles en urologie internationale - Cancirc
Room Salle: Beatty
1900-2300
Presidents Reception and Banquet (Cocktails at 18:30)

Rception et banquet prsidentiel de lAUC (Rception 18h30)
Room Salle: Alberta & New Brunswick
CUA 2012 B A NFF
91
TUESDAY / MARDI
JUNE 26 JUIN
0630-0800
0700-0710
0710-0800
1 2 3 4 5 1 2 3 4 5
Council of Canadian University Urology Chairs (CCUUC) / CCUUC

Room Salle: Palliser
CP2
Clinical Pearls That Could Change Your Practice

Des perles cliniques qui pourrait changer votre pratique
Room Salles: Van Horne A
Speaker/Confrencier: Anil Kapoor, Hamilton, ON
EF6

Managing the Negative Prostate Biopsy Prise en charge de la biopsie prostatique negative
Moderator/Modrateur: Armen Aprikian, Montreal, QC Faculty/Facult: Neil Fleshner, Toronto, ON Robert Siemens, Kingston, ON, Bryan Donnelly, Calgary, AB
CUA 2012 B A NFF
Objectives / Objectifs To review the management options for a patient with negative prostate biopsy
To appreciate the use of MRI in prostate biopsy decision-making To review the evidence for and against the use of 5-ARI in this setting. To determine the selection criteria for repeating a prostate biopsy
To better understand the interpretation of PIN and ASAP in prostate biopsy reports Examiner les options de prise en charge dans le cas dun patient ayant des rsultats ngatifs lors dune biopsie prostatique Comprendre lusage de lIRM dans le processus dcisionnel en lien avec une biopsie prostatique Examiner les donnes pour et contre lusage des I5AR dans ce contexte tablir les critres de slection pour la rptition dune biopsie prostatique
Mieux comprendre linterprtation de la noplasie intrapithliale prostatique (PIN) et de la petite prolifration acineuse atypique (ASAP) dans les rapports de biopsie prostatique
93
TUESDAY / MARDI
JUNE 26 JUIN
0800-0900
POD-05
Podium Session 5: Prostate Cancer

Sance Podium 5: Cancer de la prostate
Moderators/Modrateurs: Eric Estey, Edmonton, AB Armen Aprikian, Montreal, QC
0800-0810
POD-05.01
Effect of Denosumab on Prolonging Bone-metastasis Free Survival in Men with Non-metastatic Castrate-resistant Prostate Cancer Presenting with Aggressive Prostate-specific Antigen Kinetics
Saad, Fred1; Oudard, Stephane2; Smith, Matthew3; Shore, Neal4; Miller, Kurt5; Tombal, Bertrand6; Sieber, Paul7; Fizazi, Karim8; Van Veldhuizen, Peter9; Damiao, Ronald10; Marx, Gavin11; Morote, Juan12; Feng, Amy13; Dansey, Roger13; Goessl, Carsten13 1 Hpital Notre-Dame du CHUM, Montral, QC, Canada; 2Georges Pompidou Hospital, Paris, France; 3Massachusettes General Hospital Cancer Center, Boston, MA, United States; 4 Carolina Urological Research Center, Myrtle Beach, SC, United States; 5Charit Berlin, Berlin, Germany; 6Universit Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Belgium; 7Urological Associates of Lancaster, Lancaster, PA, United States; 8Institut Gustave Roussy, University of Paris Sud, Paris, France; 9Kansas City VA Medical Center, Kansas City, MO, United States; 10Hospital Universitario Pedro Ernesto, Rio de Janeiro, Brazil; 11Sydney Haematology and Oncology Clinic, Wahroonga NSW, Australia; 12Hospital Vall dHebron, Barcelona, Spain; 13Amgen Inc, Thousand Oaks, CA, United States
94
0810-0820
0820-0830
CUA 2012 BANFF
POD-05.02
Need for Intervention and Survival in a Cohort of Patients on Active Surveillance (AS) for Low-risk Prostate Cancer
Preston, Mark1; Paly, Jonathan1; Carrasquillo, Robert2; Coen, John1; Zietman, Anthony1; Smith, Matthew R.1; Wu, Chin-Lee1; McDougal, W. Scott1; Feldman, Adam S.1 1 Massachusetts General Hospital, Boston, MA, United States; 2Harvard Medical School, Boston, MA, United States
POD-05.03
A Population-based Analysis of Pathological Outcomes Following Radical Prostatectomy in Academic vs. Non-academic Institutions
Nayak, Jasmir; Mau, Elke; Drachenberg, Darrel; Suderman, Derek; Guilbert, Kimi; Mak, Giselle; Lambert, Pascal; Quon, Harvey University of Manitoba, Winnipeg, MB, Canada
TUESDAY / MARDI
JUNE 26 JUIN
0830-0840
POD-05.04
Between-surgeon Variation in Outcomes of Radical Prostatectomy for Clinically Localized Prostate Cancer: Analysis of 1014 Consecutive Men Treated at the University of Alberta
1
Fairey, Adrian1; Jacobsen, Niels2; Yasui, Yataku2; Liu, Qi2; Voaklander, Don2; Estey, Eric2 University of Southern California, Los Angeles, CA, United States; 2University of Alberta, Edmonton, AB, Canada
0840-0850
POD-05.05
Population-based Study of Long-term Rates of Surgery for Urinary Incontinence following Radical Prostatectomy for Prostate Cancer
Nam, Robert; Herschorn, Sender; Loblaw, Andrew; Liu, Ying; Klotz, Laurence; Carr, Lesley; Kodama, Ronald; Saskin, Rek; Law, Calvin Sunnybrook Health Sciences Centre, Toronto, ON, Canada
0850-0900
1
POD-05.06
A Randomized Trial Comparing External Beam Radiation and Cryotherapy in Localized Prostate Cancer: 10 Year Follow-up
CUA 2012 B A NFF
Donnelly, Bryan1; Saliken, John2; Brasher, Penny2; Lau, Harold2; Trpkov, Kiril3; Robinson, John3 1 Prostate Cancer Centre Calgary, Calgary, AB, Canada; 2Tom Baker, Calgary, AB, Canada; 3 Calgary Lab Services, Calgary, AB, Canada
0800-1000
CUAJ Editorial Board Meeting

Comit de rdaction du Journal de lAUC
Room Salle: Angus
0900-0950
EF7

Controversies in Castrate-resistant Metastatic Prostate Cancer Controverses entourant le cancer mtastatique de la prostate rsistant la castration
Moderator/Modrateur: Alan So, Vancouver, BC Faculty/Facult: Neil Fleshner, Toronto, ON
Objectives / Objectifs Review the new developments and recent clinical trial results of novel agents in patients with castrate resistant prostate cancer (CRPC)
95
TUESDAY / MARDI
2 3 1 2 3 1 2 3 1 2 3
JUNE 26 JUIN
Define the role of the Urologist as well as multi-disciplinary approach to the management of CRPC Assess state-of-the-art management of CRCP, both in terms of guidelines as well as novel agents that will be available in the near future Examiner les rcents dveloppements et rsultats dessais cliniques portant sur les nouveaux agents chez les patients atteints dun cancer de la prostate rsistant la castration (CPRC) tablir le rle de lurologue et dune approche multidisciplinaire dans la prise en charge du CPRC valuer la prise en charge de pointe du CPRC, tant sur le plan des lignes directrices que des nouveaux agents qui seront lancs sur le march dans un avenir rapproch
0950-1010
Break / Pause
Room Salle: Foyer
96
1010-1040
SOA9

CUA 2012 BANFF
Robotics and Innovation / Robotique et innovation

Introduction: Trevor Schuler, Edmonton, AB Speaker/Confrencier: Richard Satava, Seattle, WA
Objectives / Objectifs Understand the new technologies such as robotics, surgical rehearsal and other innovations which are improving the practice of surgery and how to implement them into daily practice
Discover how the new technologies in the laboratory, such as nanotechnology and tissue engineering, will require a fundamental change in the practice of surgery Be aware of the moral and ethical implications of advanced medical technologies and their impact on individuals, behavior, society and human kind
Comprendre les nouvelles technologies comme la robotique, les systmes de rptition des interventions chirurgicales et autres innovations amliorant la pratique chirurgicale et comment les mettre en uvre dans la pratique quotidienne Dcouvrir comment les nouvelles technologies utilises en laboratoire, comme la nanotechnologie et lingnierie tissulaire, exigeront un changement fondamental dans la pratique de la chirurgie Rchir aux rpercussions morales et thiques des technologies mdicales avances et leur impact sur les particuliers, les comportements, la socit et
TUESDAY / MARDI
1 1 3 1 2 3
JUNE 26 JUIN
lhumanit
1040-1125
Urological Jeopardy / Jeu Les grosses ttes de lurologie

1125-1240
EF8
Educational Forum 8 and LUNCH / Forum ducatif 8 et DJEUNER

Exploring New Options in the Treatment of ED/BPH?: Uts and Testosterone Replacement Therapy Explorer des nouvelles options dans le traitement de lED, de lHBP et des TUBA et le traitement de remplacement de la testostrone
Moderator/Modrateur: Gerald Brock, London, ON Faculty/Facult: Franois Bnard, Montral, QC, Curtis Nickel, Kingston, ON, Gerald Brock, London, ON
Objectives / Objectifs To critically evaluate evolving data on hypogonadal men and androgen replacement therapy
To assess the existing scientific support for use of PDE5is in BPH/LUTS
To understand the role of PDE5s in the use of LUTS and ED in the comorbid patient
valuer, avec un sens critique, les donnes en volution sur les hommes atteints dhypogonadisme et le traitement de remplacement andrognique valuer les donnes scientiques existantes appuyant le recours aux inhibiteurs de la PDE5 dans le traitement de lHBP ou des TUBA
Comprendre le rle des inhibiteurs de la PDE5 dans le traitement des TUBA et de la DE chez le patient atteint de comorbidits
1240-1440
MP-01
Moderated Poster Session 1: Prostate Cancer

Sance de posters modrs 1: Cancer de la prostate

Moderators/Modrateurs: Bryan Donnelly, Calgary, AB
CUA 2012 B A NFF
97
TUESDAY / MARDI
JUNE 26 JUIN
MP-01.01
The Impact of a Sensitivity Adapted Antimicrobial Prophylactic Strategy on Prostate Biopsy Sepsis
Rowe, Neal; Breau, Rodney H.; Cagiannos, Ilias; Zvonar, Rosemary; Fergusson, Dean; Lavallee, Luke T.; Mallick, Ranjeeta; Morash, Christopher G. University of Ottawa, Ottawa, ON, Canada
MP-01.02
Serum Adipokine Levels Improve Prostate Cancer Prediction Compared to Clinical Data Only
Margel, David1; Trottier, Greg1; Yap, Stanley1; Connor, Mike2; Elharram, Malik1; Bhindi, Bimal1; Kulkarni, Girish1; Finelli, Antonio1; Zlotta, Alexandre1; Fleshner, Neil1 1 Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada; 2University of York, Toronto, ON, Canada
98
MP-01.03
PCA3 Test as an Adjunct in Diagnosis of Prostate Cancer

Yutkin, Vladimir1; Al-Zahrani, Ali1; Williams, Andrew1; Hidas, Guy2; Martinez, Carlos1; Izawa, Jonathan1; Pode, Dov2; Chin, Joseph1 1 University of Western Ontario, Uro-Oncology Fellowship Program, London, ON, Canada; 2 Hadassah and Hebrew University Medical Center, Jerusalem, Israel
CUA 2012 BANFF
MP-01.04
Percentage of Gleason 4 on Repeat Biopsy: How Much Matters?

Punnen, Sanoj; Glass, Allison; Cowan, Janet; Carroll, Peter University of California, San Francisco, CA, United States
MP-01.05
Diagnostic Accuracy of Seminal Vesicle Biopsy in Evaluating Seminal Vesicle Invasion: Comparison with MRI
Suntharasivam, Thiru; Hameed, Ammar; Doble, Andrew Urology Department, Addenbrookes University Hospital, Cambridge, United Kingdom
MP-01.06
Ultra-extended Prostate Biopsy Improves Detection of Pathologic Progression in Patients on Active Surveillance for Prostate Cancer
Wong, Lih-Ming1; Trottier, Greg1; Fleshner, Neil1; Lawrentchuk, Nathan1; Kulkarni, Girish1; Zlotta, Alexander2; Trachtenberg, John1; Toi, Ants3; Timilshina, Narhari4; Finelli, Antonio1 1 Department of Urology, Princess Margaret Hospital, Toronto, ON, Canada; 2Department of Urology, Mount Sinai Hospital, Toronto, ON, Canada; 3Department of Radiology, Princess Margaret Hospital, Toronto, ON, Canada; 4Division of General Internal Medicine & Clinical Epidemiology, University Health Network, Toronto, ON, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-01.07
Is There a Role for Routine Anterior Zone Sampling during Transrectal Ultrasound Guided Saturation Prostate Biopsy
Cole, Eric1; Shayegan, Bobby1; Matsumoto, Edward1; Greenspan, Michael1; Daya, Dean2; Patlas, Michael3; Pinthus, Jehonathan1 1 McMaster Institute of Urology, Hamilton, ON, Canada; 2McMaster Department of Pathology, Hamilton, ON, Canada; 3McMaster University Department of Radiology, Hamilton, ON, Canada
MP-01.08
International Multi-centre Study Examining Selection Criteria for Active Surveillance in Men Undergoing Radical Prostatectomy
Wong, Lih-Ming1; Neal, David2; Johnston, Richard2; Shah, Nimesh2; Warren, Anne2; Hovens, Chris3; Goldenberg, Larry4; Gleave, Martin4; Costello, Anthony3; Corcoran, Niall3 1 Princess Margaret Hospital, Toronto, ON, Canada; 2Addenbrookes Hospital, Cambridge, United Kingdom; 3The Australian Prostate Cancer Centre at Epworth and Departments of Urology and Surgery, Royal Melbourne Hospital, Melbourne, Australia; 4The Vancouver Prostate Centre, Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada
MP-01.09
Gleason Upgrading and Increased Cancer Volume on Repeat Prostate Biopsy in Patients on Active Surveillance (AS)
CUA 2012 B A NFF
Preston, Mark A.1; Carrasquillo, Robert2; Paly, Jonathan J.1; Coen, John J.1; Zietman, Anthony I.1; Smith, Matthew R.1; Wu, Chin-Lee1; McDougal, W. Scott1; Feldman, Adam S.1 1 Massachusetts General Hospital, Boston, MA, United States; 2Harvard Medical School, Boston, MA, United States
MP-01.10
Multi-institutional Validation of the CAPRA-S Score to Predict Outcomes after Radical Prostatectomy
Punnen, Sanoj1; Freedland, Stephen2; Presti, Joseph3; Aronson, William4; Terris, Martha5; Kane, Christopher6; Amling, Christopher7; Carroll, Peter1; Cooperberg, Matthew1 1 University of California, San Francisco, CA, United States; 2Duke University, Durham, NC, United States; 3Stanford University, Palo Alto, CA, United States; 4University of California, Los Angeles, CA, United States; 5Medical School of Georgia, Augusta, GA, United States; 6 University of California, San Diego, CA, United States; 7Oregon Health Sciences University, Portland, OR, United States
MP-01.11
High Intensity Focused Ultrasound for Localized Prostate Cancer: Impact of Nadir PSA on Cancer Control
Shayegan, Bobby1; Dason, Shawn1; Pinthus, Jehonathan1; Farrokhyar, Forough2; Orovan, William1 1 Division of Urology, McMaster University, Hamilton, ON, Canada; 2Department of Surgery, McMaster University, Hamilton, ON, Canada
99
TUESDAY / MARDI
JUNE 26 JUIN
MP-01.12
Radical Prostatectomy in Patients with High Risk Prostate Cancer: Predicting Oncological Outcomes in a Single Series
Autran Gomez, Ana Maria; Chin, Joseph; Izawa, Jonathan London Health Sciences Centre, University of Western Ontario, London, ON, Canada
MP-01.13
Prospective, Randomized Use of the VLOC Vesicourethral Anastamosis during Robot-assisted Radical Prostatectomy: Long-term Follow-up
1
Zorn, Kevin1; Trinh, Quoc-Dien2; Liberman, Dan2; Elhakim, Assaad2 University of Montral (CHUM), Montral, QC, Canada; 2University of Montreal Hospital Center (CHUM), Montreal, QC, Canada
MP-01.14
100
Comparison of Open and Robotic-assisted Prostatectomy: The University of British Columbia Experience
Gagnon, Louis-Olivier; Lynch, Kenny; Hurtado, Antonio; Goldenberg, Larry; Gleave, Martin Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
MP-01.15
CUA 2012 B A NFF
How Does Robot-assisted Laparoscopic Radical Prostatectomy Compare to Open Surgery in Men with High Risk Prostate Cancer?
Punnen, Sanoj; Cowan, Janet; Carroll, Peter University of California, San Francisco, CA, United States
MP-01.16
Positive Surgical Margins at Radical Prostatectomy: Population-based Averages within PSA and Gleason Strata
Izard, Jason1; Salazar, Marco2; Chatterjee, Suman3; Lin, Daniel1; Wright, Jonathan1 Department of Urology, University of Washington, Seattle, WA, United States; 2Sound Urological Associates, Edmonds, WA, United States; 3William Osler Health Centre, Brampton, ON, Canada
MP-01.17
Prostate Cancer Less than Two Cells from the Surgical Margin Predicts Biochemical Recurrence
Izard, Jason1; True, Lawrence2; May, Philip1; Ellis, William1; Lange, Paul1; Lin, Daniel1; Wright, Jonathan1 1 Department of Urology, University of Washington, Seattle, WA, United States; 2 Department of Pathology, University of Washington, Seattle, WA, United States
TUESDAY / MARDI
JUNE 26 JUIN
MP-01.18
Striated Muscle in Radical Prostatectomy Specimens: Is It Predictive of Post-prostatectomy Urinary Incontinence?

Skeldon, Sean; Gani, Johan; Evans, Andrew; Van der Kwast, Theo; Radomski, Sidney University of Toronto, Toronto, ON, Canada
MP-01.19
Radiotherapy after Radical Prostatectomy: Treatment Recommendations Differ between Urologists and Radiation Oncologists
Lavalle, Luke T.1; Fergusson, Dean2; Grenon, Renee3; Morgan, Scott4; Momoli, Franco2; Morash, Christopher1; Cagiannos, Ilias1; Breau, Rodney H.1 1 Division of Urology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada; 2Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada; 3Childrens Hospital of Eastern Ontario, Ottawa, ON, Canada; 4Division of Radiation Oncology, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada
MP-01.20
CUA 2012 B A NFF
Osteoporosis Management Program Decreases the Incidence of Hip Fracture in Prostate Cancer Patients on Androgen Deprivation Therapy
Chien, Gary1; Zhumkhawala, Ali1; Gleason, Joseph1; Cheetham, Craig1; Niu, Fang1; Dell, Richard2; Jacobsen, Steven3 1 Kaiser Permanente, Los Angeles, CA, United States; 2Kaiser Permanente, Downey, CA, United States; 3Kaiser Permanente, Pasadena, CA, United States
MP-01.21
Testosterone Suppression: Impact of Testosterone Level on Disease Progression in Advanced Prostate Cancer
Dason, Shawn; Tong, Justin; Allard, Christopher; Shayegan, Bobby Division of Urology, McMaster University, Hamilton, ON, Canada
MP-01.22
Inadequate Testosterone Suppression in Prostate Cancer Patients Failing on GnRH Agonists: Preliminary Data from the Delay Study
Casey, Richard1; Morales, Alvaro2; Siemens, Robert3 1 The Male Health Centre, Oakville, ON, Canada; 2Queens University, Kingston, ON, Canada; 3 Queens University, Oakville, ON, Canada Richard Casey1 and Alvaro Morales2
101
TUESDAY / MARDI
JUNE 26 JUIN
1240-1440
MP-02
Moderated Poster Session 2: Endourology/Stones

Sance de posters modrs 2: Endo-urologie/Lithiases
Room Salle: Beatty
Moderators/Modrateurs: Ryan Paterson, Vancouver, BC Darren Beiko, Kingston, ON
MP-02.01
Holmium Laser Enucleation of the Prostate for Glands Larger than 200 Grams
Bhojani, Naeem; Mandeville, Jessica A.; Boris, Ronald S.; Lingeman, James E. Indiana School of Medicine, Department of Urology, Indianapolis, IN, United States
MP-02.02
102
Impact of 5-alpha Reductase Inhibitors on Enucleation and Morcellation Efficiency during Holmium Laser Enucleation of the Prostate
Bhojani, Naeem; Mandeville, Jessica A.; Boris, Ronald S. Indiana School of Medicine, Department of Urology, Indianapolis, IN, United States
CUA 2012 B A NFF
MP-02.03
Early Outcomes of Office-based Laser Vaporization of the Prostate with the High Power Diode Laser
Davis, Jeffrey; Patel, Roshan; Culkin, Daniel; Sindhwani, Puneet University of Oklahoma, Health Sciences Center, Oklahoma City, OK, United States
MP-02.04
Novel Ultra-low Dose Non-contrast CT (NCCT) for Urolithiasis: Prospective Comparison of Diagnostic Accuracy with Concurrent Standard Dose Imaging
Sivalingam, Sri; Pickhardt, Perry; Ruma, Julie; Nakada, Stephen Y. University of Wisconsin, WI, United States
MP-02.05
Does a Routine Baseline Plain Radiograph Influence the Need for Subsequent Imaging Studies in Patients with Ureteral Calculi?
Foell, Kirsten1; Ordon, Michael2; Ghiculete, Daniela2; Honey, R. John DA.2; Pace, Kenneth T.2 St. Michaels Hospital, Toronto, ON, Canada; 2St. Michaels Hospital, University of Toronto, Toronto, ON, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-02.06
Urolithiasis Prevention Beginning in the Emergency Room: Support for Early Intervention During the Acute Event
Sivalingam, Sri; Penniston, Kris; Nakada, Stephen Y. University of Wisconsin, Madison, WI, United States
MP-02.07
Characterization of Patients with Heterozygous Cystinuria

Elkoushy, Mohamed; Andonian, Sero
MP-02.08
Office-based Ureteral Stent Placement Is Feasible and Effective for Acute, Obstructing Ureteral Calculi
Sivalingam, Sri; Tamm-Daniels, Inge; Nakada, Stephen Y. University of Wisconsin, Madison WI, United States
MP-02.09
Variations among Urology Trainees in Their Use of Fluoroscopy during Ureteroscopy

Elkoushy, Mohamed; Andonian, Sero McGill University Health Center, Montreal, QC, Canada
MP-02.10
Prediction of Calcium Oxalate Monohydrate Stone Composition during Ureteroscopy

Hamidizadeh, Reza; Teichman, Joel M. H. Department of Urologic Sciences, The University of British Columbia, Vancouver, BC, Canada
MP-02.11
Backstop Eliminates Retropulsion and Withstands Ho:YAG Energy
Melnyk, Megan1; Sea, Jason1; Teichman, Joel1; Qiu, Jinze3; Wang, Bingqing3; Milner, Thomas2; Chew, Ben1; Robinson, Michael1 1 University of British Columbia, Vancouver, BC, Canada; 2University of Texas, Austin, TX, United States
MP-02.12
The Safety of Percutaneous Nephrolithotomy (PNL) in an Elder Population: Outcomes and Complications of Septuagenarians, Octogenarians and Nonagenarians
1
De, Shubha1; Thalivasan, Simone2; Pareek, Gyan2; Haleblian, George2 Dalhousie University, Department of Urology, Halifax, NS, Canada; 2Brown University, Department of Urology, Providence, RI, United States
CUA 2012 B A NFF
103
TUESDAY / MARDI
JUNE 26 JUIN
MP-02.13
Withdrawn
MP-02.14
Retrograde Access for Percutaneous Nephrolithotomy: Is This The Way to Go?

Sivalingam, Sri1; Al-Essawi, Turki2; Hosking, Denis2 1 University of Wisconsin, Madison, WI, United States; 2University of Manitoba, Winnipeg, MB, Canada
MP-02.15
Without Stone Culture Infectious Kidney Organisms Are Misidentified in almost 1/4 of Patients Undergoing Percutaneous Nephrolithotomy 104
1
Bhojani, Naeem1; Williams, James C.2; Mandeville, Jessica A.1; Lingeman, James E.1 Indiana School of Medicine, Department of Urology, Indianapolis, IN, United States; 2Indiana School of Medicine, Department of Anatomy, Indianapolis, IN, United States
MP-02.16
CUA 2012 B A NFF
Interim Analysis of a Multi-centre Randomized Controlled Trial Comparing Three Different Modalities of Newer Lithotrites for Intracorporeal Lithotripsy
Arsovska, Olga1; Miller, Nicole2; Krambeck, Amy3; Humphreys, Mitchell3, Matlaga, Brian4; Nakada, Stephen5; Nadler, Robert6; Lingeman, James7; Razvi, Hassan8; Paterson, Ryan1; Chew, Ben1 1 University of British Columbia, Vancouver, BC, Canada; 2Vanderbilt University Medical Center, Nashville, TN, United States; 3Mayo Clinic College of Medicine, Phoenix, AZ, United States; 4 Johns Hopkins -Baltimore, MD, United States; 5University of Wisconsin, Madison, WI, United States; 6Northwestern University, Chicago, IL, United States; 7Methodist Urology, Indianapolis, IN, United States; 8University of Western Ontario, London, ON, Canada
MP-02.17
Combined Percutaneous Nephrolithotomy/Parathyroidectomy under One Anesthetic in Patients with Primary Hyperparathyroidism and Stones
Bhojani, Naeem1; Mandeville, Jessica A.1; Grafs, Richard2; Lingeman, James E.2 1 Indiana School of Medicine, Department of Urology, Indianapolis, IN, United States; 2 Indiana School of Medicine, Department of General Surgery, Indianapolis, IN, United States
MP-02.18
Shock Wave Lithotripsy Referral Patterns Changes Over a Decade at a Single Centre
TUESDAY / MARDI
JUNE 26 JUIN
MP-02.20
How Accurate Are Urologists at Estimating Lesion Size Endoscopically?

Massaro, Peter1; Abdolell, Mohamed2; Norman, Richard1 1 Department of Urology, Dalhousie University, Halifax, NS, Canada; 2Department of Diagnostic Radiology, Dalhousie University, Halifax, NS, Canada
1240-1440
MP-03
Moderated Poster Session 3: Renal

Sance de posters modrs 3: Rnal
Room Salle: Van Horne B
Moderators/Modrateurs: Anil Kapoor, Hamilton, ON Jun Kawakami, Calgary, AB
MP-03.01
Does the Method of Bladder Cuff Excision Affect Disease Recurrence after Nephrouretectomy for Upper Tract Urothelial Carcinoma? A Single-centre Comparison of Three Bladder Cuff Excision Methods
Allard, Christopher; Alamri, Abdulaziz; Matsumoto, Edward; Dason, Shawn; Kapoor, Anil McMaster Institute of Urology, Hamilton, ON, Canada
MP-03.02
Regional Differences in Practice Patterns and Associated Outcomes for Upper Tract Urothelial Carcinoma in Canada: Outcomes from the Canadian Upper Tract Collaboration
Wassim, Kassouf1; Rendon, Ricardo2; Bell, David2; Izawa, Jonathan3; Chin, Joseph3; Kapoor, Anil4; Matsumoto, Edward4; Lattouf, Jean-Baptiste5; Saad, Fred5; Lacombe, Louis6; Fradet, Yves6; Fairey, Adrian7; Jacobson, Niels7; Drachenberg, Darryl8; Cagiannos, Ilias9; So, Alan10; Black, Peter10; Metcalfe, Michael10 1 McGill University, Montral, QC, Canada; 2Dalhousie University, Halifax, NS, Canada; 3 University of Western Ontario, London, ON, Canada; 4McMaster University, Hamilton, ON, Canada; 5University of Montreal, Montreal, QC, Canada; 6Laval University, Quebec, QC, Canada; 7University of Alberta, Edmonton, AB, Canada; 8University of Manitoba, Winnipeg, MB, Canada; 9University of Ottawa, Ottawa, ON, Canada; 10University of British Columbia, Vancouver, BC, Canada
CUA 2012 B A NFF
105
TUESDAY / MARDI
JUNE 26 JUIN
MP-03.03
Impact of Body Mass Index (BMI) on Outcomes of Patients with Upper and Lower Urinary Tract Cancers Treated by Radical Surgery: Results from a Canadian Multicenter Collaboration
Bachir, Bassel G.1; Aprikian, Armen G.1; Izawa, Jonathan I.2; Chin, Joseph L.2; Fradet, Yves3; Fairey, Adrien4; Estey, Eric4; Jacobsen, Niels4; Rendon, Ricardo5; Cagiannos, Ilias6; Lacombe, Louis3; Tanguay, Simon1; Lattouf, Jean-Baptiste7; Kapoor, Anil8; Matsumoto, Edward8; Saad, Fred7; Bell, David5; Black, Peter C.9; So, Alan I.9; Drachenberg, Darrel10; Kassouf, Wassim1 1 McGill University Health Center, Montreal, QC, Canada; 2University of Western Ontario, London, ON, Canada; 3Laval University, Quebec, QC, Canada; 4University of Alberta, Edmonton, AB, Canada; 5Dalhousie University, Halifax, NS, Canada; 6University of Ottawa, Ottawa, ON, Canada; 7University of Montreal, Montreal, QC, Canada; 8McMaster University, Hamilton, ON, Canada; 9University of British Columbia, Vancouver, BC, Canada; 10University of Manitoba, Winnipeg, MB, Canada
MP-03.04
106
A Population-based Study of Surgeon Characteristics Associated with the Uptake of Contemporary Techniques in Renal Surgery
Yap, Stanley1; Alibhai, Shabbir1; Margel, David1; Abouassaly, Robert2; Timilshina, Narhari1; Finelli, Antonio1 1 University of Toronto, Toronto, ON, Canada; 2University Hospitals Case Medical Center, Cleveland, OH, United States
CUA 2012 B A NFF
MP-03.05
Association between Comorbidity and Survival after Radical Nephroureterectomy: Results from the Canadian Upper Tract Collaboration
Fairey, Adrian1; Jacobsen, Niels2; Tanguay, Simon3; Rendon, Ricardo4; Bell, David4; Izawa, Jonathan5; Chin, Joe5; Kapoor, Anil6; Matsumoto, Edward6; Black, Peter7; So, Alan7; Lattouf, Jean-Baptiste8; Saad, Fred8; Drachenberg, Darrell9; Cagiannos, Ilias10; Lacombe, Louis11; Fradet, Yves11; Kassouf, Wassim3 1 University of Southern California, Pasadena, CA, United States; 2University of Alberta, Edmonton, AB, Canada; 3McGill University, Montral, QC, Canada; 4Dalhousie University, Halifax, NS, Canada; 5University of Western Ontario, London, ON, Canada; 6McMaster University, Hamilton, ON, Canada; 7University of British Columbia, Vancouver, BC, Canada; 8 University of Montreal, Montreal, QC, Canada; 9University of Winnipeg, Winnipeg, MB, Canada; 10University of Ottawa, Ottawa, ON, Canada; 11Laval University, Quebec City, QC, Canada
MP-03.06
Ipsilateral Adrenalectomy at the Time of Radical Nephrectomy Does It Impact Overall Survival?
Yap, Stanley1; Alibhai, Shabbir1; Abouassaly, Robert2; Timilshina, Narhari1; Margel, David1; Finelli, Antonio1 1 University of Toronto, Toronto, ON, Canada; 2University Hospitals Case Medical Center, Cleveland, OH, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-03.07
Oncolytic Virotherapy Combined with Targeted Therapy for the Treatment of Renal Cell Carcinoma
1
Lawson, Keith1; Shi, Zhong Qiao1; Spurrell, Jason1; Kawakami, Jun2; Morris, Don1 Department of Oncology, University of Calgary, Calgary, AB, Canada; 2Division of Urology, Department of Surgery, University of Calgary, Calgary, AB, Canada
MP-03.08
Clinical Role of the SWI/SNF Complex Gene PBRM1 in Clear Cell Renal Cell Carcinoma
Morales, Carlos; Kurban, Ghada; Matevski, Donco; Massey, Christine; Evans, Andrew; Gallie, Brenda L.; Jewett, Michael A.S. University Health Network, Princess Margaret Hospital, Toronto, ON, Canada
MP-03.09
Canadian Kidney Cancer Information System (CKCis): a Prospective Platform to Better Understand Outcomes of Patients with Kidney Cancer
Tanguay, Simon1; Kapoor, Anil2; Wood, Lori3; Heng, Daniel4; Zhihui, Liu5; Hanley, James5; Lane, Kelly6; Chow, Raymond6; Hamilton, Wendella1; Jewett, Michael7 1 McGill University Health Center, Montreal, QC, Canada; 2McMaster University, Hamilton, ON, Canada; 3Capital District Health Authority, Halifax, NS, Canada; 4Alberta Health Services, Calgary, AB, Canada; 5McGill University, Montral, QC, Canada; 6University Health Network, Toronto, ON, Canada; 7University Health Center, Toronto, ON, Canada
MP-03.10
Validation of a Partial Nephrectomy Bench Model Developed via a Novel Material Engineering Process
Alamri, Abdulaziz; Abdulla, Alym; Madjeruh, John; Matsumoto, Edward McMaster University, Hamilton, ON, Canada
MP-03.11
Alyami, Fahad Dalhousie University, Halifax, NS, Canada
Laparoscopic Partial Nephrectomy for 4 cm Renal Masses
MP-03.12
Defining Small Renal Masses trifecta after Laparoscopic Partial Nephrectomies
Blouin, Annie-Claude1; Dujardin, Thierry2; Audet, Jean-Franois2; Caumartin, Yves2; Lacombe, Louis2; Imbeault, Annie2; Fradet, Vincent2; Fradet, Yves2; Pouliot, Frdric2 1 Universit Laval, Quebec, QC, Canada; 2Centre hospitalier universitaire de Qubec, Quebec, QC, Canada
CUA 2012 B A NFF
107
TUESDAY / MARDI
JUNE 26 JUIN
MP-03.13
Fuhrman Grade Does Not Improve the Discriminant Ability in Patients with Papillary Renal Cell Carcinoma
Ismail, Salima; Sun, Maxine; Abdo, Ala; Djahangirian, Orchid; Hanna, Nawar; Karakiewicz, Pierre Cancer Prognostics and Health Outcome Unit, University of Montreal Health Center, Montreal, QC, Canada
MP-03.14
Comparative Study for Carbonic Anhydrase-ix, Vascular Endothelial Growth Factor and Platelet Derived Growth Factor Receptor-alpha Immunohitochemical Expression in Renal Cell Carcinoma
Bishr, Mohamed1; Le Page, Cecile1; Gannon, Philippe O.1; Barres, Vronique1; Albadine, Roula2; Saad, Fred2; Lattouf, Jean-Baptiste2 1 Centre de recherche du Centre hospitalier de lUniversit de Montral (CRCHUM) and Institut du cancer de Montral, Montral, QC, Canada; 2Centre hospitalier de lUniversit de Montral (CHUM), Montral, QC, Canada
108
MP-03.15
Percutaneous Renal Cryoablation: Results from a Prospective Study

1
CUA 2012 B A NFF
Metcalfe, Charles1; Welsh, Mike2; Donnelly, Bryan3 University of British Columbia, Vancouver, BC, Canada; 2University of Calgary, Department of Radiology, Calgary, AB, Canada; 3University of Calgary, Division of Urology, Calgary, AB, Canada
MP-03.16
Contrast-enhanced Ultrasound for Follow-up after Radiofrequency Ablation of Small Renal Masses
Kapoor, Anil1; Allard, Christopher1; Matsumoto, Edward1; Coret, Andu2 1 McMaster University, Institute of Urology, Hamilton, ON, Canada; 2McMaster University, Department of Radiology, Hamilton, ON, Canada
MP-03.17
Prophylactic vs. Selective Ureteral Stenting in Preventing Ureteric Complications Post Renal Transplant: a Retrospective Review
Ordon, Michael; Ghiculete, Daniela; Stewart, Robert; Pace, Kenneth; Honey, R. John DA. St. Michaels Hospital, Toronto, ON, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-03.18
Supplemental Hydrogen Sulphide Reduces Graft Inflammation and Modulates Inflammatory and Anti-apoptotic Gene Expression in Renal Grafts Transplanted Following Prolonged Cold Storage
1
Lobb, Ian1; Liu, Weihua2; Garcia, Bertha2; Lan, Zhu3; Sener, Alp4 Microbiology and Immunology, University of Western Ontario, Matthew Mailing Centre, London, ON, Canada; 2Pathology, University of Western Ontario, London, ON, Canada; 3 Surgery, University of Western Ontario, Matthew Mailing Centre, London, ON, Canada; 4 Surgery and Microbiology and Immunology, University of Western Ontario, Matthew Mailing Centre, London, ON, Canada
MP-03.19
Does Donor Side Affect Outcomes? A Comparison of Right versus Left Allografts in Deceased Donor Renal Transplantation
Ordon, Michael; Ghiculete, Daniela; Stewart, Robert; Pace, Kenneth; Honey, R. John DA. St. Michaels Hospital, Toronto, ON, Canada
MP-03.20
Detrimental Effects of Prolonged Warm Renal Ischemia Reperfusion Injury Are Abrogated by Supplemental Hydrogen Sulphide: an Analysis Using Real-time Intravital Microscopy
Zhu, Justin1; Kalbeisch, Melanie1; Bihari, Relka1; Lobb, Ian1; Davison, Michael1; Mok, Amy1; Lawendy, Abdel1; Sener, Alp2 1 University of Western Ontario, London, ON, Canada; 2Matthew Mailing Center for Translational Transplant Studies, London, ON, Canada
MP-03.21
En Bloc Adult Organ Transplantation
Tran, Kim-Chi1; Taqi, Ali1; Warren, Jeff2; Caumartin, Yves3; Nguan, Christopher4; McAlister, Vivian1; Luke, Patrick1 1 University of Western Ontario, London, ON, Canada; 2University of Ottawa, Ottawa, ON, Canada; 3University of Laval, QC, Canada; 4University of British Columbia, Vancouver, BC, Canada
MP-03.22
Maximal Kidney Length Predicts Need for Native Nephrectomy in Patients with Autosomal Dominant Polycystic Kidney Disease Undergoing Renal Transplantation
Cristea, Octav1; Yanko, Daniel2; Langford, Sarah2; House, Andrew2; Stitt, Larry1; Sener, Alp2; Luke, Patrick2 1 Schulich School of Medicine & Dentistry, London, ON, Canada; 2London Health Sciences Centre, London, ON, Canada
CUA 2012 B A NFF
109
TUESDAY / MARDI
JUNE 26 JUIN
MP-03.23
Risk Stratification and Management Strategy for Undetected Thrombophilia in Pediatric Renal Transplant Recipients
Davis, Jeffrey; Sindhwani, Puneet; Turman, Martin University of Oklahoma, Health Sciences Center, Oklahoma City, OK, United States
1240-1440
MP-04
Moderated Poster Session 4: Voiding Dysfunction

Sance de posters modrs 4: Troubles mictionnels
Room Salle: Van Horne C
Moderators/Modrateurs: Ron Gerridzen, Ottawa, ON Richard Baverstock, Calgary, AB
110
MP-04.01
The Role of Dutasteride in Preventing BPH Clinical Progression in Asymptomatic Men with an Enlarged Prostate
Toren, Paul; Margel, David; Kulkarni, Girish; Finelli, Antonio; Zlotta, Alexandre; Fleshner, Neil University of Toronto, Toronto, ON, Canada
CUA 2012 B A NFF
MP-04.02
Comparison of Ultrasound and Fluoroscopic Imaging for Urodynamic Assessment of Non-neurogenic Voiding Dysfunction in Males
Bacsu, Chasta-Dawne1; Tse, Vincent2; Chan, Lewis2 1 Concord Repatriation General Hospital, Saskatoon, SK, Canada; 2Concord Repatriation General Hospital, Sydney, Australia
MP-04.03
Does Independently-interpreted Retrograde Urethrography Accurately Diagnose and Stage Anterior Urethral Stricture Disease?
Bach, Phil; Rourke, Keith University of Alberta, Edmonton, AB, Canada
MP-04.04
Do Cuff Size/Reservoir Size Impact Erosion, Revision, Infection and Outcome Rates in Patients Who Underwent AUS Placement for Stress Urinary Incontinence after Primary Treatment for Prostate Cancer
Popovic, Mihailo; Lucas, Steven; Haddad, Joseph; Singla, Ajay Wayne State University, School of Medicine, Urology, Detroit, MI, United States
TUESDAY / MARDI
JUNE 26 JUIN
MP-04.05
The Sphincter Sum: a Practical and Effective Tool for Evaluating Patients with Post-prostatectomy Incontinence
Gustafson, Paul University of British Colombia Urology, Vancouver, BC, Canada
MP-04.06
Revision Urethroplasty for Recurrent Urethral Stricture: a Comparative Analysis of Efficacy and Outcomes
Levine, Max A.; Kinnaird, Adam S.; Rourke, Keith F. Division of Urology, University of Alberta, Edmonton, AB, Canada
MP-04.07
Primary Realignment versus Suprapubic Cystostomy for the Management of Posterior Urethral Distraction Defects: a Systematic Review and Meta-analysis
Barrett, Keith; Braga, Luis H.; Davies, Timothy O. McMaster University, Division of Urology, Hamilton, ON, Canada
MP-04.08
CUA 2012 B A NFF
The Mesh Wallstent (UroLume) in the Treatment of Detrusor External Sphincter Dyssynergia in Men with Spinal Cord Injury
Binsaleh, Saleh1; Laplante, Michael2 1 King Saud University, Faculty of Medicine, Riyadh, Saudi Arabia; 2McGill University, Montral, QC, Canada
MP-04.09
Surgical Treatment of Male Incontinence Using the Argus Male Sling: Our First 5-Case Experience
1
Baverstock, Richard1; Carlson, Kevin1; Amaral, Nicole1; Herschorn, Sender2 vesia [Alberta Bladder Centre], Division of Urology, University of Calgary, Calgary, AB, Canada; 2Division of Urology, University of Toronto, Toronto, ON, Canada
MP-04.10
A Potential Gold Standard for Reconstruction of Long Segment Bulbar Urethral Strictures - Intermediate Outcomes of the Dorsal Onlay Augmented Anastomosis with Buccal Mucosa Graft
Hoy, Nathan; Kinnaird, Adam; Rourke, Keith University of Alberta, Division of Urology, Edmonton, AB, Canada
111
TUESDAY / MARDI
JUNE 26 JUIN
MP-04.11
Effect of Baseline Characteristics of Subjects with Overactive Bladder on Changes in Daytime and Nighttime Urgency Urinary Incontinence Episodes Following Antimuscarinic Treatment
Herschorn, Sender1; Wang, Joseph2; Ntanios, Fady2 1 University of Toronto, Toronto, ON, Canada; 2Pzer Inc., New York, NY, United States
MP-04.12
The Selective B3-Adrenoreceptor Agonist Mirabegron Is Effective and Well Tolerated in Patients with Overactive Bladder Syndrome
1
Herschorn, Sender1; Nitti, Victor2; Auerbach, Stephen3; Lee, Misun4; Martin, Nancy4 University of Toronto, Toronto, ON, Canada; 2New York University School of Medicine, New York, NY, United States; 3Hoag Memorial Presbyterian Hospital, Newport Beach, CA, United States; 4Astellas, Deereld, IL, United States
112
MP-04.13
Open-label, Ascending Dose Cohort Study of LiRIS (lidocaine-releasing intravesical system) in Women with Moderate to Severe Interstitial Cystitis
Steele, Stephen S.1; Nickel, J. Curtis1; Steinhoff, Gary2; Egerdie, Blair3; Gajewski, Jerzy4; Bailly, Greg4; Himes, Julie5 1 Queens University, Kingston, ON, Canada; 2University of British Columbia, Victoria, BC, Canada; 3The University of Western Ontario, Kitchener, ON, Canada; 4Dalhousie University, Halifax, NS, Canada; 5Taris Biomedical, Lexington, MA, United States
CUA 2012 B A NFF
MP-04.14
Noninvasive Diagnosis of Painful Bladder Syndrome / Interstitial Cystitis Using Near Infrared Spectroscopy
Shadgan, Babak; Stothers, Lynn; Macnab, Andrew University of British Columbia, Vancouver, BC, Canada
MP-04.15
Monitoring of Lower Urinary Tract Function in Patients with Spinal Cord Injury Using Near Infrared Spectroscopy
Shadgan, Babak; Stothers, Lynn; Macnab, Andrew; Nigro, Mark University of British Columbia, Vancouver, BC, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-04.16
The Signal Transduction of Skin Electrode Can Launch on the Bladder of Diabetic Rabbits and Ameliorate Its Hypomotility
Wang, Xinmin1; Zhang, Qingmei1; Xu, Ping1; Cao, Lin1; Xue, Meng1; Wang, Wei2 Department of Endocrinology, The Second Clinical Medical College of Jinan University (Shenzhen Peoples Hospital), Shenzhen, China; 2 H. Medical and Health Physics, McMaster University, Hamilton, ON, Canada
1
MP-04.17
Cost-effectiveness of Sacral Neuromodulation in Refractory Overactive Bladder: a Canadian Perspective

Gajewski, Jerzy1; Corcos, Jacques2; Dwyer, Neil T3; Gray, Gary4; Hassouna, Magdy5; Magali, Robert6; Tu, Le-Mai7; Sadri, Hamid8 1 Dalhousie University, Halifax, NS, Canada; 2Jewish General Hospital, Montreal, QC, Canada; 3 Moncton Hospital, Moncton, NB, Canada; 4Royal Alexandra Hospital, Edmonton, AB, Canada; 5 Toronto Western Hospital, Toronto, ON, Canada; 6Foothills Hospital, Calgary, AB, Canada; 7 Centre hospitalier universitaire de Sherbrooke, Sherbrooke, QC, Canada; 8Medtronic of Canada, Brampton, ON, Canada
MP-04.18
Sacral Neuromodulation Failures

Chang, Michelle; Gajewski, Jerzy Department of Urology, Dalhousie University, Halifax, NS, Canada
MP-04.19
A Cost-effectiveness Analysis of Tension-free Vaginal Tape vs. Burch Colposuspension for Female Stress Incontinence
Elterman, Dean; Chughtai, Bilal; Laudano, Melissa; Li, Philip; Tyagi, Renuka; Kavaler, Elizabeth; Te, Alexis; Kaplan, Steven; Lee, Richard Weill Medical College of Cornell University, New York, NY, United States
MP-04.20
Cox, Ashley; Herschorn, Sender; Carr, Lesley Sunnybrook Health Science Centre, Toronto, ON, Canada
Urinary Tract Mesh Erosion Following Female Pelvic Surgery
MP-04.21
Long-term Outcomes of Pessary Use in Women with Pelvic Organ Prolapse

Ramsay, Sophie; Bouchard, Frederick; Tu, Le Mai Universit de Sherbrooke, Sherbrooke, QC, Canada
CUA 2012 B A NFF
113
TUESDAY / MARDI
JUNE 26 JUIN
MP-04.22
Management and Outcomes of Complex versus Simple Female Urethral Diverticula

Carlson, Kevin University of Calgary/vesia [Alberta Bladder Centre], Calgary, AB, Canada
MP-04.23
Developing a Multi-disciplinary Lower Urinary Tract Centre: the vesia [Alberta Bladder Centre] Experience
Baverstock, Richard1; Carlson, Kevin2 1 vesia [Alberta Bladder Centre], Calgary, AB, Canada; 2vesia [Alberta Bladder Centre] Division of Urology, University of Calgary, Calgary, AB, Canada
1440-1450
Break / Pause
Room Salle: Foyer
114
1450-1600
MP-05
Moderated Poster Session 5: Pediatric Urology

Sance de posters modrs 5: Urologie pdiatrique
Room Salle:Van Horne C CUA 2012 B A NFF
Moderators/Modrateurs: Peter Metcalfe, Edmonton, AB Peter Anderson, Halifax, NS
MP-05.01
Impact of Side of Allograft Placement and Location of Arterial Anastomosis on Delayed Renal Function after Pediatric Renal Transplantation
Figueroa, Victor H.; Lorenzo, Armando J.; Kim, Wooheon T.; Romao, Rodrigo L.P.; Pippi Salle, Joao L.; Koyle, Martin A.; Taylor, Katherine The Hospital for Sick Children, Toronto, ON, Canada
MP-05.02
Minimally Invasive Open Technique for Management of Upper Pole Ectopic Ureter in Children with Duplicated Systems
Sheikh, Adeel1; Zaidi, Adil2; DeMaria, Jorge1; Luis, Braga1 McMaster Institute of Urology, Hamilton, ON, Canada; 2St. Georges University, Great River, NY, United States
TUESDAY / MARDI
JUNE 26 JUIN
MP-05.03
Observation versus Immediate Intervention in Ureteropelvic Junction Obstruction: Does It Matter?

Stearns, Gillian1; Reeder, Jay1; Barrieras, Diego2; Houle, Anne-Marie2; Franc-Guimond, Julie2; Riddell, Jonathan1 1 SUNY Upstate, Syracuse, NY, United States; 2CHU Sainte-Justine, Montral, QC, Canada
MP-05.04
A Prospective Study Using a New Bulking Agent for the Treatment of Pediatric Vesicoureteral Reflux: Bulkamid
1
Cloutier, Jonathan1; Blais, Anne-Sophie2; Moore, Katherine2; Bolduc, Stphane2 Division of Urology CHUL, CHUQ, Quebec, QC, Canada; 2Division of Urology, CHUL-CHUQ, Universit Laval, Quebec, QC, Canada
MP-05.05
Does Routine Ultrasounds Change Management in the Follow-up of Patients with Vesicoureteral Reflux?
Wildgoose, Petra1; Weber, Bryce2; Lorenzo, Armando3; Bagli, Darius3; Farhat, Walid3; Harvey, Elizabeth3; Pippi Salle, Joao Luiz3 1 McMaster Medical School, Calgary, AB, Canada; 2Alberta Childrens Hospital, Calgary, AB, Canada; 3Hospital for Sick Children, Toronto, ON, Canada
MP-05.06
Methodological Quality Assessment of Randomized Controlled Trials in Hypospadias Literature

Braga, Luis1; Lorenzo, Armando2; Vizcarra, Rachel1; Pemberton, Julia1; DeMaria, Jorge1; Byrne, Roisin3 1 McMaster University, Hamilton, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3 University of Calgary, Calgary, AB, Canada
MP-05.07
Is There a Role for Prophylactic Antibiotics after Stented Hypospadias Repair?

Kanaroglou, Niki; Alotay, Abdulhakim; Romao, Rodrigo; Koyle, Martin; Lorenzo, Armando; Bagli, Darius; Farhat, Walid Sick Kids, Toronto, ON, Canada
CUA 2012 B A NFF
115
TUESDAY / MARDI
JUNE 26 JUIN
MP-05.08
The Effect of Androgen Stimulation on Post-operative Complication Rates after Penoscrotal Hypospadias Repair: a Systematic Review and Meta-analysis
Cole, Eric1; Wright, Ian1; Lorenzo, Armando2; Pemberton, Julia1; Vizcarra, Rachel1; Farrokhyar, Forough1; Braga, Luis1 1 McMaster University, Hamilton, ON, Canada; 2University of Toronto, Toronto, ON, Canada
MP-05.09
Clitoroplasty and Vaginoplasty in Adolescents and Adults with Disorders of Sex Development (DSD): Lessons Learned
Pippi Salle, Joao L.1; Romao, Rodrigo L.P.1; Allen, Lisa1; DeMaria, Jorge2; Braga, Luis H.P.2; Jednak, Roman3; Dave, Sumit4; Lorenzo, Armando J.1; Farhat, Walid1; Koyle, Martin1; Bagli, Darius1 1 The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; 2 McMaster University, Hamilton, ON, Canada; 3McGill University, Montral, QC, Canada; 4 University of Western Ontario, London, ON, Canada
116
MP-05.10
CUA 2012 B A NFF

1
Correlation of Ultrasound (US) with Laparoscopy (LAP) in Kuwaiti Patients (pts) with Unilateral Non-palpable Testicles (NPT): Impact of Weight (WT) and Contralateral Testicular Size
Elsawy, Mohamed1; El-Hout, Yaser2; Gupta, Vipul1; Farhat, Walid2; Alsaid, Abdulnasser1 Ibn Sina Hospital, Sulaibikhat, Kuwait; 2Sick Kids Hospital, Toronto, ON, Canada
MP-05.11
Attempt at Fertility Preservation in Two Children with Paratesticular Rhadomyosarcoma

Spelliscy, Courtney; Kiddoo, Darcie University of Alberta, Edmonton, AB, Canada
MP-05.12
Urodynamic Improvements after Medical Treatment of Partial Bladder Outlet Obstruction in an Animal Model
Maciejewski, Conrad1; Tredget, Edward2; Metcalfe, Peter1 University of Alberta, Division of Urology, Edmonton, AB, Canada; 2University of Alberta, Division of Plastic Surgery, Edmonton, AB, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-05.13
Outcomes Following Fecal Continence Procedures in Patients with Neurogenic Bowel Dysfunction
Kiddoo, Darcie; Metcalfe, Peter; Hoy, Nathan University of Alberta, Edmonton, AB, Canada
MP-05.14
Onabotulinumtoxin A Endoscopic Detrusor Injection for the Treatment of Neurogenic Bladder in Children: Effect of Dose Adjustment, Multiple Injections and Avoidance of Reconstructive Procedures
Figueroa, Victor H.; Romao, Rodrigo L.P.; Pippi-Salle, Joao L.; Kanaroglou, Niki; Koyle, Martin A.; Bagli, Darius J.; Lorenzo, Armando J. The Hospital for Sick Children, Toronto, ON, Canada
1450-1600
MP-06
Moderated Poster Session 6: ED, Peyronies Disease, Infertility

Sance de posters modrs 6: ED, maladie de La Peyronie et infertilit
Room Salle: Beatty
Moderators/Modrateurs: Serge Carrier, Montreal, QC Peter Pommerville, Victoria, BC
MP-06.01
Antinuclear Antibody Titres Are Not Significantly Altered in Peyronies Disease
Shamloul, Rany1; Bella, Anthony J.1; Zappagigna, Christopher2 1 University of Ottawa, Civic Hospital, Ottawa, ON, Canada; 2University of Ottawa, Ottawa, ON, Canada
MP-06.02
A Novel Rat Model for Peyronies Disease That Demonstrates Durability and Functional Detriments
1
Garcia, Francisco1; De Young, Ling2; Chung, Eric3; Brock, Michael2; Brock, Gerald4 Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada; 2Lawson Health Research Institute, London, ON, Canada; 3Department of Urology, Princess Alexandria Hospital, Brisbane, Australia; 4St. Josephs Health Care, Division of Urology, London, ON, Canada
CUA 2012 B A NFF
117
TUESDAY / MARDI
JUNE 26 JUIN
MP-06.03
Efficacy and Histologic Changes of Repeated Saline or Intralesional Verapamil Injections and Traction Therapy in an Animal Model of Peyronies Disease
Garcia, Francisco1; Chung, Eric2; De Young, Ling3; Wang, Peter1; Brock, Michael3; Brock, Gerald4 1 Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada; 2Department of Urology, Princess Alexandria Hospital, Brisbane, Australia; 3Lawson Health Research Institute, London, ON, Canada; 4St. Josephs Health Care, Division of Urology, London, ON, Canada
MP-06.04
Do Patients Know Their Nerve-sparing Status Following Radical Prostatectomy? 118

Skeldon, Sean; Gani, Johan; Radomski, Sidney University of Toronto, Toronto, ON, Canada
MP-06.05
Erectile Function Recovery Following Nerve Sural Grafting in Open Radical Prostatectomy
CUA 2012 B A NFF
Autran Gomez, Ana Maria; Izawa, Jonathan; Chin, Joseph London Health Sciences Centre, University of Western Ontario, London, ON, Canada
MP-06.06
Resident Training Laboratory, Held in Conjunction with Conference, Meaningfully Impacts Resident Technical Skills and Perceptions for Penile Implant Surgery
Zappavigna, Christopher1; Christine, Brian2; Bella, Anthony J.1 1 University of Ottawa, Division of Urology, Ottawa, ON, Canada; 2 Urology Centers of Alabama, Birmingham, AL, United States
MP-06.07
Robotic Assisted versus Pure Microsurgical Vasectomy Reversal: Prospective Control Trial
Gudeloglu, Ahmet1; Brahmbahtt, Jamin2; Priola, Karen1; Parekattil, Sijo1 University of Florida and Winter Haven Hospital, Winter Haven, FL, United States; 2 University of Tennessee, Memphis, TN, United States
MP-06.08
Cost-effectiveness of Varicocelectomy and Percutaneous Embolization in the Management of Varicocele-associated Infertility

Klinghoffer, Zachary; Kovac, Jason; Fischer, Marc Anthony McMaster University, Hamilton, ON, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-06.09
Use of Clomiphene Citrate for Male Idiopathic Infertility: Interim Analysis of a Prospective Study
1
Langille, Gavin1; Spencer, Leia2; Jarvi, Keith2; Grober, Ethan2; Lo, Kirk C.2 Dalhousie University, Halifax, NS, Canada; 2University of Toronto, Toronto, ON, Canada
1450-1600
MP-07
Moderated Poster Session 7: Bladder

Sance de posters modrs 7: Vessie
Room Salle: Coleman
Moderators/Modrateurs: Fred Saad, Montreal, QC Joseph Chin, London, ON
MP-07.01
Safety of Intravesical Mycobacterial Cell Wall-DNA Complex Given Immediately Postsurgery in Patients with Non-muscle-invasive Bladder Cancer
Morales, Alvaro1; Jablonski, David2; Lihou, Christine3; Lang, Zig3; Champagne, Monique4; Cohen, Zvi4 1 Queens University, Kingston, ON, Canada; 2Winter Park Urology Associates, Orlando, FL, United States; 3Endo Pharmaceuticals Inc, Chadds Ford, PA, United States; 4Bioniche Life Sciences Inc, Pointe-Claire, QC, Canada
MP-07.02
The Impact of Concomitant Carcinoma in Situ on Upstaging Following Radical Cystectomy for Bladder Cancer
Ya, Faysal1; Aprikian, Armen1; Chin, Joseph2; Fradet, Yves3; Izawa, Jonathan2; Estey, Eric4; Fairey, Adrian4; Rendon, Ricardo5; Cagiannos, Ilias6; Lacombe, Louis3; Lattouf, Jean-Baptiste7; Bell, David5; Drachenberg, Darrel8; Kassouf, Wassim1 1 McGill University, Montral, QC, Canada; 2University of Western Ontario, London, ON, Canada; 3 Laval University, Quebec, QC, Canada; 4University of Alberta, Edmonton, AB, Canada; 5 Dalhousie University, Halifax, NS, Canada; 6University of Ottawa, Ottawa, ON, Canada; 7 University of Montreal, Montreal, QC, Canada; 8University of Manitoba, Winnipeg, MB, Canada
MP-07.03
Young Age Predicts Favorable Disease Characteristics and Outcomes among Patients with Urothelial Carcinoma of the Bladder
1
Izard, Jason1; Wright, Jonathan1; Black, Peter2; Porter, Michael1 Department of Urology, University of Washington, Seattle, WA, United States; 2 Department of Urologic Sciences, University of British Colombia, Vancouver, BC, Canada
CUA 2012 B A NFF
119
TUESDAY / MARDI
JUNE 26 JUIN
MP-07.04
Evaluation of the Survival Benefit of Multidisciplinary Care in High Risk Bladder Cancer
Sandhu, Gurdarshan1; Nepple, Kenneth1; Schoenberg, Mark2; Strope, Seth1 1 Washington University School of Medicine, St. Louis, MO, United States; 2The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, United States
MP-07.05
Increased Expenditures on Follow-up Care after Definitive Surgery for Bladder Cancer
Sandhu, Gurdarshan; Nepple, Kenneth; Grubb 3rd Robert; Yang, Liu; Strope, Seth Washington University School of Medicine, St. Louis, MO, United States
MP-07.06
120
Utilization of Peri-operative Chemotherapy for Bladder Cancer: a Population-based Study

Siemens, D. Robert1; Rhee, Jonathan1; Tannock, Ian2; Peng, Yingwei1; Li, Gavin1; Mackillop, William1; Booth, Chris1 1 Queens University, Kingston, ON, Canada; 2Princess Margaret Hospital, Toronto, ON, Canada
CUA 2012 B A NFF
MP-07.07
Utilization and Predictors of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Veterans Health Administration
Sandhu, Gurdarshan1; Luo, Suhong2; Zeringue, Angelique2; Carson, Kenneth2; Nepple, Kenneth1; Strope, Seth1; Hudson, MLiss2; Grubb 3rd, Robert2 1 Washington University School of Medicine, St. Louis, MO, United States; 2VA St. Louis Healthcare System, Department of Veterans Affairs, St. Louis, MO, United States
MP-07.08
Laparoscopic Radical Cystectomy - Is There Evidence of Learning Curve? Experience of 60 Consecutive Cases Performed in a High Volume Tertiary Cancer Centre
Khan, Faisal1; Abroaf, Ahmed2; Jackson, M1; Durkan, G C1; Heer, R1; Soomro, NA1; Johnson, MI1 1 NHS, Newcastle, United Kingdom; 2NHS Freeman Hospital, Newcastle, United Kingdom
TUESDAY / MARDI
JUNE 26 JUIN
MP-07.09
Hypoxia Is Independently Associated with Poor Outcome in Urothelial Bladder Cancer Patients Treated with Radical Cystectomy
Bostrom, Peter J1; Thoms, John1; van Rhijn, Bas WG1; Ahmed, Omer1; Evans, Andrew1; Mirtti, Tuomas2; Sykes, Jenna1; Milosevic, Michael1; Zlotta, Alexandre R3; Bristow, Robert G1 1 University Health Network, Toronto, ON, Canada; 2Helsinki University Hospital, Helsinki, Finland; 3Mount Sinai Hospital, University Health Network, Toronto, ON, Canada
MP-07.10
Heat Shock Protein 70 (HSP70) as a Recurrence Marker for PT1 Bladder Cancer
Stakhovskyi, Oleksandr1; Margel, David1; van der Kwast, Theodorus H.1; van Rhijn, Bas W.G.1; Bostrom, Peter J.1; Bristow, Robert G.1; Fleshner, Neil E.1; Jewett, Michael A.S.1; Bapat, Bharati2; Zlotta, Alexandre R.3 1 University Health Network, Toronto, ON, Canada; 2Mount Sinai Hospital, Samuel Lunenfeld Research Institute, Toronto, ON, Canada; 3Mount Sinai Hospital, University Health Network, Toronto, ON, Canada
MP-07.11
How Should Locoregionally Recurrent or Advanced Primary Malignancies of the Bladder or Ureter Be Managed? Potential Role of Multimodality Therapy Incorporating Surgery and Intraoperative Radiotherapy
Choo, Richard; Hallemeier, Christopher; Haddock, Michael Mayo Clinic, Rochester, MN, United States
MP-07.12
Tumor Stage on Re-staging Transurethral Resection Predicts Recurrence and Progression Free Survival of High Risk Superficial Bladder Cancer
1
Bishr, Mohamed1; Lattouf, Jean-Baptiste2; Latour, Mathiew2; Saad, Fred2 Centre de recherche du Centre hospitalier de luniversit de Montral (CRCHUM) and Institut du cancer de Montral, Montral, QC, Canada; 2Centre hospitalier de luniversit de Montral (CHUM), Montral, QC, Canada
1450-1600
MP-08
Moderated Poster Session 8: Miscellaneous

Room Salle: Van Horne B
Sance de posters modrs 8: Sujets divers

Moderators/Modrateurs: Trevor Schuler, Edmonton, AB Robert Siemens, Kingston, ON
CUA 2012 B A NFF
121
TUESDAY / MARDI
JUNE 26 JUIN
MP-08.01
Preliminary Results of the Resident Manpower Survey by the CUA Socioeconomic Committee: Are We Training too Many Urologists?
Drachenberg, Darrel; Kaler, Kamaljot University of Manitoba, Winnipeg, MB, Canada
MP-08.02
Incorporating Patient Simulation into In-training Exams to Assess CanMEDS Competencies in Urology Residents
Nguyen, Laura; Roberts, Matthew; Watterson, James University of Ottawa/The Ottawa Hospital, Ottawa, ON, Canada
MP-08.03
The Newly Graduated Canadian Urologist: Underemployed and Overtrained? 122

Welk, Blayne1; Kodama, Ron2; MacNeily, Andrew3 1 University of Western Ontario, London, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3University of British Columbia, Vancouver, BC, Canada
MP-08.04
CUA 2012 B A NFF
Trends in Matching to Urology Residency in Canada: Are We Becoming Non-competitive?
Melnyk, Megan; Mickelson, Jennifer J; MacNeily, Andrew E Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada
MP-08.05
Video Laparoscopic Trainers vs. Less Expensive Simple Laparoscopic Trainers

Nguyen, Tim1; Braga, Luis2; Matsumoto, Edward2 Queens University, Kingston, ON, Canada; 2McMaster University, Hamilton, ON, Canada
MP-08.06
Do Hunners Ulcers Represent Bladder Ischemia?
Melnyk, Megan; Teichman, Joel University of British Columbia, Department of Urological Sciences, Vancouver, BC, Canada
MP-08.07
Trials and Tribulations of a Canadian Interstitial Cystitis Research Clinic

Nickel, J Curtis; Irvine-Bird, Karen; Robb, Sylvia Queens University, Kingston, ON, Canada
TUESDAY / MARDI
JUNE 26 JUIN
MP-08.08
Cannabis (Marijuana) Use in Men with Chronic Prostatitis / Chronic Pelvic Pain Syndrome
1
Nickel, J Curtis1; Tripp, Dean1; Katz, Laura1; Ginting, Jessica1; Ware, Mark2; Santor, Darcy3 Queens University, Kingston, ON, Canada; 2Montreal General Hospital, Montreal, QC, Canada; 3 University of Ottawa, Ottawa, ON, Canada
MP-08.09
The Clinical Spectrum of Anterior Urethral Stricture: Detailed Analysis of a Large Single Institution Cohort
Rourke, Keith; Hickle, Jonathan University of Alberta, Edmonton, AB, Canada
MP-08.10
Impact of Radiotherapy on Surgical Repair and Outcomes in Patients with Rectourethral Fistula
Elliott, Daniel; Poskus, Tomas; Umbreit, Eric; Larson, David; Beddy, David; Dozois, Eric Mayo Clinic, Rochester, MN, United States
MP-08.11
Comprehension and Preferences for Graphical Representations of Quality of Life after Prostate Cancer Treatment
Izard, Jason1; Hartzler, Andrea2; Gore, John2 1 Department of Urology, University of Washington, Seattle, WA, United States; 2 Department of Medical Education, University of Washington, Seattle, WA, United States
MP-08.12
Population-based Assessment of Enterocystoplasty Complications among Adult Patients

1
Welk, Blayne1; Herschorn, Sender2; Law, Calvin2; Nam, Robert2 University of Western Ontario, London, ON, Canada; 2University of Toronto, Toronto, ON, Canada
1450-1600
MP-09
Moderated Poster Session 9: Basic Science

Sance de posters modrs 9: Science fondamentale

Moderators/Modrateurs: Alan So, Vancouver, BC Peter Black, Vancouver, BC
CUA 2012 B A NFF
123
TUESDAY / MARDI
JUNE 26 JUIN
MP-09.01
Knockdown of Integrin-linked Kinase Reduces Invasive and Metastatic Potential of Renal Cell Carcinoma by Impeding Epithelial to Mesenchymal Transition
Han, Kyungseok; Raven, Peter; Awrey, Shannon; Li, Estelle; Ladan, Fazli; Gleave, Martin; So, Alan Vancouver Prostate Centre, Vancouver, BC, Canada
MP-09.02
Enhanced Tumor Oxygenation Following Short-term Sunitinib Therapy in a Renal Cell Carcinoma Model: an Unexpected Finding
Chapman, David; Wuest, Melinda; Mercer, John; Wiebe, Leonard; Moore, Ronald University of Alberta, Edmonton, AB, Canada
MP-09.03
124
Evasive Resistance to VEGF-targeted Anti-angiogenic Therapy Is Acquired by Activation Angiogenesis Pathways Independent of VEGF in Renal Cell Carcinoma
Han, Kyungseok; Raven, Peter; Gust, Kilian; Awrey, Shannon; Li, Estelle; Ladan, Fazli; Gleave, Martin; So, Alan Vancouver Prostate Centre, Vancouver, BC, Canada
CUA 2012 B A NFF
MP-09.04
Quantitative Proteomic Analysis of Exosome-enriched Extracellular Microvesicles Obtained Following an in vitro Model of Urinary Tract Obstruction
1
Orton, Dennis1; Doucette, Alan1; Maksym, Geoffrey1; MacLellan, Dawn2 Dalhousie University, Halifax, NS, Canada; 2Dalhousie University, IWK Health Centre, Halifax, NS, Canada
MP-09.05
Rat Bone Marrow Derived Mesenchymal Stem Cell Therapy in a Parkinsonian Animal Model of Detrusor Overactivity
Campeau, Lysanne1; Soler, Roberto2; Pareta, Rajesh1; Sivanandane, Sittadjody1; Opara, Emmanuel1; Andersson, Karl Erik1 1 Wake Forest University, Institute for Regenerative Medicine, Winston-Salem, NC, United States; 2Division of Urology, Federal University of Sao Paulo, Sao Paulo, Brazil
TUESDAY / MARDI
JUNE 26 JUIN
MP-09.06
Intrathecal Cannabinoid Agonist Effects in Cystometric Evaluation of Normal Rats

Campeau, Lysanne1; Fllhase, Claudius2; Russo, Andrea3; Hedlund, Petter3; Andersson, Karl Erik1 1 Wake Forest University, Institute for Regenerative Medicine, Winston-Salem, NC, United States; 2Department of Urology, University Hospital Grohadern, LMU, Munich, Germany; 3 Urological Research Institute, San Raffaele University, Milan, Italy
MP-09.07
Rational Targeting of Fibroblast Growth Factor Receptor (FGFR)-3 in Bladder Cancer

Gust, Kilian1; McConkey, David2; Hegarty, Paul2; Awery, Shannon1; Bondaruk, Jolanta1; Czerniak, Bogdan2; Dinney, Colin2; Black, Peter1 1 Vancouver Prostate Centre, Vancouver, BC, Canada; 2MD Anderson Cancer Center, Houston, TX, United States
MP-09.08
Circulating Interlukin-6 and Nerve Growth Factor Are Associated with Periprostatic Fat Length and Cancer Detection among Non-obese Men Presenting for Prostate Biopsies
Margel, David1; Trottier, Greg1; Yap, Stanley1; Connor, Mike2; Elharram, Malik1; Bhindi, Bimal1; Fleshner, Neil1 1 Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada; 2University of York, Toronto, ON, Canada
MP-09.09
Heat Shock Protein 70 (HSP70) and FGFR3 in Non-muscle-invasive Bladder Cancer Treated with BCG: Gene and Protein Expression Analysis in Two Validation Cohorts
van Rhijn, Bas W.G.1; Stakhovskyi, Oleksandr1; Margel, David1; van der Kwast, Theodorus H.1; Bostrom, Peter J.1; Bristow, Robert G.1; Milosevic, Michael1; Bapat, Bharati2; Kim, Wun-Jae3; Zlotta, Alexandre R.4 1 University Health Network, Toronto, ON, Canada; 2Mount Sinai Hospital, Samuel Lunenfeld Research Institute, Toronto, ON, Canada; 3Chungbuk National University College of Medicine, Chungbuk, Republic of Korea; 4Mount Sinai Hospital, University Health Network, Toronto, ON, Canada
CUA 2012 B A NFF
125
TUESDAY / MARDI
JUNE 26 JUIN
MP-09.10
NF-appa B p65 as Prognostic Tool in Prostate Cancer: an Immunohistochemical Study from Biopsy Samples
Labouba, Ingrid1; Gannon, Philippe O.1; Forest, Valrie1; Le Page, Ccile1; Storoz, Cristina1; Benaissa, Mustapha1; Pierrard, Aurore1; Lessard, Laurent1; Mes-Masson, Anne-Marie2; Saad, Fred3 1 Centre de recherche du Centre hospitalier de luniversit de Montral (CRCHUM), Montral, QC, Canada; 2CRCHUM / Institut du cancer de Montral, Department of Medicine, Universit de Montral, Montral, QC, Canada; 3Division of Urology, CHUM, Universit de Montral, CRCHUM, Montral, QC, Canada
MP-09.11
A New Molecular Imaging System Based on Both Transcriptional and Genomic Amplification to Detect Prostate Cancer Cells in vivo
1
126
Pouliot, Frederic1; Sato, Makoto2; Huyn, Steve2; Karanikolas, Breanne2; Wu, Lily2 Department of Surgery, Urology Division, Laval University, Quebec, QC, Canada; 2IMED and UCLA, Los Angeles, CA, United States
1600-1615
Closing Ceremonies, Awards, CUASF Astellas Winners

Crmonies de clture, prix, gagnants Astellas FBAUC
Room salle: Van Horne A
CUA 2012 B A NFF
UNMODERATED POSTER SESSIONS / SANCE DE POSTERS NON-MODRS
UP-001
Orthotopic Continent Urinary Diversion vs. Ileal Conduit: Comparison of Intraoperative and In-hospital Complications, Blood Transfusion, Length of Stay, and In-hospital Mortality
Djahangirian, Orchidee; Schmitges, Jan; Tian, Zhe; Karakiewicz, Pierre; Ismail, Salima Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, QC, Canada
UP-002
Techniques and Agents Used to Conserve Blood During Radical Cystectomy: a Survey of the Society of Urologic Oncology
Punjani, Nahid1; Lavalle, Luke T.2; Momoli, Franco3; Cagiannos, Ilias2; Morash, Chris2; Fergusson, Dean3; Breau, Rodney H.2 1 University of Ottawa, Ottawa, ON, Canada; 2University of Ottawa, Division of Urology, Ottawa, ON, Canada; 3Ottawa Hospital Research Institute, Ottawa, ON, Canada
UP-003
Should CT Urogram Be the First Radiological Investigation to Evaluate Visible Haematuria?

Akhter, Waseem; Sheikh, Mazher; Kilburn, Karen; Peedikayil, Abraham; Palit, Victor University Hospital of North Tees and Hartlepool NHS Trust, Hartlepool, United Kingdom
UP-004
Laparoscopic Robot-assisted Radical Cysto-prostatectomy

Bladou, Franck McGill University, Jewish General Hospital, Montreal, QC, Canada
UP-005
Survival Impact of Postoperative Expenditures by High Volume Surgeons Following Definitive Surgery for Bladder Cancer
Sandhu, Gurdarshan; Nepple, Kenneth; Yang, Liu; Grubb 3rd, Robert; Strope, Seth Washington University School of Medicine, St. Louis, MO, United States
UP-006
Is There a Role for the mTOR Pathway in Non-muscle Invasive Bladder Cancer?
Blais, Jean-Philippe; Hovington, Hlne; Brisson, Herv; Lacombe, Louis; Caumartin, Yves Centre Hospitalier Universitaire de Qubec, Quebec, QC, Canada
UP-007
Meta-analysis of the Efficacy and Safety of Darifenacin and Other Anticholinergics for Managing Overactive Bladder
Elhilali, Mostafa1; Piwko, Charles2; Vincente, Colin2; Sabapathy, Suthacar2; Tu, Le Mai3; Valiquette, Luc4; Finarson, Thomas R.5; Ahmad, Asma6 1 Mcgill University, Royal Victoria Hospital, Montreal, QC, Canada; 2Pivina Consulting, Montreal, QC, Canada; 3FRCSC University of Sherbrooke, QC, Canada; 4FRCSC Universit de Montral, Montreal, QC, Canada; 5University of Toronto, Toronto, ON, Canada; 6Pivina Consulting, Mississauga, ON, Canada
CUA 2012 B A NFF
127
UP-008
Pre-operative Sarcopenia Associated with Renal Function Outcomes in Patients Treated for Renal Masses by Extirpative Surgery
Hennessey, Katherine K.; Michael, Amanda; Elias, Rami; Kapoor, Anil; Shayegan, Bobby; Matsumoto, Edward D.; Mourtzakis, Marina; Di Sebastiano, Katie; Duivenvoorden, Helga; Pinthus, Jehonathan H. McMaster University, Hamilton, ON, Canada
UP-009
Renal Tumor Ablation for pT1 Lesions: Patterns of Recurrence and Follow-up Recommendations
Rutkowski, John; Muruve, Nic Cleveland Clinic Florida, Weston, FL, United States
UP-010
Cystatin C for Early Detection of Acute Kidney Injury after Laparoscopic Partial Nephrectomy
Al Esawi, Anwar; Nadeau, Genevive; Caumartin, Yves; Bergeron, Alain; Guimezap, Jackson; Fradet, Vincent; Caron, Andr; Dujardin, Thierry; Fradet, Yves; Lacombe, Louis CHUQ-Laval University, Quebec, QC, Canada
128
UP-011
Ex-vivo Partial Nephrectomy with Autotransplant to Treat Complex Renal Tumors: Case Report and Review of the Literature
CUA 2012 B A NFF
Nayak, Jasmir; Archambault, Jason; Koulack, Joshua; McGregor, Thomas University of Manitoba, Winnipeg, MB, Canada
UP-012
LKB1 Drives Adiponectin Receptor 1 Expression in Clear Cell Renal Cell Carcinoma: from Tumor Development to Disease Characteristics
Zareba, Piotr; Duivenvoorden, Wilhelmina; Beatty, Laura; Lhotak, Sarka; Lu, Jian-Ping; Austin, Richard; Daya, Dean; Pinthus, Jehonathan McMaster University, Hamilton, ON, Canada
UP-013
Kidney Cancer Survivorship Survey: Gap Between Urologist and Survivor Perceptions
Basiuk, Joan1; Jewett, Michael2; Maskens, Deborah3; Canil, Christina4 1 Kidney Cancer Canada, Toronto, ON, Canada; 2Princess Margaret Hospital / University of Toronto, Toronto, ON, Canada; 3Kidney Cancer Canada, Guelph, ON, Canada; 4The Ottawa Hospital Cancer Centre / University of Ottawa, Ottawa, ON, Canada
UP-014
Comparison of Renal Function Outcomes Between Laparoscopic Partial Nephrectomy with Early Unclamping versus Laparoscopic Partial Nephrectomy with Zero Ischemia
Tse, Richard1; Karreman, Erwin2; Maslany, Jogan1; Knaus, Russel1; Tse, Edward1 1 University of Saskatchewan, Regina, SK, Canada 2 University of Saskatchewan, Regina QuAppelle Health Region, Regina, Saskatchewan
UP-015
Reduction of Renal Parenchymal Volume and Renal Function in Patients after Partial Nephrectomy for Renal Cell Carcinoma (RCC)
Ajzenberg, Henry1; Legere, Laura1; Satkunasivam, Raj2; Finelli, Antonio1; Kachura, John3; OMalley, Martin3; Tuchscherer, Paul4; Quinn, Paul4; Choi, Jung4; Jewett, Michael1 1 Princess Margaret Hospital, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3 Toronto General Hospital, Toronto, ON, Canada; 4Toronto Western Hospital, Toronto, ON, Canada
UP-016
Results of a Survey on the Management of Upper Tract Urothelial Cancer

Zappavigna, Christopher; Rowe, Neal; Morash, Christopher G.; Breau, Rodney; Cagiannos, Ilias University of Ottawa, Division of Urology, Ottawa, ON, Canada
UP-017
Management of Collecting Duct Carcinoma: a Systematic Review, Management Approach, and Case Series
Dason, Shawn1; Sheridan-Jonah, Anna1; Allard, Christopher1; Kajal, Babita2; Aziz, Tariq2; Gill, Jaskirat3; Jamshaid, Hira3; Kapoor, Anil1 1 Division of Urology, McMaster University, Hamilton, ON, Canada, 3Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; 4McMaster University, Hamilton, ON, Canada
UP-018 UP-019
Withdrawn
Improving Outcomes Through the Development of Quality Indicators (QI) in Renal Cell Cancer (RCC)
Finelli, Anthony1; Bjarnason, Georg2; Black, Peter3; Cagiannos, Ilias4; Heng, Daniel5; Kapoor, Anil6; Kollmannsberger, Christian7; Mohammadzadeh, Forough8; Moore, Ronald9; Soulieres, Denis10; Tanguay, Simon11; Venner, Peter12; Jewett, Michael1; Rendon, Ricardo13; Wood, Lori13 1 Princess Margaret Hospital (UHN), Toronto, ON, Canada; 2Sunnybrook Odette Cancer Center, Toronto, ON, Canada; 3Department of Urological Sciences, UBC, Vancouver, BC, Canada; 4 University of Ottawa, Ottawa, ON, Canada; 5Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada; 6Juravinski Cancer Center, Hamilton, ON, Canada; 7BCCA Vancouver Cancer Center, University of British Colombia, Vancouver, BC, Canada; 8UHN, Toronto, ON, Canada; 9Department of Urology, University of Alberta, Edmonton, AB, Canada; 10Department of Medicine, Universit de Montral, Montreal, QC, Canada; 11McGill University Health Center, McGill University, Montreal, QC, Canada; 12Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada; 13QEII HSC, Dalhousie University, Halifax, NS, Canada
UP-020
Rising Incidence of Upper Tract TCC (UTTCC) in Kettering, United Kingdom

1
Khan, Faisal1; Payne, David2; Al-Sudani, Mohammed2; Khan, Zeb2; England, Roland2 Freeman Hospital, Newcastle, United Kingdom; 2NHS, Kettering, United Kingdom
CUA 2012 B A NFF
129
UP-021
The Fer Kinase, a Nuclear Effector of Growth-promoting Factors Favoring Castration-resistant Prostate Cancer
Rocha, Joice1; Zouanat, Fatima1; Benidir, Tarik1; Zoubeidi, Amina2; Hamel, Lucie1; Scarlata, Eleonora1; Aprikian, Armen1; Chevalier, Simone1 1 Urologic Oncology Research Group, McGill University, Montreal, QC, Canada; 2The Vancouver Prostate Cancer, University of British Columbia, Vancouver, BC, Canada
UP-022
Single Photon Emission Computed Tomography/CT Imaging of Metastases Using Prostate Specific Membrane Antigen Antibody
Chevalier, Simone1; Derbekyan, Vilma1; Scarlata, Eleonora1; Moffett, Serge2; Hamel, Lucie1; Zouanat, Fatima1; Aprikian, Armen1; Anidjar, Maurice1 1 McGill University Health Centre Research Institute, Montreal, QC, Canada; 2ProScan, Montreal, QC, Canada
UP-023
130
PSA Bounce Following Prostate Brachytherapy for Clinically Localized Prostate Adenocarcinoma: a Single Institution Study with Minimum 3 Years Follow-up
Nayak, Jasmir; Ong, Aldrich; Bews, Jeff; Chowdhury, Amit; Drachenberg, Darrel University of Manitoba, Winnipeg, MB, Canada
UP-024
UP-025
UP-026
CUA 2012 B A NFF
Is Perineural Invasion in Prostate Biopsies Associated with Adverse Pathological Outcomes? Old Paradigm Revisited
Margel, David1; Elharram, Malik1; Finelli, Antonio1; Zlotta, Alexandre1; Trachtenberg, John1; Evans, Andrew2 1 Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada; 2Department of Pathology, University Health Network, University of Toronto, Toronto, ON, Canada
The Association between Male Pattern Baldness and Second to Forth Finger Ratio with Prostate Cancer: a Prospective Cohort Study
Margel, David; Venkateswaran, Seetha; Darwish, Abbas; Chadwick, Karen; Fleshner, Neil Division of Urology, Department of Surgical Oncology, University Health Network, University of Toronto, Toronto, ON, Canada
Coexisting Prostate Cancer Found at the Time of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia: Predicting Its Presence and Grade in Analyzed Tissue
Bhojani, Naeem; Boris, Ronald S.; Mandeville, Jessica A.; Lingeman, James E. Indiana School of Medicine, Department of Urology, Indianapolis, IN, United States
UP-027
Prostate Cancer Screening: Attitudes and Practices of Family Physicians in Ontario

Allard, Christopher1; Lusis, Janis2; Dason, Shawn1; Kapoor, Anil1 1 McMaster Institute of Urology, Hamilton, ON, Canada; 2Brampton Hospital, Brampton, ON, Canada
UP-028
Transrectal Ultrasound with Vibroelastography for the Detection of Prostate Cancer

Gagnon, Louis-Olivier1; Mahdavi, Sara2; Moradi, Mehdi2; Baghani, Ali2; Jones, Edward3; Salcudean, Septimiu2; Goldenberg, Larry1 1 Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; 2 Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada; 3 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
UP-029
Human Prostate Cancer Magnetic Resonance Elastography and Correlation with Histology
Gagnon, Louis-Olivier1; Sahebjavaher, Ramin2; Garteiser, Philippe3; Sinkus, Ralph3; Baghani, Ali2; Moradi, Mehdi2; Jones, Edward4; Nguan, Chris1; Goldenberg, Larry1; Salcudean, Septimiu2 1 Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; 2 Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada; 3 Hpital Beaujon, Centre de Recherche Biomdicale Bichat Beaujon (CRB3), Paris, France; 4 Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
UP-030
Changes in Positive Surgical Margins over Time Reflect a Risk Migration in Patients Undergoing Radical Prostatecomy at a Tertiary Care Center
Longpre, Michelle; Gleave, Martin; Harriman, David; Hurtado-Coll, Antonio University of British Columbia, Vancouver, BC, Canada
UP-031
Holmium Laser Ablation of the Prostate Gland (HoLAP) Followed by Brachytherapy (BT) for Treatment of Patients with Clinically Localized Prostate Carcinoma (PC) and Obstructive Urinary Symptoms (LUTS)
Kumar, Surendra Oakwood Annapolis Hospital, Wayne, MI, United States
UP-032
Identification of Thrombotic Risk for Men with Advanced Prostate Cancer: a Pilot Study Evaluating Hemostatic Status Using Thromboelastography
Siemens, D. Robert; Toukh, Mazen; Othman, Maha; Black, Angela; Graham, Charles Queens University, Kingston, ON, Canada
CUA 2012 B A NFF
131
UP-033
Predictors of Failing Active Surveillance on the 2nd Prostatic Biopsy

Wong, Lih-Ming1; Trottier, Greg1; Fleshner, Neil1; Lawrentchuk, Nathan1; Kulkarni, Girish1; Zlotta, Alexandre2; Trachtenberg, John1; Toi, Ants3; Finelli, Antonio1 1 Division of Uro-oncology, Princess Margaret Hospital, Toronto, ON, Canada; 2Division of Urology, Mount Sinai Hospital, Toronto, ON, Canada; 3Department of Radiology, Princess Margaret Hospital, Toronto, ON, Canada
UP-034
Prostate Cancer Detection after Multiple Negative Biopsies

Metcalfe, Charles; Metcalfe, Michael; Goldenberg, Larry; Gleave, Martin; Black, Peter; So, Alan University of British Columbia, Vancouver, BC, Canada
UP-035
Intermediate Clinical Outcomes of Robot-assisted Laparoscopic Prostatectomy (RALP)

Wong, Carson1; Gu, Xiao2; Spaliviero, Massimiliano2 1 SouthWest Urology, Inc., Middleburg Heights, OH, United States; 2University of Oklahoma Health Sciences Center, Oklahoma, OK, United States
132
UP-036
Factors Influencing Choice of Robotic-assisted vs. Open Radical Prostatectomy for Prostate Cancer Treatment
Chien, Gary; Chang, Allen; Thomas, Anil; Derboghossians, Armen; Slezak, Jeffrey Kaiser Permanente, Los Angeles, CA, United States
UP-037
UP-038
UP-039
CUA 2012 B A NFF
What Is the Prevalence and Impact of Depression, Anxiety, and Distress in Patients with Newly Diagnosed Localized Prostate Cancer?
Punnen, Sanoj; Cowan, Janet; Whitson, Jared; Carroll, Peter; Cooperberg, Matthew University of California, San Francisco, CA, United States
Autologous Retropubic Urethral Sling: a Novel, Quick, Intraoperative Technique for Improving Continence after Robot-assisted Laparoscopic Prostatectomy
Punnen, Sanoj; Cowan, Janet; Whitson, Jared; Carroll, Peter University of California, San Francisco, CA, United States
Predictors of Gleason 8 Cancer among Men with Gleason 7 and 8 Cancer on Prostate Biopsy Cores
Heimrath, Olivier P.; Belanger, Eric C.; Kos, Zuzana; Cagiannos, Ilias; Morash, Christopher G.; Lavalle, Luke T.; Preston, Mark; Breau, Rodney H. University of Ottawa, Ottawa, ON, Canada
UP-040
Comparison of Serum Testosterone Levels in Prostate Cancer Patients Receiving LHRH Agonist Therapy with or without the Removal of the Prostate
Venkateswaran, Seetha1; Margel, David1; Yap, Stanley1; Hersey, Karen1; Locke, Jennifer1; Yip, Paul2; Fleshner, Neil1 1 Princess Margaret Hospital, Toronto, ON, Canada; 2Toronto General Hospital, Toronto, ON, Canada
UP-041
A Prospective Phase II Trial of Stereotaxic Hypofractionated Cyberknife (CK) Treatment for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy (EBRT)
Fortin, Israel; Bahary, Jean-Paul; Saad, Fred; Ploquin, Laurence; Lambert, Carole; Barkati, Maroie; Nguyen, Thu Van; Waters, Alexandra CHUM, Montreal, QC, Canada
UP-042
Involvement of TBK1 in Prostate Cancer Progression through IKK Cellular Localization Control
1
Huon, Yannick1; Pant, Benjamin1; Mes-Masson, Anne-Marie1; Saad, Fred2 CRCHUM, ICM and Faculty of Medicine, Universit de Montral, Montreal, QC, Canada; 2 CRCHUM, ICM, Faculty of Medicine and Division of Urology, CHUM, Universit de Montral, Montreal, QC, Canada
UP-043
The Association between Aspirin and Non-steroidal Anti-inflammatory Drug Use and the Risk of Prostate Cancer Detection upon Biopsy
Bhindi, Bimal; Margel, David; Fernandes, Kimberly; Trottier, Greg; Hersey, Karen; Finelli, Antonio; Trachtenberg, John; Toi, Ants; Evans, Andrew; van der Kwast, Theodorus; Fleshner, Neil University Health Network, Toronto, ON, Canada
UP-044 UP-045 UP-046
Withdrawn Withdrawn
Active Surveillance for Prostate Cancer in Patients with a PSA >10

Toren, Paul; Timilshina, Narhari; Kulkarni, Girish; Fleshner, Neil; Finelli, Antonio University of Toronto, Toronto, ON, Canada
CUA 2012 B A NFF
133
UP-047
Targeting the Proprotein Convertases in Prostate Cancer

Day, Robert1; DAnjou, Franois1; Couture, Frdric1; Levesque, Christine1; Kwaitkowska, Anna1; Routhier, Sophie1; Desjardins, Roxane1; Gurin, Brigitte2; Doueik, Alexandre3; Carmel, Michel3; Sabbagh, Robert3 1 Institut de pharmacologie de Sherbrooke et Universit de Sherbrooke, Sherbrooke, QC, Canada; 2Centre dimagerie molculaire de Sherbrooke et Universit de Sherbrooke, Sherbrooke, QC, Canada; 3Centre hospitalier universitaire de Sherbrooke et Universit de Sherbrooke, Sherbrooke, QC, Canada
UP-048
Histopathological Features Following Prostate High Intensity Focus Ultrasound Salvage Therapy for Radiation-failure
Autran Gomez, Ana Maria; Chang, Susanne; Gomez-Lemus, Jose; Lee, Linda; Izawa, Jonathan; Chin, Joseph London Health Sciences Centre, University of Western Ontario, London, ON, Canada
UP-049
134
Insight into Dietary Prevention of Prostate Cancer: Effects of Fish Oil and Krill Oil on Inflammation
Moreel, Xavier; Dong, Ruijing; Julien, Pierre; Fradet, Vincent Laval University, Quebec, QC, Canada
UP-050
Inconsistent Testosterone Monitoring and Antiandrogen Use in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
CUA 2012 B A NFF
1 1
Dalla Nora, Sergio1; Shayegan, Bobby2 Ferring Inc., North York, ON, Canada; 2Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada
UP-051
Single Nucleotide Polymorphisms (SNPs) Associated with Late Radiation Toxicity after Prostate Brachytherapy
Leong, Nelson1; Parliament, Matthew1; Martell, Kevin2; Ghosh, Sunita2; Pervez, Nadeem1; Pedersen, John1; Yee, Don1; Murtha, Albert1; Amanie, John1; Usmani, Nawaid1 1 Cross Cancer Institute, Edmonton, AB, Canada; 2University of Alberta, Edmonton, AB, Canada
UP-052
Prostate Cancer Antigen 3 Density Shows Similar Predictive Value of Positive Prostate Biopsy as Prostate Cancer Antigen 3 Alone
Dovirak, Ostap1; Goode, Roland2; Marshall, Susan2; Consiglio, Joseph2; Duff, Michael2; Chevli, Kent2 1 State University of New York at Buffalo, Department of Urology, Buffalo, NY, United States; 2 State University of New York at Buffalo, Buffalo, NY, United States
UP-053
Use of Patient Educational Technologies (PET) by Patients Diagnosed with Prostate Cancer
Carlson, Kevin1; Crump, R. Trafford2; Baverstock, Richard1 University of Calgary, Calgary, AB, Canada; 2University of British Columbia/Centre for Health Services and Policy Research, Vancouver, BC, Canada
UP-054
Comparison of Pathological Outcomes of Radical Prostatectomy in African Americans and Caucasians Who Are Potential Candidates for Active Surveillance
Popovic, Mihailo; Lucas, Steven Wayne State University, School of Medicine, Urology, Detroit, MI, United States
UP-055
Ontarios First 18th Choline Prostate PET Images: Histology and Multi-parametric MRI Correlation
Gibson, Eli1; Rachinsky, Irina2; Gaed, Mena3; Romagnoli, Cesare2; Lee, Ting-Yim1; Gmez, Jos A.4; Moussa, Madeleine4; Crukley, Cathie3; Chin, Joseph L.5; Bauman, Glenn S.6; Ward, Aaron D.7 1 Robarts Research Institute, The University of Western Ontario, London, ON, Canada; 2 Department of Medical Imaging, The University of Western Ontario, London, ON, Canada; 3 Lawson Health Research Institute, London, ON, Canada; 4Department of Pathology, The University of Western Ontario, London, ON, Canada; 5Department of Urology, The University of Western Ontario, London, ON, Canada; 6Department of Oncology, The University of Western Ontario, London, ON, Canada; 7Department of Medical Biophysics, The University of Western Ontario, London, ON, Canada
UP-056
Laparoscopic Robot-assisted Extended Pelvic Lymph Node Dissection for High Risk Prostate Cancer
1
Bladou, Franck1; Luz, Murillo2; Anidjar, Maurice2 McGill University, Jewish General Hospital, Montreal, QC, Canada; 2McGill University, Montreal, QC, Canada
UP-057
Comparative Morbidity between Salvage High Intensity Focused Ultrasound and Cryotherapy for Radiorecurrent Prostate Cancer
Al-Zahrani, Ali; Yutkin, Vladimir; Autran Gomez, Ana Maria; Chin, Joseph Division of Urology, Department of Surgery, London Health Sciences Centre, University of Western Ontario, London, ON, Canada
UP-058
A Nomogram Containing the NF-kappa B p65 Biomarker Predicts Biochemical Recurrence of Prostate Cancer Patients Following Radical Prostatectomy
Gannon, Philippe O.1; Lessard, Laurent1; Stevens, Louis-Mathieu2; Labouba, Ingrid1; Forest, Valrie1; Bgin, Louis R.3; Minner, Sarah4; Tennstedt, Pierre5; Schlomm, Thorsten5; MesMasson, Anne-Marie6; Saad, Fred7 1 Centre de recherche du Centre hospitalier de luniversit de Montral (CRCHUM), Montreal, QC, Canada; 2Division of Cardiac Surgery, CHUM, CRCHUM, Montreal, QC, Canada; 3Division of Anatomic Pathology, Hopital Sacr-Coeur de Montral, Montreal, QC, Canada; 4Institute of Pathology, University Medical Center Hamburg-Eppendorff, Hamburg, Germany; 5MartiniClinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorff, Hamburg, Germany; 6CRCHUM / Institut du cancer de Montral, Department of Medicine, Universit de Montral, Montreal, QC, Canada; 7Division of Urology, CHUM, Universit de Montral, CRCHUM, Montreal, QC, Canada
CUA 2012 B A NFF
135
UP-059
Management of Post Radiation Therapy Complications among Prostate Cancer Patients: a Single Surgeon Experience
Flannigan, Ryan1; Baverstock, Richard2 1 University of British Columbia, Vancouver, BC, Canada; 2vesia [Alberta Bladder Centre], Division of Urology, University of Calgary, Calgary, AB, Canada
UP-060
Salvage High Intensity Focused Ultrasound for Local Prostate Cancer Recurrence after Brachytherapy
1
Alzahrani, Ali1; Yutkin, Vladimir2; Autran Gomez, Ana Maria2; Chin, Joseph2 London Health Sciences Centre, London, ON, Canada; 2Division of Urology, Department of Surgery, London Health Sciences Centre, University of Western Ontario, London, ON, Canada
UP-061
Holmium Laser Transurethral Incision of the Prostate (Hol-TUIP): Predictors of Long Term Outcome
Elshal, Ahmed; Elmansy, Hazem; Elhilali, Mostafa McGill University, Urology Department, Montreal, QC, Canada
136
UP-062
Evaluation of Autonomic Nervous System Activity by 24 Hour Holter Monitorization in Men with Benign Prostate Hyperplasia
CUA 2012 B A NFF
Zorba, Orhan nal; Uzun, Hakki; Cicek, Yuksel; Kirbas, Serkan; Erdogan, Turan; Yazar, Selim Rize University, Rize Medical Faculty, Rize, Turkey
UP-063
Randomized Double-blind Placebo Controlled Trial of Intradetrusor Injections of Botulinum Toxin for the Treatment of Refractory Overactive Bladder Secondary to Benign Prostatic Hyperplasia
Elterman, Dean; Lee, Daniel; Sheth, Seema; Chughtai, Bilal; Lee, Richard; Kaplan, Steven; Te, Alexis Weill Medical College of Cornell University, New York, NY, United States
UP-064
Evaluation of Prostate Cancer Cells Responsiveness to an EGFR Targeting Combi-molecule

Poisson, Alexis; Delvoye, Nathalie; Le Page, Cecile; Peant, Benjamin; Mes-Masson, AnneMarie; Saad, Fred ICM/CHUM, Montreal, QC, Canada
UP-065
Dynamic MRI Urethrography: Fluid Turbulence in a Urethral Stricture Model

Moles, Jonathan; Thornhill, Rebecca; Shabana, Wael; Saltel, Eric The Ottawa Hospital, Ottawa, ON, Canada
UP-066
Spicing up Radiation Treatment for Prostate Cancer

Venier, Natalie1; Colquhoun, Alexandra1; Loblaw, Andrew D.1; Fleshner, Neil2; Klotz, Laurence1; Venkateswaran, Vasundara1 1 Sunnybrook Health Sciences Centre, Toronto, ON, Canada; 2Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
UP-067
Canadian Urology Resident Scholarly Performance

Andrews, J. Matthew; Norman, Richard W. Department of Urology, Dalhousie University, Halifax, NS, Canada
UP-068
Virtual Problem-based Learning (PBL): a Needs Assessment Examining Traditional versus Virtual Problem-based Learning
Mickelson, Jennie1; Lim, Rachel2; Amandeep, Ghuman2; Gourlay, William2; Masterson, John2; MacNeily, Andrew2 1 University of British Columbia , Department of Urologic Sciences, Vancouver, BC, Canada; 2 University of British Columbia, Vancouver, BC, Canada
UP-069
A National Survey of Chief Residents on the Communicator Role in Urology Residency: Are We Communicating the Message?
Roberts, Gregory; Fuoco, Michael; Beiko, Darren; Touma, Naji; Siemens, Robert Queens University, Urology, Kingston, ON, Canada
UP-070
Is Online Script Concordance Test a Good CPD Tool to Induce Reflection on Controversial Issues in the Management of Prostate Cancer?
1
Bnard, Franois1; St-Germain, France2; Lamoureux, Cristine1; Saad, Fred3; Charlin, Bernard1 University of Montreal, Montreal, QC, Canada; 2Sano-Aventis Canada, Laval, QC, Canada; 3 Centre hospitalier universitaire de lUniversit de Montral (CHUM), Montreal, QC, Canada
UP-071
A Systematic Review on the Effect of Lysine Analogs on Blood Loss and Transfusion Requirements during Pelvic Surgery
Punjani, Nahid1; Kokolo, Madzouka B.2; Fergusson, Dean A.2; Cagiannos, Ilias3; Knoll, Gregory4; Momoli, Franco2; Morash, Chris3; Lavalle, Luke T.3; Tinmouth, Alan5; Breau, Rodney H.3 1 University of Ottawa, Ottawa, ON, Canada; 2Ottawa Hospital Research Institute, Ottawa, ON, Canada; 3University of Ottawa - Division of Urology, Ottawa, ON, Canada; 4University of Ottawa - Division of Nephrology, Ottawa, ON, Canada; 5University of Ottawa - Division of Clinical Hematology, Ottawa, ON, Canada
UP-072
Antibiotic Prophylaxis Prescribing Patterns for Trans-urethral Resection of Prostate: a Need for Canadian Guidelines?
1
Lawson, Keith1; Vicas, Ingrid2; Hofmeister, Marianna2; Lockyer, Jocelyn2; Carlson, Kevin1 Division of Urology, University of Calgary, Calgary, AB, Canada; 2Physician Learning Program, University of Calgary, Calgary, AB, Canada
CUA 2012 B A NFF
137
UP-073
En Bloc Vascular Stapling of Renal Hilum during Laparoscopic Nephrectomy

McKay, Jeffrey1; Goodman, Saul2; Neville, Christopher3; Cripps, Stephanie4; Perks, Alexandra4 1 University of British Columbia, Chilliwack, BC, Canada; 2Fraser Health Authority, Chilliwack, BC, Canada; 3Fraser Health Authority, Abbotsford, BC, Canada; 4Fraser Health Authority, Langley, BC, Canada
UP-074
Evaluation of Autonomic Nervous System Activity by 24 Hour Holter Monitorization in Women with Idiopathic Overactive Bladder
Zorba, Orhan nal; Uzun, Hakki; Cicek, Yuksel; Kirbas, Serkan; Bostan, Mehmet Rize University, Rize Medical Faculty, Rize, Turkey
UP-075
Seasonal Variation in Urological Pelvic Pain Syndromes: Seven Years of Google Search Trends
1
138
Roberts, Gregory1; Williamson, Tyler2; Teichman, Joel3; Nickel, Curtis1 Queens University Urology, Kingston, ON, Canada; 2Centre for Studies in Primary Care, Kingston, ON, Canada; 3Department of Urological Sciences, University of British Colombia, Vancouver, BC, Canada
UP-076
UP-077
UP-078
UP-079
CUA 2012 B A NFF
Sub-inhibitory Antibiotic Concentrations Negatively Affects Both the Uropathogen Staphylococcus Saprophyticus and Host Immune Responses
Fahmy, Nader; Fuller, Andrew; Goneau, Lee; MacDonald, Kyle; Erdeljan, Petar; Bathini, Varunkumar; Razvi, Hassan; Cadieux, Peter The University of Western Ontario, London, ON, Canada
First Inflatable Penile Prosthesis Infections and a Proposed Survey for Post-implant Monitoring
Narayanan, Ramkishen; Aliotta, Jessica; Leung, Tony; Duff, Michael; Barlog, Kevin; Chevli, K. Kent University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY, United States
How Many Semen Samples Are Required to Make the Diagnosis of Azoospermia?
Khambati, Aziz1; Jarvi, Keith2; Lo, Kirk2 1 University of Toronto Urology, Toronto, ON, Canada; 2Mount Sinai Hospital, Toronto, ON, Canada
Fertility of Patients with a History of Bilateral Cryptorchidism Treated: a Comparative Study about 120 Patients
Mallat, Faouzi; Hmida, Wissem; Hidoussi, Adnen; Slama, Adel; Jaidane, Mehdi; Ben Sorba, Nebil; Mosbah, Ali Faouzi Department of Urology, Sahloul, Sousse, Tunisia
UP-080
Spectrum of Ureteropelvic Junction Obstruction (UPJO) Morphological Characteristics from Infancy to Adulthood and Implications in Surgical Management
Romao, Rodrigo L.P.1; Foell, Kirsten2; Figueroa, Victor1; Lorenzo, Armando J.1; Farhat, Walid1; Pace, Kenneth T.2; Bagli, Darius1; Koyle, Martin1; Honey, R. John DA.2; Pippi Salle, Joao L.1 1 The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada; 2St. Michaels Hospital, University of Toronto, Toronto, ON, Canada
UP-081
The Challenge and Morbidity of Intermittent Ureteropelvic Junction Obstruction (IUPJO) in Children
Romao, Rodrigo L.P.; Figueroa, Victor H.; Pippi Salle, Joao L.; El-Naeema, Aziza; Lorenzo, Armando J.; Bagli, Darius; Farhat, Walid; Koyle, Martin The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
UP-082
Role of Magnetic Resonance Urography in Girls with Urinary Incontinence: a Single Centre Experience
Figueroa, Victor H.; Chavhan, Govind; Romao, Rodrigo L.P.; Lee, Justin K.; Pippi Salle, Joao L.; Bagli, Darius J.; Koyle, Martin A.; Lorenzo, Armando J.; Farhat, Walid The Hospital for Sick Children, Toronto, ON, Canada
UP-083
Peristeen Anal Irrigation as a Substitute of Mace Procedure in Children Who Are in Need of Reconstructive Bladder Surgery
Alhazmi, Hamdan; Alenezi, Husain; Salem, Mahmoud; Fouda Neel, Khalid King Saud University, Riyadh, Saudi Arabia
UP-084
Hemorrhagic Cystitis Secondary to BK Virus: a Case Report of Management with Intravesical Cidofovir in the Pediatric Patient and Review of Literature
Bidnur, Samir; Wu, Christopher; Rassekh, Rod; Mickelson, Jennifer; MacNeily, Andrew University of British Columbia, Vancouver, BC, Canada
UP-085
The Use of EMLA Cream During Circumcision: a Prospective Study about Sixty Children
Mallat, Faouzi; Hmida, Wissem; Hidoussi, Adnen; Slama, Adel; Jaidane, Mehdi; Ben Sorba, Nebil; Mosbah, Ali Faouz Department of Urology, Sahloul, Sousse, Tunisia
UP-086
Glandular Amputation during Circumcision: a Review of 12 Cases Results of a New Technique for Glans Self-transplantation
Mallat, Faouzi; Hmida, Wissem; Hhidoussi, Adnen; Slama, Adel; Jaidane, Mehdi; Mosbah, Ali Faouzi Urology, Sahloul, Sousse, Tunisia
CUA 2012 B A NFF
139
UP-087
Cystic Intratesticular Lesions in Pediatric Patients: a Retrospective Case Series

Hoag, Nathan; Afshar, Kourosh; Youssef, David; Masterson, John; Murphy, James; MacNeily, Andrew University of British Columbia, Vancouver, BC, Canada
UP-088
Retrospective Review of Diagnosis of Testicular Torsion in Boys Presenting to Pediatric Emergency Department with Acute Scrotal Pain
Liang, Teresa1; Metcalfe, Peter2; Sevcik, William2; Noga, Michelle2 1 University of British Columbia, Burnaby, BC, Canada; 2University of Alberta, Edmonton, AB, Canada
UP-089
Penoscrotal Lymphedema: Sexuality, Fertility, Functional and Aesthetic Outcome of the Surgical Treatment - Our Experience about 14 Cases
Mallat, Faouzi; Hmida, Wissem; Hidoussi, Adnen; Slam, Adel; Jaidane, Mehdi; Ben Sorba, Nebil; Mosbah, Ali Faouzi Department of Urology, Sahloul, Sousse, Tunisia
140
UP-090
Comparison of Apoptotic Gene Expression Profiles between Peyronies Disease Plaque and Control Tunica Albuginea
CUA 2012 B A NFF
Zorba, Orhan nal1; Ozgon, Gulay2; Sirma, Sema2; Ozbek, Ugur2; Kadoglu, Ates2 1 Rize University, Rize Medical Faculty, Rize, Turkey; 2Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
UP-091
Climacturia Post-prostatectomy Remains a Largely Unknown Clinical Entity in Contemporary Urologic Training Based on Results Obtained at a Resident Training Laboratory
Zappavigna, Christopher1; Christine, Brian2; Bella, Anthony J. 1 University of Ottawa, Division of Urology, Ottawa, ON, Canada; 2Urology Centers of Alabama, Birmingham, AL, United States
UP-092
Post-prostatectomy Penile Rehabilitation and Erectile Dysfunction Treatment: Senior Resident Perceptions and Institutional Practices Based on Results Obtained at a Resident Training Laboratory
Zappavigna, Christopher; Bella, Anthony J. University of Ottawa, Division of Urology, Ottawa, ON, Canada
UP-093
Leadership in Canadian Urology: What Is the Right Stuff?
Robinson, Michael; MacNeily, Andrew; McInnes, Colin; Lennox, Peter; Carr, Nicholas; Skarlicki, Daniel; Masterson, John; Arneja, Jugpal University of British Columbia, Vancouver, BC, Canada
UP-094
What Is the Best Local Anesthesia during Extracorporeal Shockwave Lithotripsy? Prospective Randomized Clinical Study Comparing EMLA and Lidocaine
Mallat, Faouzi; Hmida, Wissem; Hidoussi, Adnen; Slama, Adel; Jaidane, Mehdi; Ben Sorba, Nebil; Mosbah, Ali Faouzi Urology, Sahloul, Sousse, Tunisia
UP-095
Trans-splenic Percutaneous Nephrolithotomy with Secondary Procedure via the Same Tract
Bhojani, Naeem; Mandeville, Jessica A.; Boris, Ronald S.; Lingeman, James E. Indiana School of Medicine, Department of Urology, Indianapolis, IN, United States
UP-096
Uric Acid Stone Prevalence Doubles in the Severely and Morbidly Obese (BMI>35) Compared to the Overweight (BMI 25-30)
Sivalingam, Sri; Penniston, Kris; Nakada, Stephen Y. University of Wisconsin, Madison, WI, United States
UP-097
Targeted Intervention versus Conservative Intervention for the Prevention of Kidney Stone Recurrence
Arsovska, Olga; Wu, Christopher; Sutton, Roger A. L.; Paterson, Ryan F.; Chew, Ben H. University of British Columbia, Vancouver, BC, Canada
UP-098
Pulsed Fluoroscopy in Ureteroscopy and Percutaneous Nephrolithotomy

UP-099
Laparoscopic Nephrectomy with Intact Specimen Extraction for Massive Polycystic Kidney Disease: Updated Technique and Outcome Analysis
Bansal, Rahul Kumar; Tu, Hin Yu Vincent; Kapoor, Anil McMaster Institute of Urology, St. Josephs Healthcare Hamilton, Hamilton, ON, Canada
UP-100
Urologists in Cyberspace: Evaluating Quality of American Urologists Websites on the Internet

Yan, Hanmu; Margel, David; Fleshner, Neil; Wong, Lih-Ming Department of Urology, Princess Margaret Hospital, Toronto, ON, Canada
UP-101
Robotic-assisted Microsurgery: the Initial 603 Case Experience

Gudeloglu, Ahmet; Priola, Karen; Parekattil, Sijo University of Florida and Winter Haven Hospital, Winter Haven, FL, United States
CUA 2012 B A NFF
141
UP-102
Assessment of the Understanding of Androgen Deprivation Therapy (ADT) Associated Side Effects in Primary Care Physicians
Soeyonggo, Tony1; Locke, Jennifer1; Del Giudice, Lisa2; Alibhai, Shabbir3; Fleshner, Neil4; Warde, Padraig5 1 Faculty of Medicine, University of Toronto, Toronto, ON, Canada; 2Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; 3Department of Medicine, University Health Network, Toronto, ON, Canada; 4Department of Surgery (Urology), Princess Margaret Hospital, Toronto, ON, Canada; 5Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
UP-103
Senior Resident Perceptions of Industry Interaction with Prosthetic Urologists Based on Results Obtained at a Resident Training Laboratory
Zappavigna, Christopher; Bella, Anthony J. University of Ottawa, Division of Urology, Ottawa, ON, Canada
142
UP-104
Factors Affecting Surgical Performance and Operating Room Safety in Urology: a Preliminary Evaluation
Lee, Jason Y.1; Gettman, Matthew2; Landman, Jaime3; McDougall, Elspeth M.3; Sundaram, Chandru P.4; Sweet, Robert5; Zorn, Kevin C.6 1 St. Michaels Hospital, University of Toronto, Toronto, ON, Canada; 2Mayo Clinic, Rochester, MN, United States; 3University of California - Irvine, Orange, CA, United States; 4Indiana University, Indianapolis, IN, United States; 5University of Minnesota, Minneapolis, MN, United States; 6University of Montreal (CHUM), Montreal, QC, Canada
UP-105
UP-106
UP-107
CUA 2012 B A NFF
The Management of Post-transplant Lymphoceles: Changes in Practice at lHtel-Dieu de Qubec
Deschnes-Rompr, Marie-Pier; Diallo, Yoro; DeSerres, Sacha; Houde, Isabelle; Caumartin, Yves Centre hospitalier universitaire de Qubec, Quebec, QC, Canada
Factors Associated with an Increased Risk of Delayed Graft Function in Donation after Cardiac Death Kidneys
Boyle, S.L.1; McGregor, Thomas B.2; Moser, Mike3; Sharpe, Mike3; Luke, Patrick3 1 The University of Western Ontario, Department of Surgery, Division of Urology, London, ON, Canada; 2University of Manitoba, Department of Surgery, Division of Urology, Transplant and MIS, Winnipeg, MB, Canada; 3The University of Western Ontario, Department of Surgery, Division of Urology and Transplant, London, ON, Canada
Debilitating Lower Urinary Tract Symptoms in the Post-renal Transplant Population Can Be Predicted Pre-transplantation
Dion, Marie; Cristea, Octav; Langford, Sarah; Luke, Patrick; Sener, Alp University of Western Ontario, London, ON, Canada
UP-108
Thymoglobulin Differentially Increases CDR Naive T-cell Proliferation Following Renal Transplantation
Ullah, Shahnoor1; Telfer, Siobhan2; Mok, Amy3; Jevnikar, Anthony4; Luke, Patrick2; Sener, Alp5 1 Schulich School of Medicine, The University of Western Ontario, London, ON, Canada; 2 Department of Surgery, The University of Western Ontario, London, ON, Canada; 3Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada; 4 Department of Medicine, The University of Western Ontario, London, ON, Canada; 5 Department of Surgery, Department of Microbiology and Immunology, The University of Western Ontario, London, ON, Canada
UP-109
Retubularization of the Ileocystoplasty Pouch for Conversion into an Ileal Conduit Diversion
Massaro, Peter; Gajewski, Jerzy; Bailly, Greg Department of Urology, Dalhousie University, Halifax, NS, Canada
UP-110
Conservative Management of High Post-void Residual Urine in Asymptomatic Men; Retrospective Analysis of Outcomes
Kalyanaraman, Balaji; Bracken, R. Bruce University of Cincinnati, Cincinnati, OH, United States
UP-111
No Show Rates for Follow-up after Visual Internal Urethrotomy: a Single Surgeon Experience
1
Patel, Premal1; Baverstock, Richard2 University of Calgary, Calgary, AB, Canada; 2vesia [Alberta bladder centre], Calgary, AB, Canada
UP-112
Genitourinary Tuberculosis or Not Genitourinary Tuberculosis: Case Series and Critical Look at the Challenging Diagnosis of Genitourinary Tuberculosis
Boyle, Shawna1; Amman, Justin2; Chin, Joseph3; Paulter, Stephen3; Denstedt, John3; Izawa, Jonathan3; Razvi, Hassan3 1 University of Western Ontario, London, ON, Canada; 2Department of Medical Imaging, The University of Western Ontario, London, ON, Canada; 3Division of Urology, Department of Surgery, The University of Western Ontario, London, ON, Canada
UP-113
Common Urological Presentations of the Penitentiary Population in Kingston: a Chart Review

Lee, Taehyoung; Leveridge, Michael; Touma, Naji Queens University, Kingston, ON, Canada
CUA 2012 B A NFF
143
UP-114
Targeted Robotic-assisted Microsurgical Denervation of the Spermatic Cord for Chronic Orchialgia
Gudeloglu, Ahmet; Wharton, Jessica; Priola, Karen; Parekattil, Sijo University of Florida and Winter Haven Hospital, Winter Haven, FL, United States
UP-115
Should Large Adrenal Myelolipomas (>6cm) Be Removed? Case Series and Review of Literature
Michael, Amanda; Elias, Rami; Kapoor, Anil McMaster University, Hamilton, ON, Canada
UP-116
Withdrawn
144
CUA 2012 B A NFF
INVITED SPEAKERS INDEX / INDEX DES CONFRENCIERS INVITS
Bailly, Greg G. Bnard, Franois Brock, Gerald Carlson, Kevin Chetner, Michael Donnelly, Bryan Dushinski, John Fleshner, Neil Foster, Richard Izawa, Jonathan Jacobsen, Niels Jarvi, Keith Jordan, Gerald Kapoor, Anil Kassouf, Wassim Kodama, Ron McVary, Kevin Monga, Manoj Moyad, Mark Nguyen, Hiep Nickel, Curtis Nitti, Victor Rourke, Keith Satava, Richard Schuler, Trevor Shayegan, Bobby Schoenberg, Mark Siemens, Robert So, Alan Sogani, Pramod C. Whelan, Paul
EF5 EF8 EF8 EF5 AUA, welcome EF6 EF1 EF6, EF7 SOA3 EF3 CP1 CUASS EF2, SOA2 CP2 EF3 EF2 SOA6 SOA1 SOA5 SOA8 EF4, EF8 EF5, SOA7 EF2 SOA9 EF1 EF3 SOA4 EF6 EF7 AUA EF4
CUA 2012 BA NFF
145
A Abdulla, Alym B Bach, Phil
PRESENTER INDEX / INDEX DES PRSENTATEURS
POD-04.03 UP-015 UP-003 UP-010 MP-03.10 UP-083 MP-03.01, MP-03.16, UP-027 MP-03.11 UP-057, UP-060 UP-067 UP-022 POD-01.02 MP-02.16, UP-097 MP-01.12, MP-06.05, UP-048
Ajzenberg, Henry Akhter, Waseem Al Esawi, Anwar Alamri, Abdulaziz Alhazmi, Hamdan Allard, Christopher Alyami, Fahad Al-Zahrani, Ali Andrews, J. Matthew Aprikian, Armen Archambault, Jason
Braga, Luis
146
Arsovska, Olga Autran Gomez, Ana Maria
Bachir, Bassel G. Barrett, Keith
Bacsu, Chasta-Dawne Baverstock, Richard Bnard, Franois Bhindi, Bimal Bhojani, Naeem Bidnur, Samir Binsaleh, Saleh Black, Peter
Bishr, Mohamed Bladou, Franck
Blais, Jean-Philippe Bostrom, Peter J. Boyle, Shawna
Blouin, Annie-Claude
CUA 2012 B A NFF
MP-04.03 POD-02.03, MP-03.03 POD-04.04, MP-04.02 MP-04.07 MP-04.09, MP-04.23 UP-070 UP-043 MP-02.01, MP-02.02, MP-02.15, MP-02.17, UP-026, UP-095 UP-084 MP-04.08 MP-03.14, MP-07.12 POD-03.06, MP-09.07 UP-004, UP-056 UP-006 MP-03.12 MP-07.09 UP-106, UP-112 POD-03.03, MP-05.06

C Campeau, Lysanne D Dason, Shawn Chien, Gary Choo, Richard Cole, Eric Cox, Ashley Davis, Jeffrey Day, Robert De, Shubha Carlson, Kevin Chang, Michelle E Elharram, Malik Chin, Joseph L. Dion, Marie Donnelly, Bryan Dovirak, Ostap Elias, Rami Elkoushy, Mohamed Elliott, Daniel Elsawy, Mohamed Elshal, Ahmed Elterman, Dean Chapman, David
MP-09.05, MP-09.06 MP-04.22 MP-04.18 MP-09.02 MP-01.20, UP-036 UP-055 MP-07.11 MP-05.04 MP-01.07, MP-05.08 MP-04.20 UP-053
Cloutier, Jonathan
Crump, R. Trafford
MP-01.11, MP-01.21 MP-02.03, MP-03.23 UP-047 MP-02.12 POD-02.06 UP-107 UP-001 POD-05.06 UP-052
CUA 2012 BA NFF
Desantis, Darren
Deschnes-Rompr, Marie-Pier UP-105 Djahangirian, Orchide
UP-024 UP-007 MP-02.19 MP-08.10 MP-05.10 UP-061 MP-04.19, UP-063
Elhilali, Mostafa
POD-01.04, MP-02.07, MP-02.09, MP-02.18, UP-098
147
F Fahmy, Nader Fairey, Adrian
G Gagnon, Louis-Olivier H-I Hamidizadeh, Reza Figueroa, Victor H. Finelli, Antonio Fleshner, Neil Foell, Kirsten Fortin, Israel Flannigan, Ryan Fuoco, Michael J-K Jewett, Michael A.S.
UP-076 POD-05.04, MP-03.05 MP-05.01, MP-05.14, UP-082 UP-019 UP-059 UP-102 MP-02.05 UP-041 UP-069
MP-01.14, UP-028, UP-029 MP-04.17 MP-06.02, MP-06.03 POD-04.05 MP-06.07, UP-101, UP-114 MP-04.05
Kanaroglou, Niki
148
Gajewski, Jerzy Garcia, Maurice
Garcia, Francisco
Gudeloglu, Ahmet Gustafson, Paul
Hamilton, Robert Han, Kyungseok
Heimrath, Olivier P. Herschorn, Sender Hoag, Nathan Hoy, Nathan
Huon, Yannick Izard, Jason
Ismail, Salima
Kaler, Kamaljot
Kalyanaraman, Balaji
CUA 2012 B A NFF
MP-02.10 POD-02.04 MP-09.01, MP-09.03 UP-039 MP-04.11, MP-04.12 UP-087 MP-04.10, MP-05.13 UP-042 MP-03.13 MP-01.16, MP-01.17, MP-07.03, MP-08.11
UP-013 MP-08.01 UP-110 MP-05.07

L Labouba, Ingrid Kapoor, Anil Khambati, Aziz Khan, Faisal Klotz, Laurence Langille, Gavin Lavalle, Luke Lawson, Keith Lee, Jason Y.
M Maciejewski, Conrad Kinnaird, Adam S. Klinghoffer, Zachary Kumar, Surendra Lee, Taehyoung Leong, Nelson Liang, Teresa Lobb, Ian Levine, Max A. Longpre, Michelle MacLellan, Dawn Mallat, Faouzi Margel, David Massaro, Peter McKay, Jeffrey Melnyk, Megan Metcalfe, Charles Metcalfe, Michael Michael, Amanda Mickelson, Jennifer J. Moles, Jonathan
MP-03.09 UP-078 MP-07.08, UP-020 POD-04.06 POD-01.05, MP-06.08 UP-066 UP-031
MP-09.10, UP-058 MP-06.09 MP-01.19 MP-03.07, UP-072 UP-104 UP-113 UP-051 MP-04.06 UP-088 MP-03.18 UP-030
CUA 2012 BA NFF
MP-05.12 MP-09.04
UP-079, UP-085, UP-086, UP-089, UP-094 MP-01.02, MP-09.08, UP-025, UP-040 MP-02.20, UP-109 UP-073 MP-08.04, MP-08.06 MP-03.15, UP-034 MP-03.02 UP-008, UP-115 UP-068 UP-065
149
N Nam, Robert
O-P Olesen, Jamie Nguyen, Tim Nitti, Victor North, Scott
Morales, Alvaro Morales, Carlos Moreel, Xavier R Ramsay, Sophie Nayak, Jasmir Nguyen, Laura Nickel, J. Curtis
MP-07.01 MP-03.08 UP-049 POD-05.05 UP-077 POD-05.03, UP-011, UP-023 MP-08.02 MP-08.05 MP-08.07, MP-08.08, UP-075 POD-04.01 POD-02.02
Narayanan, Ramkishen
Rutkowski, John
150
POD-03.02 POD-01.01, MP-03.17, MP-03.19 UP-111 MP-05.09 UP-064 MP-04.04, UP-054 MP-09.11 POD-05.02, MP-01.09 UP-002, UP-071 MP-01.04, MP-01.10, MP-01.15, UP-037, UP-038
Ordon, Michael Patel, Premal
Pippi Salle, Joao L. Poisson, Alexis Popovic, Mihailo Pouliot, Frdric Punjani, Nahid Punnen, Sanoj
Preston, Mark A.
Razvi, Hassan
Rhee, Jonathan Rocha, Joice
Robinson, Michael
Romao, Rodrigo L.P. Rourke, Keith Rowe, Neal
CUA 2012 B A NFF
MP-04.21 POD-01.06 MP-07.06 MP-02.11, UP-093 UP-021 POD-03.01, UP-080, UP-081 MP-08.09 MP-01.01 UP-009

S Saad, Fred T Toren, Paul
U-V-W Ullah, Shahnoor Sheikh, Adeel Sivalingam, Sri Skeldon, Sean Stearns, Gillian Stothers, Lynn Tran, Kim-Chi Tse, Richard
POD-02.01, POD-05.01 MP-07.04, MP-07.05, MP-07.07, UP-005 MP-06.01 UP-050 MP-05.02 UP-017 MP-01.22, UP-032 MP-02.04, MP-02.06, MP-02.08, MP-02.14, UP-096 MP-01.18, MP-06.04 MP-05.11 MP-07.10 MP-05.03 MP-04.13 MP-04.14, MP-04.15 MP-01.05
CUA 2012 BA NFF
Sandhu, Gurdarshan Shamloul, Rany Shayegan, Bobby Sheridan-Jonah, Anna Siemens, D. Robert
Spelliscy, Courtney Stakhovskyi, Oleksandr Steele, Stephen S. Suntharasivam, Thiru
POD-02.05, MP-04.01, UP-046 MP-03.21 UP-014 UP-099
Tu, Hin Yu Vincent
UP-108 MP-09.09 POD-03.05 MP-04.16 POD-03.04 MP-08.03, MP-08.12 MP-05.05 UP-035
van Rhijn, Bas W.G. Violette, Philippe Wang, Xinmin Weber, Bryce Welk, Blayne Wildgoose, Petra Wong, Carson Wong, Lih-Ming
MP-01.06, MP-01.08, UP-033
151
Y-Z Yafi, Faysal A. Yan, Hanmu Yanko, Daniel Yap, Stanley
MP-07.02 UP-100 MP-03.22 MP-03.04, MP-03.06 MP-01.03 POD-01.03 MP-06.06, UP-016, UP-091, UP-092, UP-103 UP-012 MP-03.20 UP-062, UP-074, UP-090 POD-04.02, MP-01.13
Yutkin, Vladimir Zadra, Joseph Zappavigna, Christopher Zareba, Piotr Zhu, Justin Zorba, Orhan nal Zorn, Kevin
152
CUA 2012 B A NFF

CUA 2012: Final Programme

Hochgeladen von

Dokumentinformationen

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

CUA 2012: Final Programme

Hochgeladen von

Copyright:

Verfügbare Formate

GENERAL INFORMATION

TABLE OF CONTENTS / TABLE DES MATIRES

SPONSORS AND EXHIBITORS / COMMANDITAIRES ET EXPOSANTS

SCIENTIFIC PROGRAM / PROGRAMME SCIENTIFIQUE DETAILED PROGRAM / PROGRAMME DTAILLS INDEX

TABLE OF CONTENTS / TABLE DES MATIRES

CUA 2012 BA NFF

Co-chairs, CUA 2012 Local Organizing Committee

CUA 2012 B A NFF

MESSAGE FROM THE CUA PRESIDENT

CUA 2012 BA NFF

EXECUTIVE COMMITTEE ANNUAL MEETING PLANNING COMMITTEE

CUA EXECUTIVE AND COMMITTEES

President President-Elect Past-President Vice-President Treasurer

Vladimir Kurgansky Christopher Morash

CONTINUING PROFESSIONAL DEVELOPMENT COMMITTEE ENDORSEMENT COMMITTEE

Joseph Chin, Chair Michael Chetner Sender Herschorn Denis Lavoie

CUA 2012 B A NFF

FINANCE COMMITTEE HISTORIAN

CUA EXECUTIVE AND COMMITTEES

INFORMATION TECHNOLOGY COMMITTEE

Marty Duffy and Howard Evans, Co-Chairs

Christopher Nguan, Chair Mike Leveridge

CUA 2012 BA NFF

POST-GRADUATE TRAINING COMMITTEE

CUA EXECUTIVE AND COMMITTEES

CUASF EXECUTIVE COMMITTEE CUASF ADMINISTRATIVE COMMITTEE CUASF SCIENTIFIC COUNCIL

CUA/ASTELLAS GRANT PROGRAM, SCIENTIFIC COUNCIL

CUA 2012 B A NFF

BOOK OF ABSTRACTS at the Kid's lounge

CERTIFICATE OF ATTENDANCE at the Kids'lounge (from 14:00)

3 Activities, snacks and lunch, on Monday

SPEAKER READY ROOM UNMODERATED POSTER DISPLAYS 5-STAR POSTERS

Found items should be handed in promptly to staff at the Registration Desk.

CUA 2012 B A NFF

LEARNING OBJECTIVES AND CANMEDS ROLE COMPETENCIES OBJECTIVES

CONTINUING PROFESSIONAL DEVELOPMENT

CUA 2012 BA NFF

FUTURE CUA MEETINGS

68th CUA 69th CUA

2015 2016 2017

Niagara Falls, ON Sheraton on the Falls Hotel

70th CUA 71st CUA

St. Johns, NL Delta St. Johns Hotel & Conference Center

Ottawa, ON The Westin Ottawa Hotel

Vancouver, BC The Westin Bayshore Hotel 9

Toronto, ON Westin Harbour Castle Hote

2014 ST. JOHNS

2013 NIAGARA FALLS

FLOOR PLAN OF THE FAIRMONT BANFF SPRINGS HOTEL

CUA 2012 BANFF

SOCIAL PROGRAM GRID

Breakfast & Private concierge Services

Opening Brunch VanHorne BC

Fun Activities, Dinner & Entertainement

Kid's Lounge: Norquay room

Breakfast & Private concierge Services

Lobby The Fairmont Banff Springs Hotel

Breakfast & Private concierge Services:

Companion's Lounge: Oak room

CUA 2012 B A NFF

Banff Springs Kid's Club

Fun Activities, Dinner & Entertainement

Kid's lounge: Norquay room